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CHAPTER ONE
INTRODUCTION AND LITERATURE REVIEW
Introduction
Molecular archeologists have uncovered trace evidence to suggest that 
early during evolution the first form of genetic information was the self-replicating 
RNA molecule (Doudna and Cech, 2002). Despite the lack of direct physical 
evidence, this  is  not hard to believe especially given the wide variety of RNA 
tertiary structures and their ability to carry out heterogeneous enzymatic 
reactions. As early RNA molecules self-replicated, mutations  must have been 
introduced that improved the fitness of the molecules (Joyce, 2002; Doudna and 
Cech, 2002).
It is  estimated that the dominance of the RNA world ended almost four 
billion years ago (Joyce, 2002). The exact selective pressure that favored the 
evolution of the heritable genetic material from RNA to DNA is unknown. Perhaps 
as the environmental milieu continued to change so too did the chemistry of 
RNA until it evolved into its more stable relative, DNA. A possible mechanism of 
DNA evolution may be based on an RNA template, as is the case in cilate 
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genome replication. Studies on genomic replication in the cilate Oxytricha trifallax 
researchers have uncovered a unique role for two forms of RNA: small RNAs 
and long macronuclear RNA. Two nuclei exist that house the genomic DNA, 
albeit in different forms. The mirconucleus is small in volume and envelops 
germline DNA. The larger macronucleus contains fragmented genomic DNA, or 
somatic DNA, in copies as high as 1000 copies per of individual gene. Genes in 
the micronucleus are “scrambled” whereas DNA in the macronucleus is 
organized to code for complete genes. It is  postulated that small RNAs in the 
micronucleus bind to short repeat sequences (or “pointers”) that aid in correctly 
joining the gene fragments resulting in sense DNA. During development DNA in 
the parental macronucleus is  transcribed to produce long macronuclear RNAs, 
which then provides  the template for unscrambling the DNA strands in the 
developing macronucleus (Mochizuki, 2010 and Nowacki et. al., 2008). The 
process of RNA-directed reorganization of DNA also occurs  in Tetrahymena 
thermophila and the mitochondrian of Diplonema papillatum. Circumstantially, the 
RNA-directed editing of genomic DNA may be the same mechanism of how 
nucleotides evolved into the more stable DNA strand of ancestral simple 
eukaryotes and, thus, multicellular organisms. Though the RNA-dominant world 
has long been extinct, the importance of RNA in biological processes remains 
evident (Joyce, 2002).   
Today, the Central Dogma of biology states that the genetic content of 
DNA is  converted, or transcribed, into messenger RNA (mRNA) (Crick, 1970). 
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The information contained within the mRNA is then translated into protein. 
Regulation of the transcription process is essential to ensure that genes are 
appropriately expressed, i.e. at the right time, in the correct location, in the 
required amount, and in coordination with the proper subset of associated genes. 
(Lewin, 1997; Little, 1999; Alberts, 1994)
Why study transcription? First, the inability to properly regulate 
transcription often disrupts cellular homeostasis, which can lead to undesirable 
events, such as  disease or the loss of organismal fitness (Lewin, 1997; Alberts, 
1994; Calkhoven, 1996). To understand how improper transcription impacts  the 
etiology of disease or the ability of cells to survive adverse environments, we 
must understand how cells normally regulate transcription. Furthermore, the 
exploration of transcription in both eukaryotes and bacteria has implications for 
understanding evolution gene regulation (Ooi and Wood 2008; Lee et al, 2007; 
Cattaneo, 2005; and Dozois, et al, 2002). The more we learn about both the 
common themes and the differences of transcriptional control in both kingdoms, 
the closer we come to uncovering clues about transcription in our common 
ancestors.  For example, the principles that govern the initial barrier to 
transcription are the same – in both kingdoms, increases or decreases of DNA 
twisting are required for gene silencing or gene transcription, respectively 
(Travers and Muskhelishvili, 2007). Finally, the more we learn about the rules of 
gene regulation, the better we are able to design transcription-based therapies to 
treat devastating diseases such as cancer, to devise strategies to defeat 
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antibiotic resistant bacteria, or to construct semi-synthetic gene circuits to 
perform desired functions. For example, one might modulate access to a 
promoter region or use a small molecule to disrupt a critical protein-DNA 
interaction (Hsu et. al., 2007; Pandolfi, 2001).  
The Process of Transcription
In general, the process of transcription is the same for eukaryotes, 
archaea, and bacteria. Transcription takes place in four stages. The first step 
requires that RNA polymerase (RNAP) bind to promoter DNA, forming a binary 
protein/DNA complex known as the closed complex (CC). Once RNAP binds to 
the promoter, the DNA strands unwind (a process known as  promoter melting or 
isomerization). The result is  known as the open complex (OC). Now, 
ribonucleotides enter the RNAP, which begins to synthesize RNA using the sense 
strand of DNA as the template. The result is a short RNA transcript. This protein/
DNA/RNA ternary complex is called the initiation complex (IC). Such short 
transcripts often abort. If so, the initiation process re-starts. If, however, 
transcription continues, the nucleoprotein complex dramatically alters its 
conformation, becoming the extremely processive form known as  the elongation 
complex (EC). Polymerization of mRNA, or transcription, continues until 
termination signals/structures are encountered (Wolfe, 2008; Higgins, 2005) 
(reviewed by Rosenberg and Court, 1979). 
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Transcription can be enhanced or inhibited at any of these steps, but most 
often regulation occurs  at one or more of the first three steps and is  most often 
mediated through the binding of positive or negative regulators. These regulators 
can bind to sequences  that overlap the promoter or bind to sequences positioned 
either upstream or downstream of the promoter. As such, transcription regulation 
depends on two distinct features: 1) sequences within the DNA (known as cis 
elements) and 2) the proteins that bind to those sequences (known as trans 
factors). Mutations  that affect either cis elements or trans factors can result in 
debilitating defects in eukaryotes and bacteria alike (Ooi, 2008; Kadonaga, 
2004).
Transcription and Human Disease
A disruption in transcription can result in an imbalance in cellular 
homeostasis, which can lead to metabolic inefficiency, arrest of cell maturation, 
reduced fitness, and cell or organismal death. Many severe human diseases 
result from aberrant gene expression (Pandolfi, 2001). Some of these diseases 
are attributed to mutations  in cis elements, while others are attributed to 
mutations in trans factors. I will now describe a few examples of both. 
Mutations in the gene that encodes  a trans factor can disrupt the normal 
function of that protein. For example, Huntington disease is  a debilitating 
neurodegenerative disorder that manifests itself when the normal huntingtin 
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(HTT) gene acquires mutations that magnifies its  endogenous CAG repeat 
(Scherzer, 2008; Cattaneo, 2005). The resulting mutant huntingtin gene (mHTT) 
contains greater than 37 CAG repeats. Since CAG encodes glutamine, this 
magnification results  in an extended polyglutamine or polyQ tract in the mutant 
protein, known as  mHTT. Normal HTT functions in numerous cellular processes, 
such as protein degradation and gene transcription. The extended polyQ tract of 
mHTT interferes with these processes. For example, the extended polyQ tract of 
mHTT disrupts  its own N-terminal nuclear export sequence (NES). This 
interference results in a buildup of mHTT proteins  in the nucleus. The nuclear 
localization of mHTT, specifically its extended polyQ domain, disrupts 
transcription. This is because many transcriptional regulators  contain glutamine-
rich domains  that mediate the interaction between transcription factors and other 
transcription-associated proteins. mHTT proteins disrupts these interactions, 
possibly by sequestering the transcription factor (Kadonaga, 2004; Imarisio, 
2008).  For example, CBP [CREB binding protein] is an important bridging 
protein (co-transcriptional activator) that is  proposed to link the DNA-bound 
CREB transcription factor to the general transcriptional machinery. CBP activity is 
required for expression of neuron survival signals through its histone 
acetyltransferase function (Lu et. al., 2003). This  activity decondenses the 
histone/DNA complex, allowing RNAP and transcription factors to gain access to 
the promoter region. The C-terminal region of CBP contains a polyQ stretch that 
mediates the interaction between CBP and CREB. mHTT protein sequesters 
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CBP, inhibiting DNA access and preventing transcription (Scherzer, 2008; 
Cattaneo, 2005).  
Mutations in the promoter sequence may also alter gene expression. The 
etiology of Alzheimer’s Disease (AD) is attributed to the buildup of a spliced 
version of the full-length amyloid precursor protein (APP) – the 44 amino acid 
long amyloid ! (A!) variant. Many tissues express APP, with the highest 
concentrations found in CNS neurons. Buildup of the A! variant form aggregates 
in brain tissue, creating plaques  and causing mental deterioration of the patient 
(Sakanyan, 2005). Typically, the plaques are the result of increased splicing of 
the full-length APP protein mediated by a mutation in the gene changing a key 
amino acid from valine 717 to an isoleucine 717. Recently, however, Theuns et 
al. (Theuns et al, 2006) identified a mutation in the APP promoter region of 
patients exhibiting early onset stages of AD. They report that this  mutation results 
in increased APP gene expression, leading to increased APP protein production, 
and a greater concentration of the A! variant. This mutation in the promoter 
region leads to AD disease progression, mirroring that of the disease mediated 
by the V717I mutation (Theuns et al, 2006; Theuns et al, 2000). Thus, this study 
has identified an alternate source of AD etiology that arises  from a mutation in 
the app promoter region rather than from a mutation in the gene itself.
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Transcription in Bacterial Pathogensis
Likewise, bacteria regulate gene expression at the level of transcription. 
This  regulation occurs in response to both external and internal signals  that 
converge to aid in directing the transcription of genes needed to adapt to and 
survive changes in the bacterium’s environment, such as the depletion of 
nutrients, the presence of antibiotics, and exposure to the host immune system. 
For example, the resultant alteration in gene program can result in the formation 
of differentiated bacterial entities, e.g. biofilms, fruiting bodies, or spores, formed 
to withstand harsh environmental conditions (Dorman and Corcoran, 2008; 
Kroos, 2007). 
Of particular interest is the survival of pathogenic bacteria in an animal 
host. Entry into a host exposes the bacterial pathogen to nutrient-limiting 
conditions, a low-pH environment, and antigen exposure to the immune system. 
To survive in the host, the pathogen must express genes that encode virulence 
proteins used to alter its immediate environment for survival such as 
permeabilizing the membrane (membrane ruffling) or immunosuppression. Such 
virulence genes must be precisely regulated to ensure proper expression. To 
achieve this  goal, bacteria have evolved sophisticated signaling networks and 
transcriptional machinery that permits them to differentiate between their in vitro 
and in vivo environments  and to properly regulate the genes required for each 
environment (Kroos, 2007).
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The machinery required to process the multitude of environmental signals 
and to properly transcribe a given gene often involves many signaling pathways 
that pass signals to multiple transcription factors that control gene expression 
from multiple promoters. Pivotal to this  process is the constellation of DNA 
remodeling proteins, also known as histone-like proteins or nucleoid-associated 
proteins (NAPs) (Higgins, 2005; Cotter, 2000). Like eukaryotic histones, these 
NAPs bind, fold, and package the DNA. As  such, they participate intimately in 
conformation-dependent processes including genome replication and the 
regulation of transcription. Of particular interest is the small heterodimeric DNA 
remodeling NAP, IHF (Integration Host Factor; ~21 KDa). IHF appears to be a 
key regulator of genes located on pathogenicity islands of Enteropathogenic 
Escherichia coli (EPEC) and Enterohemorrhagic Escherichia coli (EHEC), as well 
as  the invasion-specific genes of Shigella flexneri (Baron, 2007; Tseng et al, 
2009). The ability of IHF to remodel DNA and its  affects on the function of 
proteins bound to the promoter region is the major focus of my dissertation.
Often, the remodeling of DNA topology by NAPs provides the appropriate 
DNA conformation to allow or disallow the binding of a transcription factor to its 
DNA site. Alternatively, NAPs can mediate the bringing of a transcription factor 
into close proximity with RNAP to permit a required protein-protein contact 
(Higgins, 2005; Ohniwa, 2006). Two well-studied transcription factors, FNR and 
CRP, regulate the transcription of genes that encode proteins responsible for 
survival under very specific conditions. For example, the homodimeric FNR 
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(fumarate and nitrate reduction; ~30 KDa) is a homodimeric transcription factor 
that responds to the environmental concentration of oxygen and, in response, 
regulates genes required for cell survival under anaerobic conditions. The 
functional status of FNR depends on the state of its oxygen labile [4Fe-4S]2+ 
cluster (Kiley and Beinert, 1998). Not only is the [4Fe-4S]2+ cluster important to 
the dimerization of FNR subunits, but it also behaves as the protein’s oxygen 
sensor. In the presence of oxygen (i.e., an aerobic environment), the [4Fe-4S]2+ 
cofactor undergoes oxidation to [2Fe-2S]2+, losing two Fe and S2- atoms, leading 
to a conformational change that eliminates  DNA binding to its site (Kiley and 
Beinert, 1998). The reduction of FNR to its protein subunits thus results in 
deregulation of all FNR-dependent genes/operons. The complete depletion of 
oxygen from the environment (i.e., an anaerobic environment) restores the 
[4Fe-4S]2+ cofactor and thus the ability of FNR to bind to its DNA sites in the 
promoter regions of its  regulon members. Expression of these genes permits  the 
cell to adapt to an anaerobic environment, in part, by facilitating fermentation and 
anaerobic respiration (Ratledge and Dover, 2000). Additionally, FNR has been 
implicated as  a virulence factor. During a Neisseria meningitidis serotype B 
(MenB) infection, the host immune system attempts to clear the invading 
pathogen by cell-mediated and humoral-mediated immunity. Cell-mediated 
clearance of a MenB infection involves phagocytosis by macrophages and the 
production of small molecule antimicrobials such as nitric oxide (NO). It is under 
these harsh conditions that the pathogen encounters environments with varying 
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concentrations of oxygen. To withstand the armament of host weaponry, N. 
meningitidis must switch from aerobic metabolism to anaerobic metabolism to 
survive within the host. This transition from aerobic to anaerobic respiration is 
mediated by FNR. Deleting fnr attenuates MenB virulence in mice, suggesting 
that successful MenB disease progression requires FNR and thus at least some 
members of its regulon (Bartolini et. al. 2006).
Like FNR, the closely related transcription factor, CRP (Cyclic AMP 
Receptor Protein, also known as Catabolite Activator Protein or CAP), controls 
the expression of greater than 150 genes in response to the availability of 
catabolite-repressing carbon sources, e.g. glucose. In the absence of glucose, 
the concentration of cyclic AMP (cAMP) rises (Lewis, M. 2005; Wolfe, 2008; 
Kumari et al, 2000). This second messenger binds to the CRP dimer, altering its 
conformation, and thus activating it for binding to its  DNA site. Thus, the binding 
of cAMP permits CRP to participate in important protein-protein interactions 
(Reddy et al, 2009; Tan et al, 1991). These interactions are central to this 
dissertation.
Mutations that Alter Transcription
As described previously, mutations that alter transcription may occur in 
either the DNA sequence (cis elements) or the proteins that bind those 
sequences (trans factors). Mutations in the promoter can specifically affect the 
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binding and/or function of RNAP. Mutations in a DNA binding (DNAB) site can 
specifically influence the binding or function of an associated transcription factor. 
Finally, mutations can alter the overall structure of DNA and indirectly impact the 
binding of both RNAP and transcription factors (Ohniwa, 2006; Higgins, 2005; 
Dorman and Corcoran; 2008; El Sharoud, 2008; Hardy, 2005). Mutations in these 
cis elements  generally affect only the transcription of the downstream gene or 
operon. For this  reason, mutations in cis elements are preferable when studying 
the function of a global regulator at a particular promoter, such as the focus of 
this dissertation, the acs promoter. 
In contrast to mutations in cis elements, mutations in trans factors may 
influence the transcription of multiple genes. This  is particularly true if the trans 
factor functions  globally. For example, mutations  in RNAP that influence its ability 
to properly move through the steps of transcription are expected to exert an 
adverse effect on global transcription. Depending on the severity of the defect, 
such a mutation could be lethal (Hermsen, 2006; Hardy, 2005). Similarly, a 
mutation in a transcription factor (e.g. CRP) or a NAP (e.g. IHF) that exerts its 
influence globally would be expected to cause a global defect. Because such a 
mutation would be expected to impact a large number of genes directly and/or 
through its ability to alter the overall structure of the nucleoid, dissection of a 
given promoter is best performed with cis mutations that specifically alter the 
binding of a trans factor to the promoter region itself and not by deletion of the 
global trans factor itself. 
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In contrast, a mutation in a transcription factor (e.g., the Lac repressor), 
whose activity is limited to one or a small subset of promoters, would likely exert 
a more local effect (Fried and Crothers, 1981). For example, a mutation in a local 
negative regulator might be expected to result directly in constitutive expression 
of its regulated gene(s). Conversely, a mutant local activator that has lost its 
ability to stably bind to its DNA site within a given promoter would be expected to 
result in the loss of transcription from that promoter. 
Finally, mutations in a transcription factor or a NAP could affect any of the 
its multiple functions, including the binding of a ligand (e.g., cAMP) or covalent 
modification (e.g. phosphorylation or acetylation), oligomerization, DNA binding 
or bending, and/or the interaction of the transcription factor with RNAP (Martinez-
Antonio, 2003). The severity of any particular mutation will depend upon the 
importance of the affected gene(s).
Bacterial Transcription: the Textbook View
The typical textbook shows bacterial transcription to be rather 
uncomplicated, especially in contrast to eukaryotic transcription (for example, see 
Lewin, 1996). The structure of bacterial DNA is  often depicted as a simple linear 
“naked” structure, primarily unbound by proteins. However, this is  not the 
biologically relevant conformation. The binding of proteins to DNA to form 
nucleoprotein complexes is essential to change the “linear” state of DNA to a 
 13
biologically relevant conformation is required for such processes as DNA 
replication, repair, recombination, and transcription (Higgins, 2005; Rice, 2008). 
The topological changes of DNA can take many conformations due to the 
pliability of its phosphate backbone and the base-stacking properties of its 
nucleosides (Sinden, 1994; Rice, 2008). DNA can be contorted into a variety of 
topologies by DNA binding (DNAB) proteins that package DNA by bending, 
twisting, and spooling the overwhelmingly long genomic DNA (1 m in eukaryotes 
and 1.7 mm in eubacteria) into the eukaryotic nucleus  or the bacterial nucleoid. 
A similar process permits the packaging of viral DNA into the space-limiting 
nucleocapsid (Campos, 2009). The bending, twisting and spooling of DNA by 
DNAB proteins do not just mechanically package DNA into a small space but 
also protects the genome from nucleases and other destructive forces. 
Additionally, these protein-induced alternative states of DNA participate in the 
regulation of other DNA metabolic processes, including transcription (Lewin, 
1996; Campos, 2009). Some of the proteins involved in DNA compaction and 
transcription regulation in bacteria and eukaryotes are quite similar; for example, 
HU of bacteria is a functional homolog of the histone H1 of eukaryotes. Most, 
however, differ quite dramatically. Yet, the general themes of DNA binding and of 
base pair stacking require the same four nucleotides: adenine, cytosine, guanine, 
and thymine.
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Adenine, Cytosine, Guanine, Thymine, and Base Pair Stacking
All processes that involve DNA depend on its primary structure. This is 
particularly true for the mechanisms that regulate transcription. The fundamental 
impact on the structure and function of DNA involves the atoms that make up the 
bases, the base pair interactions, and the sugar-phosphate backbone. The 
structure, elasticity, polarity, and durability of DNA are due to the base pair 
stacking of the adenine (A), cytosine (C), guanine (G), and thymine (T) 
nucleotides in conjunction with the sugar-phosphate backbone. The overall 
stability of DNA, provided by the nitrogenous bases and the sugar-phosphate 
polymer, make it the ideal carrier of genetic information (Rice, 2008; Benham and 
Mielke, 2005). 
Sitting on the outer portion of the DNA helix is the sugar-phosphate 
backbone. Due to the phosphate moiety that covalently links  the 5’-OH of one 
nucleotide sugar to the 3’-OH of the next nucleotide sugar (the so-called 
phosphodiester bond), DNA has an overall negative charge (Sinden, 1994; Rice, 
2008). The negative charge of the sugar-phosphate backbone renders it 
conducive for attracting positively charged DNA binding proteins, such as 
eukaryotic histones and bacterial NAPs. These proteins, when bound to DNA, 
introduce the structural bends required for most DNA metabolic events (Rice, 
2008; Higgins 2005). Though the phosphate moiety is a rigid tetrahedron in 
nature, the binding of carbon to the oxygen atoms provides free rotation about 
the phosphorous-oxygen bond. The individual nucleotide is rigid, but in a polymer 
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the nucleotides have “indirect rotational flexibility” (Travers and Thompson, 
2009). Therefore, the longer the DNA strand, the more overall is its flexibility. In 
addition to providing the backbone for base stacking and general elasticity, the 
alternating 5’ and 3’ sugar phosphate moieties  give DNA directionality, or polarity 
(Sinden, 1994; Travers and Thompson, 2009). 
The phosphate moiety is bound to a sugar, which is then bound to a 
nitrogenous base. Unlike the sugars and phosphates, the nitrogenous bases of 
the nucleotides are insoluble in water. Thus, the hydrophilic sugar-phosphate 
backbone of DNA is exposed to water, while the hydrophobic bases  are hidden 
away (Sinden, 1994). The insoluble nature, or hydrophobicity, of the nitrogenous 
bases is the driving force behind the antiparallel DNA helix formation. The 
Watson-Crick base pairing between A:T, T:A, G:C, and C:G bases fit into the 
DNA helix much like stairs  of a winding staircase. The twisting staircase structure 
is  the consequence of the hydrophobic bases  shying away from the aqueous 
environment in an effort to exclude water molecules  from the DNA core (Sinden, 
1994; Benham and Mielke, 2005). Since the base pairs  cannot stack directly on 
top of one another the bases twist slightly. The slight rotation of the DNA ladder 
occurs because the length between phosphate moieties along the sugar-
phosphate chain is twice as long as the thickness of the bases. Though the 
sugar-phosphate chain mediates the slight twist in base pair stacking, it also 
limits the degree of rotation by providing a scaffold that holds the bases in place 
(Sinden, 1994).   
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The nucleic acid sequence of DNA plays a role in determining its overall 
structure, specifically the effects  of base pair stacking. Since the nitrogenous 
bases attempt to minimize contact with water, they adopt the propeller twist 
conformation (Rice, 2008; Sinden, 1994; Hassan and Calladine, 1996). The DNA 
helix structure is  determined at the atomic level by several parameters of base 
stacking within them. Of these parameters, three are considered when analyzing 
B form DNA, i.e. flexibility, translation, and rotation (Sinden, 1994). The flexibility 
of DNA owes itself to the movement of the nucleotide bases and their stacking in 
the helix. Bases encapsulated within the helix have six variables of positioning or 
‘degrees of freedom’. This positioning falls under two categories: translation and 
rotation. Translation is the movement of a base in any direction without rotation. 
Discussion about translation movement is commonly limited to the X, Y, and Z 
planes. In contrast, the rotation of a base involves twisting, rolling, and tilting 
about the long and short axes  of the base. To describe these movements and 
their relation to a base pair step, the nitrogenous bases will be referred to as 
blocks for simple illustration. Also, the sugar-phosphate backbone will not be 
considered, but serves as the framework for positioning the bases (Hassan and 
Calladine, 1996) (see Figure 1). 
Translation positioning is the movement of a block in an X, Y, and Z three-
dimensional grid. The block may move vertically along the Y-axis. The base may 
move into and out of the 2-D plane along the Z-axis. And finally it may move 
laterally along the X-axis. The movement along the X-axis is described as the 
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sliding (slide = S) of one or both blocks in relation to one another. Since block 
movement in both the Y and Z directions  is  impeded through their covalent 
attachment to the sugar-phosphate backbone, the current discussion will involve 
only sliding (Rice, 2008; Bloomfield, 2000).
The three parameters  of rotation used to describe the relative positions of 
bases are twist, roll, and tilt. Blocks may twist about their short axis – the axis 
running from top to bottom when the block is  viewed from the broad side facing 
into the hydrophobic core of the helix. The effect of rolling describes the position 
of the side edge of the base, again when viewed on the broad side, in relation to 
the horizontal axis. When the broadside of the base moves above or below, there 
is  either a positive or negative change in the angle relative to the horizontal 
plane. Tilting is an angular change of a base relative to the vertical plane. Though 
these parameters are real considerations when studying the position of base 
steps relative to one another, the real world situation introduces constraints to 
tilting. Therefore, further discussions of base pair step rotation will only be done 
so using twist (T) and roll (R) (Sinden, 1994; Hassan and Calladine, 1996; 
Bloomfield, 2000).
 
Base Pair Steps 
So far, the translation and rotation parameters for block orientation have 
been described for a single base. However, in the DNA helix, the bases are 
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ordered one after another. Therefore, the change in position of one base affects 
the neighboring bases. To better understand these relationships, we will consider 
two base pairs (four bases in all or two pairs of complementary bases) aligned 
one above the other, or a base pair step. The sugar-phosphate backbone will not 
be considered in this discussion, but the parameters are applied to the confines 
of the double helix. In addition to the backbone limiting base movement, the effort 
to exclude water between bases or avoid the creation of a vacuum also restricts 
movement and degree of this  motion. The movement of the base pair step only 
encompasses three of the six 
parameters mentioned above: 
the rotations roll (R) and twist 
(T), and the translation slide 
(S). When the R, S, and T 
values are zero (i.e., when 
there are no changes in the 
position of either base), then 
the bases  overlap perfectly in 
the d inuc leo t ide s tep as 
depicted in Figure 1A. Any 
permutations in the R, S, or T 
parameters, thus, affect the position of the neighboring base (Postow, 2005; 
Patel et al, 1983; Delmonte, 2003; Sponer et al, 1997).  
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Figure 1. Dinucleotide Slide and Twist. (A) Depicts the 
dinucleotide Slide movement in the direction of the long axis of 
each base relative to its immediate base neighbor. (B) The 
Propeller-Twist conformation of dinucleotide base pairs, placing 
one base out of plane relative to its base partner. (Modified 
from Hassan and Calladine, 1996).
The twist parameter is  properly defined as the rotation of a base about the 
local twist axis running vertically through two nearby bases. Base twisting 
provides the helical ladder of DNA, contributing an estimated 34.3° per base for 
10.5 bases, or one turn of B form DNA. Since B form DNA is not the only 
structure present within a cell, the number of bases per turn of DNA is considered 
to be 11±1 bases. However, with no changes in the R or S values, each base is 
estimated to “twist” by 36° (i.e., as you move one base at a time up the DNA 
helix, the consecutive bases will be off-angle by 36°) (Sinden, 1994, Bloomfield, 
2000). The value of the twist parameter is not uniform for the entire molecule. For 
example, the T value for folded DNA will differ from circular DNA. The twist angle 
is  sensitive to base stacking and other helical forces  (Bauer, 1993; Bauer, 1995). 
Importantly for this dissertation, protein binding to DNA also affects the twisting of 
DNA in order to accommodate the protein/DNA interaction.
The second rotation important for base motion with the DNA helix is  the 
roll parameter. Rolling results in the movement of a base that changes the 
position of the broad side of the base in relation to the horizontal plane, or long 
axis. The roll angles may vary from +20° to -10° in the B form DNA helix. Any 
rotation upward towards the minor groove is considered positive, as depicted in 
the right block of Figure 1B, and a rotation downward towards the major groove 
is negative (Sinden, 1994; Rice, 2008).     
The single translation parameter discussed here is base slide. This is the 
lateral motion of a base along the X-axis relative to a neighboring base. If the 
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upper pair of bases  in a dinucleotide step moves further to the left of the vertical 
axis than does the lower base pair, then this movement is  considered positive. 
Base pair movement towards the right of the vertical axis  is given a negative 
value. The values for these types  of base shifts may range from +3 Angstrom to 
-2 Angstrom. The sugar-phosphate chains  limit the slide for a base pair in a 
dinucleotide step (Sinden, 1994; Rice, 2008).  
The Propeller Twist
DNA base pairs  rarely occupy the same plane. Therefore, the roll angles 
of the aromatic rings of the base pairs  are slightly different. This  gives  them a 
conformation similar to an airplane’s propeller-twist (Sinden, 1994; Hassan and 
Calladine, 1996). This propeller-twist base conformation is the most common 
base position in a DNA helix. The propeller-twist maximizes base stacking 
interactions with the neighboring base, but lengthens the DNA strand and 
weakens Watson-Crick hydrogen bonds. Because base stacking tends to 
assume the propeller-twist conformation, it has been suggested that the 
sturdiness of the DNA duplex can be attributed more to the stabilization energy 
provided by base stacking than by the energy provided by Watson-Crick 
hydrogen bonds (Hassan and Calladine, 1996; Mohan, 1992). Importantly for this 
dissertation, the propeller-twist base pair conformation plays a key role in protein/
DNA interactions because it best accommodates the changes in base pair 
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stacking and the torsional strain introduced by DNA binding proteins  without 
completely disrupting the helix.
The DNA molecule must be flexible and elastic enough to withstand these 
changes without unraveling (Sinden, 1994; Calladine, 2004). Take for instance 
the binding of the minor groove binding protein IHF. This NAP protrudes a proline 
into the DNA, thus disrupting the local base pair stacking. If the bases were 
unable to alter their stacking positions  and depended solely on Watson-Crick 
hydrogen bonds, then this proline-mediated disruption would most likely induce 
strand separation, leading to inefficient protein-DNA interactions, and limiting the 
effects of IHF binding. Fortunately, base pair stacking is the major stabilizing 
force and the bases are able to twist, roll, and slide to adjust (Sinden, 1994; 
Ramakrishnan, 1993).  Finally, it should be noted that translation and rotation 
values differ in regions with different sequences. For example, a region of DNA 
containing a stretch of A’s will have a sequence-induced bend, whereas a unique 
sequence containing a mixture of all four bases  will not (Patel, 1993; Haran, 
2009). 
  
Genome Compaction
The ability of DNA molecules to absorb topological changes are credited 
to the sugar-phosphate backbone and base stacking. Though the shape of DNA 
is  easier to appreciate as a 2-D diagram or a linear ball and stick model, its true 
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nature within the cell is a folded, more compact, supercoiled structure that 
contains many regions of looped domains (secondary structure). The folding and 
unfolding of DNA in both bacteria and eukaryotes  determines whether the 
transcriptional machinery gains  access to a promoter region. Promoter access is 
governed not only by the topology of naked DNA, but also by the proteins that 
bind to DNA and alter its configuration (Higgins, 2004; Akyol, 2009). In 
eukaryotes, proteins called histones fold the genome, compacting it into a form 
that can fit within the nucleus. To achieve compaction, these large protein 
complexes spool DNA around themselves and interact with each other. By 
condensing DNA, histones physically hinder the ability of RNAP to bind to the 
promoter and transcription factors to bind to their respective DNA sites. By 
controlling the degree of compaction, therefore, histones function as gatekeepers 
that determine access to the promoter. 
Bacteria also must package their genome into a limited space. To achieve 
this, they use NAPs, which possess many of the same properties of histones and 
function in a similar, but not identical, manner (Higgins, 2004; Sherrat, 2003). 
Below, I will describe the process  by which histones and NAPs compact their 
respective genomes. 
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Compaction of the Eukaryotic Genome
The eukaryotic genome undergoes many different levels  of compaction. 
The most basic level of compaction consists  of the natural structural folds 
constituted by intrinsic base pair interactions, forming the B-DNA double helix, 
and by the intracellular density (also called molecular crowding – a physiological 
phenomenon important for all cellular processes). Base pair stacking, as a result 
of hydrophobic interactions between the nucleic acid bases, along with the 
phosphate backbone interaction with environmental water molecules, give rise to 
the B-DNA structure. Human DNA measures over 2 meter in length when all 46 
chromosomes are stretched out from end to end. But the maximum cell size 
measures 100 !m, with the nucleus measuring 10 !m. To compact the 2 meter 
DNA into the cell nucleus, the genome undergoes a 10,000-fold reduction 
(20,000 fold is the most) in volume.
The eukaryotic cell overcomes the size and volume barrier to package an 
enormous amount of DNA into the confined space of a cell by first wrapping the 
thin strands of negatively charged DNA around basic proteins  (Campos, 2009). 
These conserved basic DNAB proteins (histones) package the DNA into a tight 
structure described as “beads on a string”. This term describes the wrapping of 
the DNA strand around the histone octamers – a structure unique to eukaryotes – 
at 150 bp intervals. The histone proteins associate with DNA in a sequence-
independent manner to form a nucleosome core particle (Fig. 2). Each octamer 
core, composed of histones H2A, H2B, H3 and H4, is tethered by 50 bp of 
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“linker” DNA, hence the “beads-on-a-string” description. This DNA structure is 
then further compacted by creating loops of the protein-DNA beads. 
The continuous spooling of DNA around core histones decreases the total 
length by 7-fold, while increasing the diameter by 5-fold (the diameter of linear 
naked DNA is 2 nm, while the diameter of the ‘beads-on-a-string’ structure is 10 
nm) (Figure 2) (Lodish, 2003). This  primary nucleosome-DNA structure is further 
compacted through the interaction between the histone-associated protein H1 
and the DNA strand that exits the H2A+H2B complex, creating a 30 nm hollowed-
solenoid structure (Fig 2). Together, the 7-fold DNA compaction of the primary 
nucleosome-DNA structure and the 6-fold solenoid compaction compacts naked 
DNA by about 40-fold. 
The final nucleoid structure places  the 30 nm DNA-histone solenoid onto a 
chromosome scaffold consisting of protein lamins and topoisomerases. Lamins 
function as the structural foundation onto which the solenoid DNA lays. In 
contrast, toposiomerases associated with the chromatin relieve any supercoiling 
tension introduced by packaging and keeps the DNA solenoid intact during 
mitosis (Lodish, 2003). Thus, ultimately, the eukaryotic DNA undergoes a 
reduction in size of approximately 10,000-fold. This extreme packaging is 
necessary to fit into the double membrane nucleus, a structure that also limits 
protein/transcription factor access to the nucleoid.
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Compaction of the Bacterial Nucleoid
Early TEM studies made clear the evident discrepancies between 
eukaryotes and bacteria (e.g. the size differential and the presence of a double 
membrane enclosure for the eukaryote’s genome and lack thereof for that of the 
bacterium) (Higgins, 2004).  However, these studies also made clear the curious 
fact that the bacterial genome displayed some degree of order despite the 
absence of a dedicated organelle to enforce organization. Current images 
rebuffed earlier expectations of a widely dispersed bacterial genome with no 
sense of morphology (Eltsov and Zuber, 2006). 
The bacterial genome (or nucleoid) is localized in a structurally undefined 
region within the cell. It is not 
e n c a p s u l a t e d w i t h i n a 
membrane, a defining hallmark 
of eukaryotic cells. The length 
o f the bac ter ia l genome 
measures about 1.7 mm, while 
the length of a typical bacterial 
cell, e.g. E. coli, is 3 !m long. 
This  is  a size discrepancy of 
approximately 1000-fo ld, 
which is similar to that of eukaryotes. As with compaction of the eukaryote 
genome, macromolecular crowding contributes to the maintenance of bacterial 
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Figure 2. Histone-Mediated DNA Compaction. Histone 
octameric core spools DNA, creating a nucleosome, ultimately 
compacting genomic DNA into a 30 nm solenoid structure. 
(Adapted from Molecular Cell Biology, 1999).
genome compaction (Higgins, 2004; Azam, 1999). Gentle lysis  of E. coli cells 
releases the nucleoid, revealing strands of DNA 10 times the length of its 
intracellular size (Kavenoff and Bowen, 1976). More recent studies have shown 
that nucleoid-associated proteins  (NAPs) mediate much of the rest of the 
compaction (Higgins, 2004; Swinger and Rice, 2007). 
It is now clear that the bacterial genome is organized much like the 
eukaryotic genome and that it undergoes morphological changes similar to that 
of the eukaryote genome (Thanbichler et. al., 2005). Just as the density of the 
eukaryotic genome changes as  its proceeds  through the cell cycle (G1, S, G2, 
and M), the density of the bacterial genome correlates with the different phases 
of bacterial growth. For example, the bacterial nucleoid of actively growing and 
dividing cells (e.g. those in the exponential phase of growth) looks like a 
collection of loose 30 nm fibers, not unlike the 30 nm DNA-histone solenoid of 
the typical eukaryote. As cells slow their rates  of growth and division (i.e., during 
the transition to stationary phase), the nucleoid begins to condense, forming a 
structure that resembles coral. In contrast, the nucleoid of relatively inert cells 
(e.g., those in late stationary phase) is an extremely compact electron dense 
structure that in many ways resembles the condensed mitotic chromosome (Kim 
et al., 2004; Travers and Muskehelishvili, 2005). Like the eukaryotic genome, the 
bacterial nucleoid forms these increasingly compact structures by the formation 
of topologically isolated DNA loops. These loops are negatively supercoiled, a 
fact of vital importance for DNA metabolic events, e.g. transcription. Contained 
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within these loops is stored free energy introduced by the torsional tension that 
results from supercoiling. Relaxation of this tension, by single-strand nicking or 
double-strand breaks, renders the nucleoid unable to perform its metabolic 
processes and as such becomes functionally inert. There are an estimated 500 
supercoiled domains per chromosome, reducing the radius of gyration – defined 
as the root mean square distance of the supercoiled domains to the center of the 
chromosome. Obviously, the formation of these supercoiled loops also 
contributes to compaction of the nucleoid. Thus, looping not only maintains free 
energy but also facilitates the repair process by localizing nicked strands to one 
region (Postow et al., 2004) (Travers and Muskhelishvili, 2007) (Dorman, 1991) 
(Azam et. al., 1999) (Azam et. al., 1999) (Azam et al., 2000) (Takeyasu et. al., 
2004).
Compaction of bacterial nucleoid is mediated by NAPs, small basic 
proteins analogous to eukaryotic histone proteins. Unlike histones, the 
concentrations of NAPs change according to the phase of growth. During 
exponential phase, for example, FIS is  the predominant NAP, while Dps is 
numerically dominant during stationary phase. The physical and chemical 
properties of FIS homodimer tends to facilitate the decondensation characteristic 
of the exponential phase nucleoid, while the properties of the Dps dodecamer 
facilitate compaction of the stationary phase nucleoid (Nystrom, 2004; Ohniwa, 
2006; Roy, 2008; Jeong, 2008). 
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Like eukaryotic histones, NAPs do more than compact the genome. They 
also provide protection from nucleases and regulate DNA metabolism, including 
transcription. However, due to the limitation of bacterial cell volume, the genomic 
content must be limited to those genes that are required for survival. Reserving 
genomic space to accommodate the genes that encode the histone octamers, 
while also carrying genes that encode transcription factors  for gene expression, 
would severely decrease metabolic efficiency. Therefore, the constitutive 
interaction between DNA structural proteins (like histones) and DNA is  not seen 
in bacteria for two reasons: 1) these proteins play multiple roles  in the life of the 
cell and 2) the dynamic interplay between DNA and NAPs provides the cell with 
the ability to adjust more rapidly to the ever-changing extracellular milieu. Though 
the use of DNA binding proteins is absolutely required for the compaction of 
DNA into the very limited intracellular space, maintaining compaction is  a difficult 
task since the protein-DNA interaction is very dynamic.
Today, as technology provides  us  with the resolution necessary to clearly 
see within the tiny bacterial cell, the long-held belief that the bacterium is a 
simple organism without sophisticated spatial and temporal organization has 
begun to rapidly change. The bacterial genome clearly undergoes organized 
morphological changes  similar to that of the eukaryote genome (Thanbichler et. 
al., 2005). From the decondensed DNA fibers  of exponential phase to the 
electron dense nucleoid of late stationary phase, these changes are mediated by 
NAPs. 
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Bacterial Nucleoid Associated Proteins
Escherichia coli cells  possess twelve nucleoid proteins. Five of these 
NAPs are thought to be the major protein components  of the bacterial nucleoid: 
factor for inversion stimulation (Fis), histone-like nucleoid structuring protein 
(HNS), heat-stable nucleoid protein (HU), integration host factor (IHF), and 
stationary phase-expressed DNA binding protein from starved cells (Dps) (Azam 
and Ishihama, 1999; Ishihama, 1999).
These NAPs have structural similarities  to some eukaryotic histones and/
or transcription factors. For example, they possess DNA binding domains 
structurally similar to those found in histone proteins. Note, though, that they 
possess little or no sequence similarity. Unlike histones, some bacterial NAPs 
actively participate in multiple functions within the cell. For example, Fis and IHF 
both package the genome and function as pleiotropic regulators that bind specific 
DNA sequences. As  such, they play specific roles in the regulation of DNA 
replication and segregation, recombinatorial events, and transcription. In 
contrast, the sequence-independent DNA binding protein, Dps, appears to 
function, like histones, strictly as a packaging protein (Nystrom, 2004; Ohniwa, 
2006; Roy, 2008; Jeong, 2008; Higgins, 2004). Because NAPs perform such 
central and diverse roles, deletion of the gene that encodes a particular NAP 
almost certainly will have pleiotropic effects and the study of a physiological 
behavior in a cell that lacks a given NAP will be riddled with secondary effects. 
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Thus, to study the role of a NAP (e.g. IHF), it is preferable to simply disrupt 
binding to a specific DNA site.
Though the characteristic motions of the bases  contribute flexibility and 
adaptability to the change in the overall structure of the DNA, short regions of 
DNA are actually intrinsically stiff. NAPs can be utilized to overcome this rigidity, 
permitting genome manipulation and transcription regulation. For example, the 
binding of DNA by NAPs introduces the bends needed to promote the binding of 
transcription factors and other proteins required for the regulation of transcription. 
Below, I will describe the major NAP most central to this dissertation, IHF.
IHF
Integration Host Factor (IHF) initially was identified as an E. coli protein 
required for ! phage site-specific recombination. Since its discovery, we now 
better understand the functional significance and importance of IHF to the life 
cycle of E. coli. The requirement of IHF for cell survival and normal biological 
processes is  not limited to E. coli, as its homologues, identified in many other 
proteobacterial species such as Salmonella typhimurium, Shigella flexinerii, 
Sinorhizobium meliloti, and Neisseria gonorrhoeae, function in the same capacity 
(Hill et. al., 2002; Higgins, 2005). Universal identification of IHF, and its 
homologues, underscores the importance of protein mediated manipulation of 
DNA topology during the life cycle of the bacterium.  As is the case with E. coli, 
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the concentration of IHF varies with the stage of cell development. In exponential 
phase the estimated concentration of IHF is  6,000 dimers per cell whereas 
approximately 27,000 dimers  are present within stationary-phase cells  (roughly 
five times the number of IHF dimers measured by Ditto et. al., 1994). Not 
surprisingly the concentration of IHF dimers correlate with the status of DNA 
shape: loose, beads on a string during growth phase and tightly compacted 
under non-growth, nutrient limiting conditions. (Azam, 1999; Talukder, 1999). 
IHF, a member of the DNA binding II (DNAB II) family of DNA binding 
proteins, is a heterodimeric protein that binds  the minor groove of DNA (Fig. 3). 
Unlike the structurally similar homologous protein, HU, IHF binds DNA in a site-
specific manner, although the 30-35 bp consensus  sequence is degenerate 
(WATCARXXXXTTR where W = A or T; X = A, T, C OR G; R = A OR G). In 
addition to the 13 bp core sequence, IHF sites also contain an AT-rich region 
(depicted as WWWWWW) located 8 bases 5’ of the core 13 bases. However, 
sequence specific binding, or direct recognition, is not the only factor that 
contributes to IHF binding. Indirect recognition based on DNA structure (i.e. DNA 
bend) also provides a signal for IHF affinity (Bonnefoy and Rouviere-Yaniv, 1991; 
Thompson and Landy, 1988; Teter et. al., 2000). Direct and indirect DNA 
recognition are inherent features  of IHF and its natural interaction with DNA. This 
built-in versatility allows IHF to actively participate in transcription at specific 
promoters when cells are grown in nutrient-rich media while non-specifically 
binding DNA, and thus compacting it, when those nutrients are used up. 
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Furthermore, it has been postulated that high affinity sites, such as yjbE ORF 
and BIME gyrB sites, are nearly completely saturated with IHF dimers in 
exponential phase but the percentage of saturation changes to somewhere 
between 50 to 70% in stationary phase. The low-affinity IS1 site displayed near 
70% saturation in stationary phase, while displaying only 25 to 30% saturation in 
exponential phase, emphasizing that cell cycle phase and the proteins 
associated with cellular adjustment to the nutrient status affect the function and 
binding affinity of IHF (Murtin e. al., 1998). 
Two genes encode the IHF heterodimer: himA, the alpha subunit (Mr 
11350) and himD, the beta (Mr 10650) subunit. The alpha and beta subunits  are 
similar in sequence (25% homology), as well as structure. IHF possesses two 
distinct conformational features: 1) the alpha helical body and 2) two beta sheet 
arms, one from each subunit. The alpha helical domain mediates IHF 
dimerization, while the flexible beta sheet arms are responsible for DNA binding. 
IHF-DNA interaction results  in DNA bend angles of up to 180º. The folding of 
DNA is induced through the intercalation of proline tips  (Proalpha65 and Probeta64) 
located in the beta sheet arms between AT-bases of the minor groove of DNA. 
The disruption of the base pair stacking upon proline insertion introduces an 80º 
bend at each site. The DNA bend angle is further exacerbated through 
electrostatic interactions between the mostly positive charged body of IHF with 
the negative phosphate DNA backbone. For example, the residues Arg60 and 
Arg63 of the alpha subunit and Arg46 of the beta subunit make direct contact with 
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specific bases whereas the Ser47 residue of the alpha subunit binds the dA/dT 
tract. Due to the variation of genomic IHF sequences, the DNA bend angles 
differ. However, the closer a site is to consensus the more severe the contortion. 
This  severe conformational change increases the accessibility of the bound DNA 
to enzymes, such as recombinases and endonucleases (Higgins, 2004; 
Mengeritsky, 1993). 
The major topological changes in DNA induced by IHF, and other DNA 
binding proteins, are required for all DNA metabolic events and are universal 
themes across all bacteria, archaea, and eukaryota. Specific to this dissertation 
is  the mechanism of IHF-mediated negative regulation of transcription. For 
example, promoters sytR, galR, and Pu are all dependent on IHF binding to fold 
DNA for either activation, by bringing distant activators into close proximity with 
the RNAP holoenzyme, or repression, by folding the promoter DNA into a 
complex that traps RNAP and/or transcription factors. The protein content bound 
to a given promoter region often dictates how IHF will affect transcription. 
NAPs and Transcription: Location, Location, Location
Direct sequence recognition by proteins is an effective way to precisely 
direct specific protein binding and thus to regulate DNA processes. DNA binding 
sequences are found at origins of replication, DNA recombination sites, and 
promoters. The precise alignment of protein binding sites in relation to the origin 
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of replication or transcription start site determines the functional behavior of the 
protein within a given DNA region. However, the structural features of DNA also 
contribute to protein recognition. 
The interactions between DNA and NAPs are subcategorized into two 
groups: indirect and direct. Some NAPs (e.g. HU) bind DNA nonspecifically. They 
do not recognize a specific sequence, but rather structural features of DNA such 
as the major or minor grooves, DNA backbone, hydration shell, flexibility, and 
intrinsic curvature. The inherent bend is mostly found to be A:T-rich DNA regions. 
This  recognition of and binding to DNA based on its bent structure is termed 
indirect. Other NAPs (e.g. Fis and IHF) bind DNA specifically. They recognize 
and bind to stretches of DNA that contain their consensus sequence. Such NAPs 
are called direct binders (Higgins, 2004; Rice, 1997). However, the mechanisms 
of DNA binding by direct or indirect recognition are not mutually exclusive. For 
example, despite the identification of an IHF sequence motif, IHF also binds 
DNA non-specifically throughout the genome, an important function for DNA 
compaction. The presence of an A:T-rich region, perhaps inherently curved, 5’ of 
the consensus site, may provide the initial recognition signal for IHF binding. As 
demonstrated by Hales et al. (1994), mutations introduced into the A:T-rich 
region of DNA increases the efficiency of IHF binding (Hales, 1994). 
The direct binding NAP IHF can either enhance or inhibit transcription, 
depending upon the location of its  binding site. Like many DNA binding proteins, 
IHF can compete directly with RNAP for promoter access and thus repress 
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transcription. This  repression occurs if an IHF site is positioned such that it 
overlaps the promoter sequences that recruit RNAP. IHF also can activate 
transcription. Unlike many transcription factors, activation by IHF is  not attributed 
to direct protein-protein interactions. Instead, IHF’s importance in activation 
appears to stem from its ability to deform DNA (Rice, 1997; de Lorenzo, 1991). 
For example, the severe bend mediated by IHF binding can bring two proteins 
bound to distant sites  into close proximity. Such a scenario occurs at the Pu 
promoter of Pseudomonas putida, which transcribes genes that control the 
degradation of xylene and toluene. Activation of this promoter requires a 
transcription factor that binds an upstream activating sequence (UAS). It also 
requires that IHF bind a DNA site positioned between the UAS and the promoter. 
The binding of IHF performs two functions: it recruits RNAP to the promoter and it 
induces a sharp turn in the DNA. This  severe bend brings the UAS and its 
associated activator into close proximity to the bound RNAP, thereby activating 
transcription. Eliminating IHF binding to the Pu promoter abrogates transcription 
at this  promoter (Perez-Martin and de Lorenzo, 1997). Further evidence that IHF 
functions primarily to deform DNA comes from experiments  in which an IHF site 
has been replaced by an HU site. At certain IHF-dependent promoters, 
researchers introduced base pair mutations  within the IHF consensus site. These 
mutations ablated transcription. Promoter activity, however, was restored when 
those researchers  substituted the IHF site with an A:T-rich sequence that 
conferred a bent structure to the DNA and thereby promoted the indirect binding 
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of HU (Swinger and Rice, 2003; Swinger and Rice, 2004; Swinger and Rice, 
2007). The ability to induce dramatic changes in DNA conformation makes IHF a 
versatile protein that can be used in a variety of scenarios. In the specific case of 
transcription, as  described above, the placement of the IHF binding site within a 
promoter region can dictate how IHF regulates transcription from that promoter. 
However, the binding of other proteins (e.g. CRP) in the vicinity of the promoter 
can modulate the function of IHF. 
Interestingly, there are many examples  of promoter DNA that contain  A-
tract (or T-tracts) sequences and, therefore, curved DNA regions. Curved DNA is 
most commonly found at two locations in core promoter regions: 1) immediately 
upstream of the -35 hexamer and 2) further upstream beyond the -35, such as 
-120 of the ilvIH operon. These regions of curvature have been shown to 
enhance RNAP binding to promoter DNA as well as recruit transcription factor 
binding. The presence of curved DNA on its own affects transcription activation, 
both positively and negatively, based solely on its  structure. Likewise, 
transcription factors, such as IHF, remodel promoter DNA to regulate 
transcription. However, the effects  of curved DNA and transcription factor binding 
are not mutually exclusive. The ilvPG2 promoter, which drives the expression of 
the ilvGMEDA operon, contains  both intrinsically bent DNA at -50 and an IHF 
binding site at -90, both of which activate transcription (Pagel et. al., 1992). 
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CRP-Dependent Activation 
Most mechanistic studies of bacterial transcription activation have focused 
on simple situations in which a single transcription factor can activate a given 
promoter. Most of these 
activators bind upstream of the 
transcription start site, make 
direct contacts with RNAP, and 
recruit it to the target promoter. 
These activators partition into 
two classes  based on the 
location of their binding sites. 
Class I activators  bind to 
ups t ream loca t ions  near 
position !61, !71, !81 or !91 
relative to the transcription start 
site. They activate transcription 
by making direct contacts with the carboxy-terminal domain of the " subunit ("-
CTD) of RNAP, stabilizing the initial steps  in the pathway of open complex 
formation. In contrast, Class II activators bind sites  that overlap the !35 hexamer 
of the target promoter and, typically, activate transcription by contacting domain 
4.2 of the #70 subunit of RNAP and the "-NTD, the amino-terminal domain of ". 
In some cases, Class II activators also make productive contacts  with the "-CTD, 
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Figure 3. Crystallographic Model of IHF Bound to the !H" 
Site. The "-subunit (cyan) and $-subunit (blue) of the IHF 
heterodimer make direct contact with DNA The proline finger 
located in the beta-ribbon arm of each subunit intercalates into 
ApA steps (orange) of the minor groove. The bent 
conformation is stabilized by hydrogen bonds with the A-tract 
(magenta). Other parts of heterodimer bind to the remaining 
bases of the WATCAANNNNTTR sequence (red and green)
(Aeling et al, 2007).
which often binds upstream of the bound activator. Arguably, the best-studied 
simple transcription factor is  CRP (cAMP receptor protein, also known as CAP). 
Over 200 genes are regulated 
by CRP. This  transcription 
factor becomes activated to 
bind DNA only when bound by 
cAMP. The active cAMP–CRP 
complex (hereafter referred to 
as CRP) can function either as 
a Class I act ivator that 
contacts  the !-CTD via a well-
c h a r a c t e r i z e d s u r f a c e 
determinant called activation 
region 1 (AR1) (Fig. 4A), or as 
a Class  II activator that interacts  with RNAP via AR1 and AR2, which contacts 
RNAP via the !-NTD (Fig. 4B). CRP also can function in tandem combinations of 
both, either Class II–Class  I or Class I–Class I. These more complex 
arrangements are often called Class III (Busby and Ebright, 1999).
FNR is a paralog of CRP; in addition to AR1 and AR2, it possesses a third 
surface (AR3), which permits it to also contact region 4.2 of "70 (Fig. 4B) In CRP, 
this  surface is masked; certain mutants remove the mask, exposing this non-
native surface (Busby and Ebright, 1999; Lawson et al., 2004; Rhodius, 2000).
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Figure 4. CRP-Dependent Activation. (A) Activation by CRP 
can occur by a Class I mechanism, in which CRP binds to an 
upstream site centered near positions –61, -71, -81, -91 and 
interacts through Activation Region 1 (AR1, 1) with an !-CTD.  
(B) Activation by CRP also can occur via a Class II mechanism, in 
which the activator binds a site near the –35 hexamer and 
interacts with RNAP via two surfaces (AR1) and Activation 
Region 2 (AR2, 2). With some proteins (e.g. FNR), a third surface 
called Activation Region 3 (AR3, 3) can interact with " region 4.2.
Acetyl-CoA Synthetase 
Acetyl coenzyme A synthetase (Acs) catalyzes the conversion of acetate 
to acety l -CoA through an 
enzyme-bound acetyladenylate 
(acetyl-AMP) intermediate (Fig. 
5A) (Berg, 1956). This activity 
permits the use of acetate to 
obtain energy through the 
tricarboxylic acid cycle and 
biosynthetic subunits via the 
glyoxylate bypass (Cozzone, 
1998). E. coli cells  require Acs 
to scavenge acetate from the 
environment (Brown et al., 
1977; Kumari et al., 1995). This 
delays entry into stationary 
phase and allows cells to 
compete successfully during 
periods of carbon starvation. 
Thus, the induction of Acs 
represents a survival response 
for cells entering a nutrient poor environment (reviewed by Wolfe, 2005).
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Figure 5. Acetyl-CoA Synthetase (Acs) and Transcription 
of its Gene (acs). (A) Acs catalyzes the activation of acetate 
to acetyl-CoA in an ATP- and HS-CoA-dependent manner. 
The by-products are pyrophosphate (PPi) and adenosine 
monophosphate (AMP). The resultant acetyl-CoA enters the 
TCA cycle and the glyoxylate shunt (GS). (B) acs transcription 
is induces as glucose (glc) levels approach depletion and 
acetate (ace) concentration begins to peak. Peak 
transcription occurs as cells enter stationary phase.
Like many other genes required for the use of secondary carbon sources, 
acs is  subject to catabolite repression (Kumari et al., 2000): cells growing on their 
preferred carbon source (e.g. glucose for E. coli) inhibit acs transcription (Kumari 
et al., 2000; Oh et al., 2002; Shin et al., 1997). However, the major byproduct of 
glucose metabolism is acetate, which cells  excrete into their environment. Thus, 
the extracellular concentration of acetate rises as the concentration of glucose 
falls (Fig. 5B). Just prior to exhaustion of the glucose, cells induce acs 
transcription. This event occurs  during the transition from exponential growth to 
stationary phase (Kumari et al., 2000; Shin et al., 1997). As the culture enters 
stationary phase, transcription peaks and then decreases rapidly. A similar 
expression pattern happens during growth in tryptone broth, a mixture of amino 
acids. As  E. coli cells  exhaust L-serine, their preferred amino acid, they induce 
acs transcription (Pruss et al., 1994; Kumari et al., 2000; Browning et al., 2004). 
As with glucose, transcription peaks as the culture enters stationary phase 
(Kumari et al., 2000), decreases rapidly, and then slowly increases - this  time, in 
parallel with the concentration of extracellular acetate (Wolfe, 2005).
The enzymatic process catalyzed by Acs improves  fitness. When first 
grown on glucose or acetate as the sole carbon source and then permitted to 
starve, cells  that retain Acs out-compete those that lack Acs. The implication of 
these results is that starving cells rely on the ability of Acs to scavenge for scarce 
acetate in the environment (Wolfe, unpublished data). However, if left 
unregulated, Acs can be dangerous. Overexpression of Acs is  lethal (Kumari et 
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al., 2000). This is likely due to its use of CoA as a substrate. The unregulated 
activity of Acs  would deplete the cell’s store of CoA, which is maintained in 
limiting quantities. Thus, cells  regulate the activity of Acs (via N-lysine 
acetylation) and the transcription of acs, the gene that encodes it (reviewed by 
Wolfe, 2005). 
Regulation of acs transcription occurs primarily at the level of initiation 
(Kumari et al., 2000). As befits a critical survival gene, this regulation is  quite 
complex. What follows is  a description of the machinery that controls the initiation 
of acs transcription. 
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acs Operon and Promoter Architecture
acs is  the first gene in an operon that includes yjcH, a hypothetical gene, 
and actP (formerly known as yjcG), which encodes an acetate permease (Fig. 
6A) (Gimenenz et al., 2003) whose physiological purpose remains unknown. No 
evidence exists  for internal promoters; thus, transcription of the acs operon 
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Figure 6. The acs Operon and the nrf-acs Intergenic Region. (A) acs is the first gene in a 
three gene operon. Its transcription is controlled by 3 promoters, which transcribe divergently 
from the nrf  promoter, which drives transcription of the nrf operon. (B) The region 5’ of acs 
includes three promoters, two DNA sites for the transcription factor CRP and three sites each for 
the nucleoid proteins FIS and IHF. The numbers are in reference to the +1 of acsP2. (C) The 
repressed state of acsP1 results from the action of two nucleoid proteins (FIS and IHF) and 
several transcription factors (FNR, NsrR, NarP, and NarL). X-10, the extended –10 of the nrf 
promoter; -10, the –10 hexamer of acsP1. The numbers are in reference to the +1 of acsP1.
apparently initiates only from the regulatory region of acs, located upstream (5') 
of the acs open reading frame.
The regulatory region of acs includes three !70-dependent promoters: the 
proximal major promoter acsP2; a minor promoter called acsP2A located 18-bp 
upstream of acsP2, and the distal minor promoter acsP1 located some 200-bp 
upstream of acsP2 and acsP2A (Fig.6B) (Beatty et al., 2003; Browning et al., 
2002; Kumari et al., 2000a, Kumari et al., 2000b). 
Activation of acsP2
In vitro, RNAP alone does not efficiently transcribe the proximal acsP2. It 
does, however, bind and melt an extensive region of DNA that includes both 
acsP2 and acsP2A (Beatty et al., 2003). For efficient transcription, it requires 
CRP. Because acs transcription depends on CRP, it is  subject to catabolite 
repression (Beatty et al., 2003; Kumari et al., 2000). This well-studied regulatory 
mechanism results from the normal action of the phosphoenolpyruvate (PEP)-
dependent sugar phosphotransferase system (PTS). Using PEP as the 
phosphoryl donor, the PTS simultaneously phosphorylates  certain sugars (for 
example, glucose) and transports them across the cytoplasmic membrane into 
the cytosol, where the phosphorylated sugars enter glycolysis. As the sugars 
become scarce, the PTS instead activates adenylate cyclase, which synthesizes 
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cAMP. The cAMP can then bind the CRP homodimer, altering its conformation so 
that it can bind to its DNA sites (reviewed by Deutscher et al., 2006).
CRP can activate the major promoter acsP2 using a variant of the Class  III 
mechanism (Fig. 7C). At this 
promoter, two CRP homodimers 
bind in tandem at DNA sites 
centered at Class I positions: 
the higher affinity and proximal 
site (CRP I) is  centered at 
position -69.5, while the lower 
affinity and distal site (CRP II) is 
centered at -122.5. The binding 
of each CRP homodimer is 
predicted to incur a bend in the 
DNA up to 45º. This  bending 
helps bring each homodimer 
closer to the promoter and thus 
to the ! -CTD. Ac t i va t ion 
absolutely requires that one 
dimer bind the proximal CRP I. To achieve maximal transcription, however, a 
second dimer also must bind to the distal CRP II (Beatty et al., 2003).
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Figure 7. CRP Activates acsP2 Transcription Using the 
Class III Mechanism that Involves Tandem Class I Sites. 
CRP activates transcription by (C) inhibiting the formation of 
the nascent acsP2A OC (A) and stabilizing the pre-formed 
acsP2 OC (B). Black box, acsP2 –10 hexamer; black arrow, 
acsP2 +1; gray box, acsP2A –10 hexamer; gray arrow, 
acsP2A +1. Because the exact binding sites for the two !-
CTDs are unknown, multiple !-CTDs are shown. To indicate 
that the positions are putative, each tether and  !-CTD is 
denoted with or encompassed by a dotted line. The arrow 
indicates re-positioning of the !-CTDs by CRP.
Figure 7. CRP Activates acsP2 Transcription Using the Class III 
Mechanism that Involves Tandem Class I Sites. CRP activates transcription 
by (C) inhibiting the formation of the nascent acsP2A OC (A) and stabilizing 
the pre-formed acsP2 OC (B). Black box, acsP2 –10 hexamer; black arrow, 
acsP2 +1; gray box, acsP2A –10 hexamer; gray arrow, acsP2A +1. Because 
the exact binding sites for the two !-CTDs are unknown, multiple !-CTDs are 
shown. To indicate that the positions are putative, each tether and  !-CTD is 
denoted with or encompassed by a dotted line. The arrow indicates re-
positioning of the !-CTDs by CRP. 
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Most often CRP functions from Class I sites by stabilizing the closed 
complex (CC). Using the surface determinant AR1, the CRP dimer contacts the 
287 surface determinant of the !-CTD (Fig. 4A). This interaction stabilizes the 
CC, permitting the subsequent formation of a open complex (OC), the next 
intermediate in the transcription initiation pathway (Browning and Busby, 2004; 
Busby and Ebright, 1999). At acsP2, the mechanism is a bit more complex. 
Although CRP I, AR1 and determinant 287 help to stabilize the TCC, their 
contribution cannot be limited to this role: RNAP alone can bind both acsP2A and 
acsP2 and form TOCs, albeit in inactive forms (Fig. 7A, B) (Beatty et al., 2003).
Modulation of CRP-Dependent Activation by Nucleoid Proteins
Of the twelve nucleoid proteins of E. coli, both FIS and IHF can inhibit 
transcription of acs. Within the acs promoter region, FIS and IHF can each bind 
to three sites (Fig. 6B). Furthermore, all six sites can be occupied simultaneously. 
Finally, both nucleoid proteins function independently to antagonize CRP-
dependent activation of acsP2 (Browning et al., 2004).
Negative Regulation by FIS 
FIS can inhibit CRP-dependent acsP2 transcription directly by a 
mechanism called anti-activation. This mechanism relies on the ability of FIS to 
bind to two higher affinity sites: FIS II and FIS III (Fig. 8). FIS II (centered at -98) 
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lies between CRP II  (-122.5) and CRP I (-69.5), while FIS III  (-59) overlaps CRP 
I. Competitive DNase I footprint and electrophoretic mobility shift analyses, and in 
vitro transcription assays indicate that FIS can displace CRP from both its  sites. 
In  vivo, a mutation in FIS II that diminishes its affinity for FIS by more than ten-
fold increases acs transcription two- to three-fold during growth in tryptone broth. 
A similar increase results from a mutation that favors the binding of CRP over 
that of FIS to their overlapping sites  (CRP I and FIS III). Thus, the competition 
between FIS and CRP for binding to their overlapping and tandem sites helps to 
keep acsP2 transcription low (Browning et al., 2004). Because FIS levels rise 
dramatically during outgrowth in rich medium from stationary phase and then 
progressively diminish throughout exponential growth (Azam et al., 1999; Ball et 
al., 1992). FIS appears to be responsible for maintaining acs transcription at 
basal levels during rapid growth conditions when the activity of acs is 
unnecessary.
Negative Regulation by IHF 
The concentration of IHF in cells  harvested from early exponential growth 
has been estimated at about 0.7 nM (Murtin et al., 1998). This concentration 
increases progressively throughout growth until, during stationary phase, it 
becomes the second most abundant nucleoid protein (Azam et al., 1999; 
Ishihama, 1999). The binding of IHF to its specific sites causes the DNA to bend 
up to 180 degrees and to wrap around the protein (Lynch et al., 2003; Rice et al., 
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1996; Travers, 1997). IHF affects acs transcription by binding to three high affinity 
sites (IHF I - III) located between positions -140 and -240 relative to the +1 of 
acsP2 (Fig. 6B) (Browning et al., 2004). Of particular importance to this 
dissertation is  the observation that the 31-bp sequence IHF III causes a severe 
inhibition of CRP-dependent activation.
Concluding Remarks
The acs promoter exemplifies  the complexity of bacterial promoters. At 
first glance, transcription from the acs promoter appears to be simple enough: 
acsP2 is a weak CRP-dependent promoter activated by the tandem Class I 
variant of the Class III mechanism. Deeper study, however, shows that this 
promoter is subject to considerably more sophisticated regulatory mechanisms 
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Figure 8. FIS-Dependent Anti-Activation of CRP-Dependent acs 
Transcription. FIS out-competes CRP binding to their overlapping 
DNA sites. Because CRP cannot bind, transcription does not occur. 
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Figure 8. FIS-Dependent Anti-Activation of CRP-Depe dent acs 
Transcription. FIS out-competes CRP binding to their overlapping DNA 
sites. Because CRP cannot bind, transcription does not occur.  
that involve intricate competition between multiple transcription factors and 
multiple NAPs. 
It was the goal of my dissertation to understand how IHF III inhibits  CRP-
dependent acs transcription. The initial studies performed in collaboration with 
Bianca Sclavi led to the recognition that occupancy of IHF III causes the 
formation of a stalled nucleoprotein complex comprised of RNAP, two CRP 
homodimers, and IHF. Further investigation led to the discovery that IHF III is a 
composite sequence comprised of two overlapping DNA sites for IHF. One, 
orientated towards the promoter, sits on one face of the DNA helix orient. The 
other, orientated away from the promoter, sits on the other. Together, they control 
CRP-dependent acs transcription.
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CHAPTER TWO
MATERIALS AND METHODS
Chemicals and Biological Reagents
 Chemical reagents  were purchased from Fisher Scientific (Pittsburgh, PA) 
and Sigma Chemical Company (St. Louis, MO). !-galactosidase assay reagents 
were purchased from Pierce Biochemicals (Rockford, IL). Restriction 
endonucleases and modifying enzymes were purchased from Promega Corp. 
(Madison, WI), New England Biolabs (Beverly, MA) or Gibco BRL (Gaithersburg, 
MD). Primers were purchased from Integrated DNA technologies (Iowa). Media 
components were obtained from Difco. 
Bacterial strains, plasmids, bacteriophage, and promoter fragments
 All bacterial strains, plasmids, bacteriophage, and promoter fragments 
used in this study are listed in Tables 1-4. Derivatives  of the E. coli K-12 strain, 
AJW678, were used for all experiments.
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 By convention, all locations within the nrfA - acs intergenic region (Fig. 9A) 
are numbered relative to the transcription start site of acsP2 (+1) with upstream 
and downstream locations prefixed ‘-‘ and ‘+’, respectively.
 The constructions  of the promoter fragments FL, 1xIHF, and 0xIHF 
(pacs444, pacs236, and pacs205 respectively) were described previously (Beatty 
et al., 2003; Browning et al., 2004). Promoter fragment 1xCRP (pacs155) was 
constructed by digestion of pCB63 (Browning et al., 2004), followed by re-ligation 
to form a promoter fragment that lacked sequences upstream of CRP II. This 
construct was digested with EcoRI and BamHI, subcloned into the lacZ fusion 
vector pRS415 to generate pCB91, and recombined with the lacZ fusion vector 
!RS88, using the method of Simons et al. (Simons et al., 1987). The 
constructions of the mutations G74C and G126C, which disrupt the binding of 
CRP to CRP I and CRP II, respectively, have been described previously (Beatty 
et al., 2003). The double mutation C150G/C153G, which disrupts binding of IHF 
to IHF III, was generated using the Gene Editor site-directed mutagenesis kit 
(Promega, Madison WI). The primer IHFIII (CTGCATGTTCGTGAAAG) was used 
to mutagenize the template pCB26 (Beatty et al., 2003), generating pCB92. 
Successive promoter fragments were generated using either pCB26 (the full-
length promoter cloned into pGEMT) as a template or existing promoter 
mutations cloned into pGEMT (e.g. pCB26-F2m; Fis II mutation). For example, 
pCB92 was used as  the template to generate 1xIHF-I3m using this  plasmid as a 
template the primer pairs  P2 (GAATTCCATAACTGCATGTTC) and 2926. After 
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amplification, all promoter fragments were cloned in to TOPO2.1 vector 
(Invitrogen) and sequenced to identify any present mutations. All verified 
promoters were digested with EcoRI and BamHI and cloned into pRS415. 
Following this cloning step, all promoters  were sequenced once more and then 
recombined with !RS88. A similar strategy was  used to construct 2xIHF-I3m 
variants carrying the G74C and G126C mutations. Single lysogens of strain 
AJW678 ("lac) were constructed and verified, as  described previously (Simons 
et al., 1987). Primers specific for the ! attachment sites were used to determine 
whether the resultant lysogens were in single or multiple copies  (as described by 
Sowell et al, 1994): 
!attB (GAGGTACCAGCGCGGTTTGATC) 
!attP (TTTAATATATTGATATTTATATCATTTTACGTTTCTCGTTC)
!int (ACTCGTCGCGAACCGCTTC) 
 The "crp::Km allele was transferred from strain CB369 by generalized 
transduction with P1kc (Silhavy et al., 1984).
 For in vitro studies, we used the plasmids pSRacsFL and pSR1xIHF. The 
construction of pSRacsFL was described previously (Beatty et al., 2003). 
pSR1xIHF was constructed similarly. pSR1xIHF was PCR amplified using the 
pr imer pair P2 (GAATTCCATAACTGC-ATGTTC) and 2926Hind I I I 
(AAGCTTGTTGGGTCTGCG-ATGTTG). This facilitated subcloning of the 
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fragment with an upstream EcoRI linker and a downstream HindIII linker into the 
in vitro transcription vector pSR (Kolb et al., 1995).
 All PCR amplifications were performed in a 50 µl reaction volume. The 
reactions contained 1X PCR buffer (Promega), 3 mM MgCl2, 20 nM each primer, 
0.2 mM dNTPs and 1 U Taq polymerase. Reactions were subjected to 1 cycle of 
95oC for 5 minutes, then 30 cycles 95oC for denaturing, 68oC for annealing, and 
72oC for extension. Site-directed mutations were generated using the Gene 
Editor site-directed mutagenesis  kit (Promega), following the protocol provided. 
The resultant PCR products were subcloned into pGEM-t and the successful 
incorporation of mutations was verified by sequencing.
 For cloning and transformations, plasmids were prepared using the 
Wizard miniprep kit (Promega), following the protocol provided. All restriction 
digestions and ligations were performed according to standard methods, as 
described (Sambrook et al., 1989).
Media and growth conditions
 For strain construction procedures, cells were grown in Luria Broth (LB; 
1% (wt/vol) tryptone, 0.5% (wt/vol) yeast extract and 0.5% (wt/vol) sodium 
chloride). For !-galactosidase assays, cells were grown at 37oC in tryptone broth 
(TB; 1% (wt/vol) tryptone and 0.5% (wt/vol) sodium chloride). Media were 
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supplemented with antibiotics or 5-bromo-D-chloro-galactopyranoside (X-gal), as 
needed.
Promoter activity assays
 !-galactosidase activity was determined quantitatively using the Y-PER !-
galactosidase assay kit (Pierce Biochemical). Cells  were harvested at 
approximately one-hour intervals over a growth curve. The activities were plotted 
against optical density to standardize for subtle differences in growth rates. From 
these plots, the peak activity was identified and standardized to that of the AR2 
mutant for each promoter construct tested. The values expressed are the mean 
and the standard error of the mean of three independent measurements. Each 
experiment was performed in triplicate and assayed three to five times to 
determine the reproducibility of the data. Some reporter truncations were re-
constructed to ensure reproducibility from beginning to end. 
Protein preparation
 Purified RNA polymerase was purchased from Epicentre Technologies. 
Purified WT CRP was a kind gift from Annie Kolb (Institute Pasteur, Paris, 
France). The plasmids that encode the mutant proteins (CRP KE101 and CRP 
HL159) and the crp mutant cells were a kind gift of Nigel Savery (University of 
Bristol, UK). The mutant CRP proteins (CRP KE101 and CRP HL159) were 
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prepared, as described previously (Ghosaini et al., 1988). Purified IHF protein 
was prepared by the method of Nash et al. (Nash et al., 1987).
DNase I footprint analysis
 Footprint analysis was a modification of the protocol described by Gralla 
(Gralla, 1985). 0.1 nM supercoiled plasmid DNA was incubated with varying 
concentrations of IHF, CRP, and/or RNAP in 10 µl total volume at 37oC in 
footprinting buffer (20mM Hepes pH 8, 5 mM MgCl2, 50 mM potassium 
glutamate, 1 mM DTT, 500 µg/ml deacetylated BSA). After 20 minutes, 1 µl of 5 
µg/ml DNase I (Worthington) was added. After 20 seconds, the reaction was 
stopped by adding 10 µl of stop solution (2X Taq Platinum buffer (Invitrogen), 2.5 
nM labeled oligonucleotide, 2 µg/ml ctDNA, 240 µM dNTPs). One unit of 
Platinum Taq DNA polymerase (Invitrogen) was added.  Primer extension was 
carried out in a Robocycler PCR machine (Stratagene) for 30 cycles.  Line 
graphs of band intensities were obtained using ImageQuant Software (Molecular 
Dynamics) and standardized by the band at -35, and, when possible, bands 
upstream and downstream of the footprint.
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Potassium permanganate footprint analysis
 1 nM supercoiled plasmid DNA was incubated with varying concentrations 
of IHF, CRP, and/or RNA polymerase in 10 µl total volume at 37oC in footprinting 
buffer (20mM Hepes pH 8, 5 mM MgCl2, 50 mM potassium glutamate, 1 mM 
DTT, 500 µg/ml deacetylated BSA). After 20 minutes, 1 µl of a frozen aliquot of 
200 mM potassium permanganate was added. After 20 seconds, the reaction 
was stopped by the addition of 50 µl of stop solution (4% !-mercaptoethanol, 1.6 
M sodium acetate, 4 µg/ml ctDNA). The samples were then cleaned by a phenol/
chloroform extraction followed by ethanol precipitation. They were then 
resuspended in 10 µl of water to which 10 µl of primer extension solution was 
added (2X Taq Platinum buffer (Invitrogen), 2.5 nM labeled oligonucleotide, 5 mM 
MgCl2, 240 µM dNTPs, 1 unit of Platinum Taq (Invitrogen)). Primer extension was 
carried out in a Robocycler PCR machine (Stratagene) for 20 cycles. Bar graphs 
were obtained using ImageQuant software to quantify the band intensities, Excel 
(Microsoft) to calculate the ratio of P2A, P2UP, or P2DOWN relative to total 
intensity, and Origin (Originlab) to produce the plots.
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Table 1. Strains, plasmids and phage not listed in Tables 2-4.
Strain, plasmid, phage Relevant characteristics Source or reference
Strains
AJW678 thi-1 thr-1(Am) leuB6 metF159(Am) rpsL136 !lacX74 (Kumari et al., 2000a)
CB369 MG1655 !crp::Km C. Bausch
P90C ara !(pro-lac) thi (Simons et al., 1987)
Plasmids
pRS415 bla+ lacZ+, transcriptional (operon) fusion vector (Simons et al., 1987)
pCB26 pGEM-t carrying -411 acs through the acs ORF, 
template for site-directed mutants
(Beatty et al., 2003)
pDCRP pBR322 derivative carrying wild-type crp gene (1+2+3o) (Rhodius et al., 1997)
pDCRP/H159L pDCRP derivative carrying crpH159L allele (1-2+3o) (Rhodius et al., 1997)
pDCRP/K101E pDCRP derivative carrying crpK101E allele (1+2-3o) (Rhodius et al., 1997)
pDCRP/K52N pDCRP derivative carrying crpK52N allele (1+2+3+) (Rhodius et al., 1997)
pDCRP/H159L/K101E pDCRP derivative carrying crpH159L K101E allele  
(1-2-3o)
(Rhodius et al., 1997)
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pDCRP/H159L/K101E/
K52N
pDCRP derivative carrying crpH159L K101E K52N 
allele (1-2-3+)
(Rhodius and Busby, 2000)
pDCRP/H159L/K52N pDCRP derivative carrying crpH159L K52N allele 
(1-2+3+)
S. J. W. Busby
pDCRP/K101E/K52N pDCRP derivative carrying crpK101E K52N allele 
(1+2-3+)
S. J. W. Busby
pGEM-t pUC19-derived TA cloning vector Promega
pSR in vitro transcription vector used for all in vitro work (Kolb et al., 1995)
pRW50 promoterless lacZYA (Lodge et al., 1992)
Bacteriophages
!RS88 bla=lacZ imm434 ind, transcriptional (operon) fusion 
vector
(Simons et al., 1987)
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Table 2. Promoter fragments used in Chapter 3, with corresponding plasmid, phage, and strains.
Promoter Description Plasmid Phage WT 
strain
delta crp 
strain
Reference
pacs444 AatII-HindIII fragment 
carrying acs sequences from 
position -379 to +65
pCB33 !CB12 AJW1941 AJW2183 (Beatty et al., 
2003)
pacs236 PCR product carrying acs 
sequences from position -171 
to +65
pCB60 !CB22 AJW2026 AJW2086 (Browning et 
al., 2004)
pacs205 PCR product carrying acs 
sequences from position -140 
to +65
pCB61 !CB42 AJW2179 AJW2198 (Browning et 
al., 2004)
pacs155 PCR product carrying acs 
sequences from position -90 
to +65
pCB91 !CB39 AJW2203 AJW2199 This study
pacs236 
G74C
CRP I mutant of pacs236 pCB71 !CB29 AJW2080 AJW2192 This study
pacs236 
G126C
CRP II mutant of pacs236 pCB96 !CB45 AJW2202 AJW2812 This study
pacs236 
C150G/
C152G
IHF III mutant of pacs236 pCB96 !CB44 AJW2813 AJW2814 This study
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Table 3. Promoter fragments not listed in Tables 1 or 2, used in Chapter 4.
Promoter Description Reference
pacs1xIHF A164T predicted to affect both IHF IIIa and 
IIIb
This study
pacs1xIHF T158G predicted to affect IHF IIIb This study
pacs1xIHF A157G predicted to affect IHF IIIb This study
pacs1XIHF A156G predicted to affect IHF IIIb This study
pacs1xIHF C150A predicted to affect IHF IIIa This study
pacs1xIHF A149C predicted to affect IHF IIIa This study
pacs1xIHF A148C predicted to affect IHF IIIa This study
pacs1xIHF T142A predicted to affect both IHF IIIa and 
IIIb 
This study
pacs1xIHF A148C predicted to affect IHF IIIa This study
pacs1xIHF-VF swaps IHF IIIa with IHF IIIb This study
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Table 4. Promoter fragments not listed in Tables 1-3, used in Chapter 5.
Promoter Relevant characteristics Source or 
reference
pacs1xIHF+5 complete palindrome sequence This study
pacs1xIHF+5S upstream 5 bases (palindrome 
half-site) scrambled
This study
pacs1xIHF C152G C150G IHF III weakened This study       
pacs1xIHF C152A C153A IHF III strengthened This study
pacs2xIHF contains IHF II and IHF III This study
pacs2xIHF-A170C T169C contains IHF II and IHF III; IHF 
II weakened
This study
pacs2xIHF-A170T contains IHF II and IHF III; IHF 
II strengthened
This study
pacs2xIHF-G134C contains IHF II and IHF III; 
CRP II mutated
This study
pacs2xIHF-C177T contains IHF II and IHF III; IHF 
II mutated
This study
pacs2xIHF C152G C150G contains IHF II and IHF III; IHF 
III mutated
This study
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CHAPTER THREE
THE MULTIPLE ROLES OF CRP AT THE COMPLEX ACS 
PROMOTER DEPEND ON ACTIVATION REGION 2 AND IHF
Introduction
 Previously, the Wolfe lab reported that E. coli cells control Acs activity 
primarily at the level of transcription initiation (Kumari et al., 2000a). The 
regulatory region of acs includes three !70-dependent promoters: the proximal 
major promoter acsP2; a minor promoter called acsP2A located 18-bp upstream 
of acsP2, and the distal minor promoter acsP1 (Figs.6 and 9A) (Beatty et al., 
2003; Browning et al., 2002; Kumari et al., 2000a; Kumari et al., 2000b). 
Transcription is induced during mid-exponential phase and peaks as  cells enter 
stationary phase, whereupon it diminishes (Kumari et al., 2000a) (Fig. 5B). While 
multiple factors influence transcription (Browning et al., 2002; Kumari et al., 
2000a), CRP appears to function directly as the most critical transcription factor 
(Beatty et al., 2003; Kumari et al., 2000a).
 CRP activates the major promoter acsP2 using a variant of the Class III 
mechanism. Two CRP homodimers bind in tandem at DNA sites centered at the 
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Class I positions -69.5 and -122.5 (Figs.7C and 9A). Using the surface 
determinant AR1, each dimer contacts the !-CTD, recruiting RNAP to acsP2 
and, thus, facilitating activation of acs transcription. Activation absolutely requires  
that one dimer binds CRP I, the proximal, higher affinity site. To achieve maximal 
transcription, however, a second dimer also must bind to CRP II, the distal, lower 
affinity site (Beatty et al., 2003).
 Similar to transcription regulation in eukaryotes, bacteria transcription is 
also modulated by histone-like proteins that fold the genome into the highly 
compacted, highly organized nucleoid (Kim  et al., 2004). In both kingdoms, 
changing the DNA architecture provides a structural barrier that limits the access 
of transcription factors and RNAP. However, unlike eukaryotes, the interaction 
between DNA and bacterial histone-like proteins is  dynamic – the same nucleoid 
protein may not remain stationary to the same DNA region (The Bacterial 
Chromosome, Higgins, 2005). E. coli possesses twelve nucleoid proteins whose 
functions are as diverse as their structures (Azam et al., 1999; Ishihama, 1999). 
Of these twelve proteins, Fis and IHF inhibit transcription of acs (Browning et al., 
2004).  
 Within the acs promoter region, Fis  and IHF each bind to three sites (Fig. 
6B). Furthermore, each nucleoid protein independently antagonizes CRP-
dependent activation of acsP2. The mechanism of this  antagonism is  largely 
unknown save for the direct competition between Fis and CRP at their 
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Figure 9. The organization of the acs promoter. (A) This schematic shows the acs promoter 
region from positions -379 to +65 relative to the acsP2 transcription start site (+1). It shows the 
locations of each promoter, each CRP and IHF binding site and the extent of the promoter 
fragments. The bent arrows indicate the approximate location of each promoter and its direction of 
transcription. Inverted arrows indicate the locations of CRP I and CRP II, as determined by similarity 
to consensus. Hatched boxes designate the locations of IHF I-III, also determined by similarity to 
consensus. (B) Binding site mutations used in this study. The core consensus sequence for each 
binding is underlined and the substituted nucleotide(s) positioned above the mutated one.  (C) !-
galactosidase activity from promoter fragments pacs444 (FL), pacs236 (1xIHF), pacs205 (0xIHF), 
pacs155 (1xCRP), or pacs236 (1xIHF) variants defective for CRP I, IHF III, or CRP II fused to 
lacZYA. The wild type strain AJW678 was lysogenized with the hybrid phages "CB12, "CB22, 
"CB42, "CB39, "CB29, "CB44, or "CB45, respectively (Table 2). The resultant strains were grown 
in TB, samples harvested at one-hour intervals, the !-galactosidase activity determined, and the 
peak activity expressed as a percentage of wild-type. Each value represents the mean + SEM of at 
least three independent measurements. The percentage activities in relation to pacs444 (FL) are 
noted within each histogram.
overlapping sites, Fis III  and CRP I (Fig. 8) (Browning et al., 2004). Because its 
levels  peak dramatically during outgrowth from stationary phase and then 
progressively diminish throughout exponential growth (Azam et al., 1999; Ball et 
al., 1992), Fis likely maintains acs transcription at basal levels under rapid growth 
conditions. The role of IHF has remained less clear: in vitro it is known to bind 
simultaneously with CRP and to cause inhibition of acsP2 transcription; in vivo, 
however, the upstream sequence, which contains the two distal IHF sites, the 
minor promoter acsP1, and the divergent promoter Pnrf, has a positive effect on 
transcription (Browning et al., 2004). 
 In this  chapter, I will describe genetic and biochemical experiments 
designed to answer the following question: How does IHF inhibit transcription? 
We anticipated that the underlying mechanism would be novel because, unlike 
Fis, IHF does not compete directly with CRP for binding. To answer this question, 
we set out to: 1) test whether the 31-bp sequence that includes  IHF III was 
responsible for the lowered transcriptional profile exhibited by the acsP2 
promoter; 2) identify the factors involved in this IHF–mediated inhibition of acsP2 
transcription; 3) determine how these factors work together to inhibit acs 
transcription; and 4) determine whether Fis plays a role in this inhibitory 
mechanism. This  study demonstrates that interactions between well-
characterized regulators can, within the context of complex promoters, result in 
novel mechanisms of gene regulation that remain to be explored. 
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Inhibition of CRP-dependent transcription by IHF III depends on CRP II
 Previous results suggested the existence of multiple IHF-mediated 
nucleoprotein complexes that exert differential effects  upon acs transcription 
(Browning et al. 2004; Browning et al 2002). To simplify the testing of this 
hypothesis, we first sought to define the minimal system required for IHF-
dependent inhibition. We began with 1xIHF (also known as pacs236), an 
acs::lacZYA promoter fusion that includes the inhibitory 31-bp sequence 
(Browning et al., 2004). Since the 31-bp sequence includes IHF III (Fig. 9A), we 
determined whether it participates in the inhibition of acs transcription by 
introducing a double base pair replacement mutation (Fig. 9B) predicted to 
diminish affinity for IHF (Browning et al., 2002; Lee et al., 1991). The mutant 
promoter fusion, 1xIHF-I3m, and all others used in this study, was recombined 
into a hybrid ! bacteriophage and introduced as a monolysogen into AJW678, a 
"lac strain that is  wild-type (WT) for both acetate metabolism and crp (Table 1). 
We grew the resulting monolysogen in tryptone broth (TB) at 37oC, harvested 
cells at approximately one hour intervals, and compared its !-galactosidase 
activity to that of monolysogens that carried 1) its parent 1xIHF, 2) the smaller 
promoter fragment, 0xIHF (also known as  pacs205), that includes acsP2, CRP I, 
and CRP II, but lacks IHF III (Table 2, Fig. 9A), or 3) the full-length acs::lacZYA 
fusion (FL) from which 1xIHF and 0xIHF were derived (Table 2, Fig. 9A). The 
mutant 1xIHF-I3m exhibited about two-fold more activity than its  parent 1xIHF, 
but only about a third as much as FL and only about half as much as  0xIHF (Fig. 
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9C). These results support the supposition that IHF III  contributes  to inhibition of 
acs transcription and that sequences upstream of IHF III contribute to full 
activation. 
 To determine whether inhibition by IHF also requires the integrity of the 
DNA sites for CRP, we introduced mutations (Fig. 9B) previously shown to reduce 
affinity for CRP (Ebright et al., 1984). We incorporated these mutations into 
1xIHF and monitored the activity of the resultant constructs  (Fig. 9C). 1xIHF-C1m 
displayed about half the activity of its parent 1xIHF, approximately equivalent to 
basal levels (data not shown). In contrast, 1xIHF-C2m exhibited as much activity 
as 0xIHF, which lacks IHF III altogether. These results verify that activation of 
acsP2 transcription requires CRP I (Beatty et al., 2003) and shows that IHF-
dependent inhibition requires CRP II.
 This  latter result came as a surprise, because Beatty and co-workers had 
previously reported that disruption of the CRP II  site in the full-length promoter 
fragment (FL-C2m) exhibited two-fold less promoter activity than did its full-
length, WT FL parent (Fig 9C) (Beatty et al., 2003). To test our previous 
observation, we constructed a promoter fusion that includes CRP I  but lacks 
CRP II (1xCRP; pacs155) (Fig. 9A), and monitored the activity of the resultant 
construct (Fig. 9C). As predicted if CRP II enhanced transcription, 1xCRP 
exhibited about one-half the activity displayed by 0xIHF, which includes both 
CRP I and CRP II. In the context of 1xIHF, therefore, CRP II has the opposite 
effect, acting negatively instead of positively. 
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I n h i b i t i o n o f t r a n s c r i p t i o n 
involves K101 of CRP
 Previously, the Wolfe lab had 
s h o w n t h a t C R P - d e p e n d e n t 
activation of acs transcription from 
FL promoter depends on AR1 but 
not on AR2 (Beatty et al., 2003). To 
explore the mechanism of inhibition 
observed for 1xIHF, we performed 
similar studies on the smaller 
promoter constructs (Fig. 9A; Table 
2). By generalized transduction, we 
introduced a crp deletion allele into 
monolysogens of 0xIHF and 1xIHF. 
W e t h e n 
transformed the 
resulting strains 
w i t h a s e t o f 
plasmids, each of 
which expresses a 
CRP variant (Table 
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Figure 10. IHF III-dependent inhibition involves AR2 and AR3 of CRP. !-
galactosidase activity from promoter fragments 1xIHF, 0xIHF, and 1xIHF-C2m 
fused to lacZYA. The wild type strain AJW678 was lysogenized with the hybrid 
phage !CB22, "CB42, and "CB45, respectively. Each lysogen was deleted for 
crp and transformed with plasmids expressing wild-type CRP or mutant 
variants. Wild-type CRP possesses AR1 and AR2, but not AR3 and is 
designated as 1+2+3o. The mutants either lack AR1 (1-) or AR2 (2-) or possess 
the non-native AR3 (3+) or combinations of each. The resultant transformants 
were grown in TB, samples harvested are regular intervals, and the peak !-
galactosidase activity determined and expressed relative to the mutant that 
lacks AR2 1+2-3o. Each value represents the mean ± SEM of at least three 
independent measurements. For each promoter construct, all values were 
standardized to that obtained in the crp mutant transformed with the plasmid 
expressing the mutant CRP KE101.
1). Each variant possesses one of the eight possible combinations of WT or 
mutant versions of three surfaces  known to be involved in transcription activation. 
HL159 is defective for the AR1 surface that contacts  the !-CTD of RNAP, KE101 
is  defective for the AR2 surface that interacts with the !-NTD, and the KE52 
mutation exposes a non-native AR3 surface that contacts region 4.2 of "70. 
Activation of Class I promoters, such as acsP2, absolutely requires AR1 (Fig. 
4A). In contrast, activation of Class II promoters requires AR2 and either AR1 or 
AR3 (Fig. 4B) (reviewed by (Busby and Ebright, 1999)).
 For both 0xIHF and 1xIHF and for all other promoter constructs tested in 
this  study, activation required AR1. Without it, as we previously observed with the 
FL promoter construct (Beatty et al., 2003), promoter activity was reduced to 
basal levels, regardless of the status of the other two surfaces (Fig. 10 and data 
not shown). When AR1 was left intact, activity from 1xIHF increased in the 
absence of AR2. This  effect was reversed by the presence of AR3, while the 
effect of having both the AR2 and AR3 surfaces was additive (Fig. 10). In 
contrast, activity from 0xIHF was generally unaffected by either the status of AR2 
or the addition of the AR3 surface to the AR2-less mutant. However, the 
presence of both AR2 and AR3 inhibited transcription. We conclude that AR2 
contributes to IHF-dependent inhibition and propose that the additional presence 
of AR3 (when both AR1 and AR2 are intact) over-stabilizes RNAP on the DNA.
 Since inhibition depends upon both CRP bound at CRP II  and an intact 
AR2, we predicted that AR2 would have no effect in the absence of CRP II. To 
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test this prediction, we introduced the crp deletion allele into a monolysogen that 
carries 1xIHF-C2m, and transformed the resulting strain with plasmids  that 
express wild-type CRP or mutants defective for AR1, AR2, and/or AR3. As a 
control, we did likewise with a monolysogen that carried 1xCRP, the promoter 
construct that includes only the promoter proximal CRP I. The major difference 
between the 1xCRP and 1xIHF-C2m  was the presence of IHF III. As observed 
with all acs promoter fragments, both these promoter constructions required AR1 
for activation. With 1xCRP, like with 0xIHF, neither the lack of AR2 nor the 
addition of AR3 to the AR2 mutant exerted a significant effect. In combination, 
however, these surfaces inhibited transcription (data not shown). Surprisingly, the 
loss of AR2 decreased transcription from 1xIHF-C2m, while the presence of AR3 
suppressed this defect. As observed with 1xIHF, the combination of AR2 and 
AR3 quite severely inhibited transcription, resulting in levels comparable to that 
of mutants that lack AR1 (Fig. 10). Thus, on 1xIHF-C2m, the presence of IHF 
makes AR2 a positive component of CRP-dependent activation above that 
provided by AR1.
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Characterization of protein binding
 To understand the unexpected behaviour caused by disruption of AR2 
and/or the presence of IHF III, we characterized the binding of each protein to the 
acs promoter region in vitro. Our collaborator, Dr. Bianca Sclavi, performed 
DNase I footprint analyses of both 1xIHF (Fig. 11) and FL (Figure 12) to 
determine whether the presence of IHF bound at IHF III and CRP bound to CRP 
II can affect the binding of RNAP and the structure of the open complex. To best 
mimic in vivo conditions, I constructed supercoiled DNA templates.
CRP  
 As observed previously with the linearized FL template (Beatty et al., 
2003; Browning et al., 2004), WT CRP elicited patterns of protection and 
hypersensitive (HS) sites  characteristic of binding to both CRP I and CRP II (Fig. 
11A, lane 6; Fig. 11B; Fig. 12, lane 8). Surprisingly, CRP also elicited a pattern of 
protection and HS sites upstream of CRP II. This pattern appears consistent with 
the existence of a third, previously unidentified CRP binding site (CRP III). 
Because this  “site” bears only a vague resemblance (CTGCA n6 TCAAA) to the 
consensus sequence (TGTGA n6 TCACA, (Ebright et al., 1989; Gaston et al., 
1989)) and because we did not observe this site when using the linearized FL 
template (Beatty et al., 2003; Browning et al., 2004), we suspect that supercoiling 
might increase the affinity of the template for CRP at this site.
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Figure 11. Simultaneous binding of IHF, CRP, and RNAP results in protection between the 
tandem CRP sites. (A) 0.1 nM pSRacs236 (carrying the 1xIHFacs promoter sequences from positions 
-171 to +65) was incubated with purified IHF (20 nM), either wild-type CRP or the AR2 mutant KE101 
(100 nM), and/or increasing concentrations of RNAP, subjected to DNase I footprinting. The 
concentrations of RNAP in each reaction was as follows: lanes 1-2, 6, 13-15, 19 (0 nM); lanes 3, 7, 10, 
16, 20, 23 (10 nM); lanes 4, 8, 11, 17, 21, 24 (20 nM); lanes 5, 9, 12, 18 (50 nM). The stars and 
diamonds denote RNAP- and CRP-associated HS sites, respectively. C, no proteins; U, uncut DNA. 
(B) Line graph representing the data from lanes 12 (RNAP only, dotted line) and 9 (RNAP plus CRP, 
solid line). The stars and diamonds denote RNAP- and CRP-associated HS sites, respectively. The 
binding sites for CRP and RNAP are underlined. (C) Line graph representing the data from lanes 2 
(IHF and WT CRP, solid line) and 5 (IHF, WT CRP and RNAP, dotted line). The stars denote RNAP-
associated HS sites. The grey bar denotes the intersite region.
IHF  
 On the linearized (Browning et al., 2004) or on the supercoiled FL 
template, IHF protected an extensive stretch that corresponds to IHF I, IHF II and 
IHF III (Fig. 12, lanes 3,16). In contrast, because 1xIHF does not include the 
sequences for the two upstream sites, IHF protected only sequences that 
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Figure 12. Simultaneous binding of IHF, CRP, and RNAP results in protection between the tandem 
CRP sites. (A) 0.1 nM pSRacs444 (carrying the FL acs promoter sequences from positions -379 to +65) 
was incubated with purified IHF (20 nM), either wild-type CRP or the AR2 mutant KE101 (100 nM), and/or 
increasing concentrations of RNAP, subjected to DNase I footprinting. The concentrations of RNAP in each 
reaction was as follows: lanes 1-4, 8, 15-17, 21 (0 nM); lanes 5, 9, 12, 18, 22, 25 (10 nM); lanes 6, 10, 13, 
19, 23, 26 (20 nM); lanes 7, 11, 14, 20, 24 (50 nM). The stars and diamonds denote RNAP- and CRP-
associated HS sites, respectively. C, no proteins; U, uncut DNA.
correspond to IHF III (Fig. 11A, lanes 1, 14). With both templates, the binding of 
IHF was characterized initially by saturation of its  specific binding site(s) followed, 
at higher concentrations (>20 nM), by propagation of the footprint to adjacent 
regions of the DNA (data not shown), a behaviour indicative of binding to lower 
affinity sites. This was followed (>100 nM) by the appearance of hypersensitive 
sites (data not shown), indicative of a reorganization of the DNA, possibly due to 
the formation of a regular, compact structure.
CRP and IHF  
 The presence of 20 nM IHF (Fig. 11A, lanes 2, 15; Fig. 11C; Fig. 12, lanes 
4, 17) caused the loss of the CRP III-associated HS sites. In contrast, IHF 
exerted no substantial effect on the affinity of CRP to either CRP I or CRP II (data 
not shown). 
RNAP and CRP  
 The binding of RNAP alone provided weak protection from about -30 to 
about -18 and induced a quadruplet of HS sites at -9 to -6 (Fig. 11A, lanes 10-12; 
Fig. 11B; Fig. 12, lanes 12-14). Since RNAP alone can bind either to acsP2A or 
to acsP2 (Beatty et al., 2003), we interpret this  pattern as  the average of the 
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protection produced by the RNAP bound to acsP2 with that produced by the 
RNAP bound at acsP2A.
 The presence of CRP altered the pattern of protection and HS elicited by 
RNAP at multiple locations  (Fig. 11A, compare lanes 7-9 to lanes 10-12; Fig. 
11B; Fig. 12, compare lanes 9-11 to lanes  12-14). For example, the quadruplet of 
HS sites  disappeared. Instead, a doublet of HS sites appeared (at positions -24 
and -26) in the 17-bp spacer region between the -10 and -35 hexamers, 
indicative of a distortion of the double helix. Just downstream of the CRP I site, 
an additional protection was observed, possibly due to binding of the !-CTD as a 
result of its  interaction with AR1. The reverse also was true; the presence of 
RNAP influenced the binding of WT CRP, substantially increasing the HS 
associated with all three CRP binding sites and with the HS sites between CRP I 
and CRP II (Fig. 3A, lanes 7-9; Fig. 12, lanes 9-11). Taken together, these results 
are consistent with the formation of a cooperative interaction between CRP and 
RNAP resulting in a structural rearrangement of the open complex. 
RNAP, CRP and IHF  
 The combination of RNAP, IHF, and CRP (Fig. 11A, lanes 3-5; Fig. 11C; 
Fig. 12, lanes 5-7) increased protection throughout the region downstream of 
CRP II to about -40, especially between CRP II and CRP I. This inter-site 
protection required IHF: in its absence, RNAP (Fig. 11A, lanes  7-9; Fig. 12, lanes 
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9-11) exerted considerably less 
influence. The replacement of WT CRP with the KE101 mutant in the presence of 
IHF resulted in a significant decrease in the protection between CRP I and CRP II 
(Fig. 11A, compare lanes 16-18 to lanes 3-5; Fig. 12, compare lanes 18-20 to 
lanes 5-7). Similar results were observed with the FL template (data not shown). 
Taken together, these data show that RNAP, CRP, and IHF can bind 
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Figure 13. IHF and CRP influence open complex 
formation. (A) Potassium permanganate footprint 
analysis of complexes formed at the acs promoter 
region. The figure shows the modifications produced 
when pSRacs236 (1xIHF) was incubated with purified 
RNA polymerase in the absence or presence of IHF 
and either WT CRP or the AR2 mutant KE101 and 
subjected to potassium permanganate footprint 
analysis. The concentrations of proteins were as 
follows: RNAP (50 nM; lanes 2-9), IHF (20 nM; lanes 
3-9), WT CRP (6 nM, lane 4; 12 nM, lane 5; 50 nM, 
lane 6; 200 nM, lane 7) and CRP KE101 (12 nM, lane 
8; 200 nM, lane m9).  (B) Line graph of the data shown 
in the gel. 
simultaneously at saturating concentrations to their respective specific binding 
sites. Furthermore, they show that RNAP, IHF, and the AR2 surface of CRP are 
required for the protection observed between the two CRP binding sites. This 
inter-site protection may be interpreted as resulting from the formation of a more 
compact higher order nucleo-protein complex.
Characterization of open complex formation
 Since disruption of the lower affinity CRP binding site, CRP II, increased in 
vivo promoter activity from 1xIHF, we predicted that within this context low 
concentrations of CRP would favor transcription, while high concentrations would 
inhibit it. To test this prediction, our collaborator, Bianca Sclavi, used potassium 
permanganate, which modifies thymine residues found within single-stranded 
DNA, to probe the supercoiled 1xIHF template for strand separation by RNAP, a 
step in the process of transcription initiation called transcription open complex 
(OC) formation (Record et al., 1996). Potassium permanganate modifies single-
stranded DNA that results either from OC formation or from severe bends or 
kinks in the DNA (Sasse-Dwight and Gralla, 1989).
 In the presence of RNAP alone (Fig. 13, lane 2), modification of the 1xIHF 
template occurred over an extensive region, as observed previously with a 
linearized template of FL (Beatty et al., 2003). These modifications can be sorted 
into two groups: P2A (-30/-29/-28, -22/-19) and P2, which can be further 
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subdivided into P2UP (-13/-12, -10/-9, -7/-6) and P2DOWN (-1/+3). In the 
presence of both RNAP and 20 nM IHF (Fig. 13, lane 3), a decrease in the 
amount of modifications  at P2A occurred. Since the frequency of modification at 
P2UP did not change, we conclude that occupancy of IHF III by IHF does not 
affect the ability of RNAP to form an OC at acsP2. In contrast, the titration of WT 
CRP (Fig. 13, lanes 4-7) distinctively influenced each grouping. Increasing CRP 
concentration progressively decreased modification at P2A, while generally 
increasing modification at P2UP, as we observed previously (Beatty et al., 2003), 
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Figure 14. CRP influences the structure of the open complex independently of IHF. 
Bar graphs representing the intensity of the bands at P2DOWN compared to the intensity 
of the band at -10. The hatched bars represent the pacs236 (1xIHF) data shown in Fig. 
13, lanes 2-9; the other bars represent data from a similar analysis (performed and 
analysed simultaneously) of pSRacs444 (FL) performed in the absence of IHF (black) or 
in the presence of IHF (grey). The numbers on the x-axis denote the concentration in nM 
of either WT CRP or the mutant CRP KE101. Two pairs of reactions with no CRP are 
represented: the first was performed in the absence of IHF and the second was 
especially at -6 and -7 (Fig. 13B). Strikingly, the effect at P2DOWN was non-
linear (Fig. 13B and 14): modifications increased up to 12 nM CRP, above which 
they decreased. Since low CRP concentrations favoured occupancy of CRP I, 
while high concentration favoured binding of both CRP sites  (Beatty et al., 2003); 
data not shown), bubble extension to P2DOWN thus inversely correlates with 
occupancy of CRP II. Strikingly, the OC formed in the presence of the KE101 
mutation was more open at its downstream end independently of the CRP 
concentration. Under these conditions, we could observe an increase in the 
intensity of the bands at -1 and +3 and a decrease of the intensity of the bands at 
-9, -7 and -6 (Fig 13B and 14). This  observation supports the hypothesis that the 
AR2 surface is involved in an interaction between RNAP and CRP bound at 
CRP I and that the binding of WT CRP to CRP II can stabilize this  interaction and 
affect the structure of the resulting OC. Since we observed similar behaviour with 
FL in either the absence or presence of IHF (Fig. 14), this effect of CRP at the 
acs promoter appears to be general.
CRP stabilizes the OC in the presence of binding to lower affinity sites by 
IHF
 Since 20 nM IHF did not exert a large effect on the RNAP footprint, we 
speculated that the negative effect of IHF observed previously on FL in vitro 
(Browning et al., 2004) might be due to its binding to lower affinity sites. 
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Therefore, we followed the formation of the OC at increasing RNAP 
concentrations at a moderately higher concentration of IHF (30 nM). At this 
concentration, IHF inhibited OC formation at both acsP2A and acsP2, even at the 
highest RNAP concentration tested. However, the addition of either WT CRP 
(Fig. 15A) or KE101 (Fig. 15B) following the addition of IHF permitted RNAP to 
form a OC at acsP2, but not at acsP2A. This  was true even at the lower 
concentration of WT CRP (12 nM). Thus, the CRP-RNAP complex can 
successfully compete with this concentration of IHF for access to the acsP2 
promoter, while RNAP alone cannot.
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Figure 15. Binding of IHF to low affinity sites inhibits RNAP binding in the absence of CRP. Open 
complex formation on P2/P2A by permanganate assay on pacs236 (1xIHF) DNA. (A). RNAP titrations 
in the presence of WT CRP at 12 nM (thin bars) or 200 nM (thick bars). RNAP (10, 20, 30, 50, 75 nM) 
binds to both the P2 and P2A promoter in the absence of other proteins. In the presence of CRP, 
RNAP binds with similar affinity to P2 and no longer forms an open complex at P2A. (B) 30 nM IHF 
inhibits formation of open complex at both P2A and P2. The presence of either WT CRP or KE101 
allows RNAP to form an open complex. In the presence of the KE101 mutant or at low CRP 
concentrations (12 nM) the band at -1 of P2 increases in intensity. This concentration of CRP suffices 
to stabilize the open complex in the presence of IHF. 
Discussion
The multiple roles of CRP during activation of acs transcription
 Previously, we reported that in vitro RNAP alone could form an open 
complex (OC) at both acsP2A and acsP2. These OCs, however, were poorly 
productive, as determined by in vitro transcription assays. In contrast, the 
presence of CRP favoured OC formation at acsP2 and inhibited OC formation at 
acsP2A and, as a result, activated transcription in vitro. Similarly, activation of 
transcription in vivo required CRP, its AR1 surface, and an intact CRP I. On the 
basis of these observations, we proposed that CRP “focused” RNAP to acsP2 
(Beatty et al., 2003). In the current study, we show that the binding of CRP does 
not substantially increase the extent of OC formation by RNAP on the acsP2 
promoter. Instead, it causes a rearrangement of the interactions that RNAP 
makes with that promoter and thus stabilizes a different form of the OC (see 
below). The increased stability of this  ternary CRP-RNAP-acsP2 complex 
activates transcription at multiple levels. First, it inhibits the formation of nascent 
binary RNAP-acsP2A complexes, but cannot successfully compete with pre-
existing ones (data not shown). Second, it results in a conformation of the open 
complex that permits RNAP to initiate transcription and to overcome barriers to 
elongation. Third, it stabilizes the OC in the presence of non-specific IHF binding. 
This  third effect might be important in vivo when IHF accumulates, which occurs 
during entry into stationary phase (see below).
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 The following evidence supports this  model. (1) On naked DNA, in the 
absence of CRP, the majority of OC are formed at acsP2A (Figs. 13, 14 and 15). 
(2) The presence of even small amounts of CRP dramatically diminished OC 
formation at acsP2A, without significantly altering the amount of OC formation at 
acsP2, although it did affect its structure (Figs. 13, 14 and 15). (3) The presence 
of small amounts of RNAP influenced the pattern of CRP-dependent DNase I 
protection and HS and vice versa (Figs. 11 and 12), consistent with a cooperative 
interaction between RNAP and CRP. (4) Disruption of AR1 reduced the CRP-
dependent inhibition of RNAP-acsP2A complex formation (data not shown), most 
probably by decreasing the cooperativity of the CRP-RNAP interaction. This 
reduced cooperativity would diminish the stability of the ternary CRP-RNAP-
acsP2 complex and, thus, provide an opportunity for unbound RNAP to bind to 
free acsP2A. (5) In vivo activation of acs transcription depends upon both AR1 
(Beatty et al., 2003) (Fig. 10) and determinant 287 (Beatty et al., 2003), a surface 
patch of the !-CTD known to interact with AR1 (Busby and Ebright, 1999).
Most often the role of CRP at a Class  I promoter (e.g. lac) is  to stabilize 
interactions of RNAP with the promoter. Stabilization of the closed complex 
permits the subsequent formation of a OC (Busby and Ebright, 1999). At the 
acsP2 promoter, this is  still true (Fig. 16A) and is important for the CRP-RNAP 
complex to compete with IHF and possibly other nucleoid proteins (see below). 
However, RNAP alone can bind the acsP2 promoter, albeit in an inactive open 
conformation (Beatty et al., 2003). This inactivity might result from improper 
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positioning of the !-CTD as observed at the malT promoter, whose binding site 
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Figure 16. Model of the complexes formed at the acsP2 promoter. RNAP alone can form an open 
complex at the acsP2 promoter. This complex, however, is inactive (Beatty et al., 2003). The occupation of 
CRP I by a CRP dimer mediates a change in the structure of the open complex by making contact between 
its AR1 surface and that of the !-CTD of RNAP. This results in a deformation of the spacer, stabilization of 
the P2 TOC at the expense of the P2A TOC, and transcription from the former. Depending upon the 
concentration of CRP, this interaction can lead to two distinct open complexes: TOCA (top) and TOCI 
(bottom). These two complexes differ in the extent of opening at the downstream end of the bubble and in 
the level of transcription in vivo. Concentrations of CRP that lead to the occupation of CRP I alone favor the 
formation of the forward-leaning TOCA, in which the DNA is open to the -1 to +3 positions (A). 
Concentrations that favor the occupation of both CRP sites favor the formation of the backward-leaning 
TOCI (B). TOCI is stabilized by an interaction with the AR2 region of CRP. The increased number of 
interactions formed in this complex, compared to those formed in TOCA, increases the stability of RNAP on 
the promoter, which results in increased transcription. The additional occupation of IHF III either increases 
or decreases transcription, depending upon the status of CRP II. When CRP II is not occupied, the binding 
of IHF enhances transcription, perhaps by increasing the stability of the open complex (C). When both CRP 
sites are occupied, the binding of IHF to IHF III results in significantly reduced transcription, possibly 
because compaction of the upstream elements overstabilizes the complex. The binding of IHF also causes 
increased protection between the two CRP sites, possibly through a rearrangement of the interaction of the 
!-CTDs with the upstream elements (D and F). This protection depends upon the presence of AR2, and 
thus can only occur in the TOCI conformation. Occupation of the upstream IHF sites alleviates much of the 
IHF III-dependent compaction (F). The thickness of the arrows indicates the relative transcription from each 
complex. Note that although RNAP possesses only two !-CTDs, in some cases three or more !-CTDs are 
shown in order to represent a number of possible contacts.
for !-CTD (i.e. UP element) and single binding site for CRP resemble CRP I of 
acsP2 and the DNA sequence located immediately downstream (Tagami and 
Aiba, 1999). To activate acsP2 transcription (in the absence of IHF), CRP 
performs two roles. The first role is to inhibit the binding of RNAP to the 
overlapping promoter, acsP2A. The second is to restructure the OC. By analogy 
to the malT promoter, occupancy of CRP I by CRP might reposition the !-CTD to 
a more favourable position through an interaction with its AR1 surface (Tagami 
and Aiba, 1999), resulting in distortion within the spacer and stabilization of a OC 
open at its downstream end. The end result would be a complex that is more 
efficient in promoter escape.
The role of AR2
 AR2, a well-characterized surface patch of CRP, has been shown to 
activate transcription of Class II promoters by interacting with the !-NTD of 
RNAP (Busby and Ebright, 1999; Lawson et al., 2004). To the best of our 
knowledge, AR2 has never been reported to play a role in the regulation of a 
Class I promoter or of a Class III promoter comprised of tandem Class I sites, 
such as acsP2. Yet here, we determined that in vivo AR2 could influence AR1-
dependent activation of this  Class III promoter, acting to either inhibit or activate 
transcription depending upon context. Furthermore, we showed in vitro that 
disruption of the AR2 surface results  in a different structure of the OC, similar to 
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the one observed at low WT CRP concentrations, when CRP II is  less likely to be 
occupied. 
 We propose that the presence of CRP bound at CRP II contributes to the 
recruitment of the RNAP to the promoter through an AR1-!-CTD interaction (see 
below), causing enhanced transcription as expected for a Class III promoter 
comprised of tandem Class I sites (Fig. 16, compare panels A and B). This long-
range interaction results in a bend in the upstream DNA that permits an 
additional stabilizing contact via the AR2 surface between RNAP and CRP bound 
to CRP I. We further propose that two distinct versions of the OC can form at 
acsP2 in the presence of CRP (Fig. 16). The first version, termed OCA, is 
expanded at its downstream end (to include positions -1 and +3). It is associated 
with the occupancy of CRP I  and/or the absence of the AR2 surface. The second 
version, termed OCI, is more open at its  upstream end (at positions -6 and -7). It 
is  associated with the occupancy of both CRP sites  by WT CRP and, because of 
the presence of additional upstream elements (e.g. CRP bound CRP II), with a 
more stable RNAP-DNA interaction.
 In the context of the 1xIHF promoter construct, where the binding of IHF to 
IHF III accentuates the bending of upstream DNA, these additional upstream 
stabilizing interactions can result in a decrease in the amount of transcription 
(Fig. 16D). This  model is supported by the following observations. First, the 
reduced transcriptional activity exhibited by 1xIHF required IHF, CRPII  and an 
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intact AR2. Second, with IHF bound at its specific sites, additional protection was 
observed between the two CRP sites, but only in the presence of the intact AR2 
surface. Third, the non-native AR3 surface could replace AR2. Intriguingly, 
evidence exists  that AR3, a native surface of the CRP paralog FNR, inhibits 
transcription from certain semi-synthetic FNR-dependent Class  III promoters 
(Wing et al., 1995). Remarkably, an AR2-dependent interaction also could exert a 
positive role. Maximal transcription from 1xIHF-C2m (which includes CRP I and 
IHF III, but not CRP II) depended upon the presence of both IHF and AR2 as well 
as the inability of CRP to bind at CRP II (Fig. 16C).
 The mechanism by which the AR2 and AR3 surfaces  of a CRP dimer 
bound at a Class I position can interact with RNAP remains unclear; however, it 
seems reasonable to propose that they do so by interacting with their known 
RNAP targets, i.e. the !-NTD and region 4.2 of !70, respectively. These 
interactions could take place through a bend in the DNA region between the 
binding sites for the two proteins  (i.e. CRP I and acsP2) or, alternatively, by 
displacing RNAP from the promoter to bind next to CRP.
 Whether OCI and OCA correspond to RPO1 and RPO2 as defined by 
Record and co-workers (Record et al., 1996) or the moribund and active 
complexes described by Shimamoto and co-workers (Kubori and Shimamoto, 
1996; Susa et al., 2006) remains to be determined (Hsu, 2002). In the first case, 
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OCI would be a necessary intermediate in the formation of OCA. In the second 
case, these complexes would be the products of a branched pathway.
The roles of IHF
 IHF is an abundant nucleoid protein that contributes to the organization 
and the condensation of the chromosome. Estimated to be about 0.7 nM during 
early exponential growth (Murtin et al., 1998), its  concentration further increases 
throughout growth to become the second most abundant nucleoid protein during 
stationary phase (Azam  et al., 1999; Ishihama, 1999). When IHF binds to its 
specific sites, it causes a large distortion of the DNA where the double helix 
bends up to 180 degrees and wraps around the protein (Lynch et al., 2003; Rice 
et al., 1996; Travers, 1997). On the acs promoter, IHF can affect transcription 
from three high affinity sites  (IHF I - III) located between –140 and –240 upstream 
of the transcription start site (Browning et al., 2004). 
 A major goal of this investigation was to understand the mechanism by 
which IHF binding could influence the activity of RNAP at this promoter. On the 
basis of our results, we propose a model by which IHF uses two distinct 
mechanisms to affect transcription. The first mechanism depends on the binding 
of IHF to its specific sites and results in the formation of a wrapped nucleoprotein 
complex that also includes both CRP and RNAP. In contrast, the second 
mechanism depends on the role of IHF as a nucleoid protein that, when present 
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at higher concentrations, binds to lower affinity, less specific, sites  and, in the 
process, inhibits open complex formation.
The first mechanism is supported by the following observations: (1) the 
presence of IHF on its three specific sites in the FL construct or on the IHF III  site 
of the truncated 1xIHF does not inhibit the formation of an open complex in vitro 
in either the presence or the absence of CRP (Figs. 13-15). However, in the 
presence of both RNAP and CRP, IHF does mediate increased protection of the 
region between the two CRP sites (Figs. 11 and 12). (2) IHF-dependent 
transcription inhibition in vivo requires both IHF III and CRP II (Fig. 9). It also 
requires that at least one CRP dimer possess an intact AR2 (Fig. 10). Thus, this 
mode of IHF-dependent inhibition likely results from the formation of a multi-
protein complex where a multitude of stabilizing contacts made by RNAP results 
in the formation of a poised OC as described above (Fig. 16D). 
 That over-stabilization of the OC by IHF could contribute to negative 
regulation in vivo is  supported by observations made previously in the context of 
the FL WT acsP2 promoter construct. In this context, specific single alanine 
substitutions in the !-CTD subunit of RNAP resulted in an increase in the amount 
of transcription (Beatty et al., 2003). These mutations  were located at R265, a 
residue that enhances interaction with DNA; L260 and L262, residues located 
close to and perhaps part of determinant 261, known to interact with region 4 of 
sigma; and T301 and I303, which are either part of the DNA interaction 
determinant or of some previously unknown surface. Mutation of these amino 
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acids could either decrease the stability of the open complex allowing for a faster 
escape or result in a less tightly wrapped multi-protein structure.
 A second mode of IHF-dependent repression results from binding to lower 
affinity sites  in the promoter region.  While the three specific sites become 
protected with an affinity of about 2 nM, we can observe the appearance of 
additional DNase I protection due to binding to these lower affinity sites 
beginning at 30 nM (data not shown). Under these conditions, IHF inhibits OC 
formation by RNAP, which can be overcome by the presence of low 
concentrations of CRP (Fig. 15). With IHF bound to its lower affinity sites, RNAP 
cannot form the closed complex, presumably due to the low stability of these 
initial interactions. In contrast, IHF at this higher concentration does not inhibit 
the binding of RNAP in the presence of CRP, even when the transcription factor 
is  present at the lower concentration (12 nM) tested (Fig. 15). It appears  that 
CRP can stabilize the closed complex enough to compete successfully with IHF 
and, thus, form an OC. This mechanism might be essential for transcription to 
proceed in the face of the increased amounts of IHF as the cells enter stationary 
phase (Azam et al., 1999). 
 Intriguingly, IHF also enhanced CRP-dependent activation in both the 
1xIHF and FL constructs  (Fig. 16C). In the 1xIHF construct, this  was observed in 
vivo only when CRP II remained unoccupied, exemplified by the mutant 1xIHF-
C2m construct (Fig. 10). In vitro results  suggest that it could also occur on the 
WT promoter whenever CRP concentrations are low and, hence, CRP II remains 
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unoccupied. Since the CRP-RNAP complex cannot compete with preformed OC 
at acsP2A, the presence of 12 nM CRP only partially inhibited OC formation at 
acsP2A. In contrast, the combined presence of IHF and 12 nM CRP resulted in 
the formation of virtually no open complex at acsP2A (Fig. 15). Thus, the 
occupation of IHF III both increases the probability that an OC will form at acsP2 
and, as described above, the probability that the OC eventually will become 
poised, i.e. when the CRP concentration rises to levels  that favour binding at 
CRP II.
 In vivo, the upstream sequence that includes IHF I and IHF II exerts  an 
overall positive effect on transcription ((Browning et al., 2004) and Fig. 9). It still 
cannot be excluded that this  positive effect could result from the binding to this 
region of some as yet unidentified transcription factor; however, we currently 
favour the possibility that it results  from the ability of the multi-protein complex to 
stabilize a DNA geometry that favours transcription initiation. The high affinity of 
IHF for these sites (about 2 nM, data not shown) suggests that they might be 
partially occupied most of the time in vivo and, thus, might play a role in the local 
organization of the nucleoid (Murtin et al., 1998), especially under growth 
conditions that favour strong activation of the acs promoter. It is anticipated that 
large differences in the local structure of the DNA and its degree of supercoiling 
would occur when IHF binds to all three sites (Fig. 16F) relative to when it binds 
only IHF III (Fig. 16D). These differences could directly affect the efficiency of 
transcription initiation (Travers, 2007).
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 While we did not observe a substantial difference in the overall affinity of 
RNAP for acsP2, or of CRP for its sites, we cannot exclude the possibility that the 
presence of IHF exclusively at IHF III and the resulting changes in DNA structure 
might affect the on and off rates  of binding. An increased stability of the complex 
would result in a slower koff. When combined with a decrease in kon, possibly 
caused by reduced accessibility to the promoter, this  would result in an 
unchanged affinity constant. We are currently investigating this possibility.
 While investigation of the 1xIHF promoter construct permitted identification 
of AR2 as a potential mediator of stabilizing interactions  with upstream elements, 
it should not be ignored that the CRP II-, IHFIII- AR2-dependent inhibition 
observed with this truncated promoter construct could occur within the context of 
the FL WT promoter. The two upstream IHF sites  co-localize with binding sites  for 
other transcription factors (NarL/P and FNR) and with at least one promoter, 
acsP1. Competition has been reported between IHF bound at IHF I and both 
RNAP and FNR for their overlapping sites and between IHF bound at IHF II and 
NarL/P for their overlapping sites (Browning et al., 2002; Browning et al., 2005). 
One could easily imagine that competition between IHF and these other proteins 
might result in incomplete saturation of the two upstream IHF sites, especially 
when faster growth rates keep the IHF pool small enough to only half-saturate its 
highest affinity sites (Murtin et al., 1998). If the degree of wrapping of the nucleo-
protein complex depends inversely on the number of IHF sites that become filled, 
then at low IHF concentrations, a tightly wrapped complex would result in over-
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stabilization, poising the RNAP on the promoter (Fig. 16D). As growth slows and 
more IHF sites become filled, the structure would become “loosened”, allowing 
for more efficient escape of the poised RNAP (Fig. 16F). Because the RNAP 
would already be present at acsP2 in the poised OC, it could respond rapidly to 
the need to utilize acetate as a carbon source, a requirement that occurs as cells 
approach stationary phase and the IHF pool approaches its maximum.
 The global regulator CRP, like the nucleoid protein IHF, has many low 
affinity sites  on the chromosome (Grainger et al., 2005). CRP III may be one of 
them. However, it is contained completely within a high affinity IHF site (IHF III) 
that is likely to be filled as the cells  reach stationary phase. Since this low affinity 
CRP site also appears to be dependent on the supercoiling of the DNA and the 
negative supercoiling of the DNA decreases as the cells reach stationary phase 
(Travers and Muskhelishvili, 2005), the affinity of CRP III would be expected to be 
at its lowest when IHF approaches its  highest concentration. Thus, the question 
remains whether this low affinity CRP site functions in vivo and, if so, whether 
that function is  positive or negative. In either case, the presence of low affinity 
sites for both IHF and CRP raises a much larger issue. Although the primary role 
of nucleoid proteins is to fold and organize the chromosome and the primary role 
of global regulators is  to modulate transcription, their roles  often overlap. The 
exact role in both cellular processes will depend upon the interplay between high 
and low affinity sites  of any given protein and the competition for overlapping 
sites.
!"#
Concluding thoughts
 It is  typically thought that the regulation of transcription depends on the 
ability of one or a small set of transcription factors to recruit RNAP to the 
promoter and to form a complex active for transcription. These interactions must 
stabilize the active 
c o m p l e x o n t h e 
promoter long enough 
to allow for RNAP to 
begin transcription. 
 The regulation of 
the acsP2 promoter 
depends on a delicate 
balance of protein-
D N A a n d 
protein-protein 
interactions  that 
p e r m i t s 
in tegrat ion o f 
several different 
signals, each of 
which reflects  different aspects of the metabolic state of the cell. For acsP2, the 
most important signals appear to be those represented by the concentrations of 
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Figure 17. IHF-mediated inhibition requires Fis II. (A) This schematic shows 
the 1xIHF promoter fragment with its promoters (P2 and P2A, bent arrows) and its 
CRP, FIS and IHF binding sites. Inverted arrows indicate the locations of CRP I 
and CRP II, as determined by similarity to consensus. Open rectangles designate 
the locations of FIS II and FIS III and the hatched box designates the location of 
IHF III, also determined by similarity to consensus. The FIS III sequence is shown 
below and the substituted nucleotide is positioned below the mutated one.  (B) !-
galactosidase activity from promoter fragments FL, 1xIHF, 0xIHF, or 1xIHF-F2m 
variant fused to lacZYA. The resultant strains were grown in TB, samples 
harvested at one-hour intervals, the !-galactosidase activity determined, and the 
peak activity expressed as a percentage of wild-type. Each value represents the 
mean + SEM of at least three independent measurements. The percentage 
activities in relation to FL are noted within each histogram.
CRP, IHF and FIS. The specific pattern of acs transcription results  from the 
requirement for a combination of specific amounts of these three global 
regulators. Activation occurs through rearrangements  of the OC in addition to 
stabilization against binding to lower affinity sites by IHF and other nucleoid 
proteins. In contrast, inhibition can occur by over-stabilization of the OC by CRP 
as in the context of 1xIHF. The resulting complex (comprised of IHF bound at 
IHF III, CRP dimers bound at CRP II and CRP I, and RNAP bound at acsP2) 
could fold into a wrapped conformation that inhibits escape due to numerous 
interactions between RNAP and several upstream elements  (Fig. 16D). Inhibition 
of transcription at such a late stage in the process of forming a transcriptionally 
active complex could facilitate a rapid response upon a change in nutritional 
status.
 In summary, during the early stages of exponential phase, FIS inhibits  acs 
transcription by steric hindrance of CRP binding (Browning et al., 2004). Acetyl-
CoA synthetase is a high affinity enzyme that permits  the scavenging for and 
metabolism of small amounts of acetate previously excreted into the medium; 
thus as the primary carbon source becomes depleted, the activation of the acs 
promoter by small amounts of CRP-cAMP would delay entrance into stationary 
phase. Thus, the proposed mechanism would link activation of acs transcription 
to this transitional period. Furthermore, once the primary and secondary carbon 
sources become depleted, the further increase in cAMP concentration would 
result in formation of the inhibitory complex, reflecting the reduced metabolic 
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rate. Finally, condensation of the nucleosome in stationary phase by IHF and 
other nucleoid proteins would result in inhibition of open complex formation at 
acsP2.
This study was published as:
 Sclavi, B., Beatty, C. M., Thach, D. S., Fredericks, C. E., Buckle, M., and 
Wolfe, A. J. 2007. The multiple role of CRP at the complex acs promoter depend 
on activation region 2 and IHF. Molecular Microbiology 65:425-440.
 What follows are experiments related to but not included in Sclavi et al. 
These experiments specifically explore the role of the NAP Fis and of FIS II, its 
DNA site that sits between but does not overlap the two CRP sites. 
Fis-Dependent Inhibition of Transcription
 Previously, we reported that the nucleoid protein, Fis, binds three sites 
within the acs promoter region (FIS I, FIS II, and FIS III) (Fig. 6B). We also 
reported that Fis  inhibits acs transcription (Browning et al 2004). Part of this 
inhibition can be attributed to anti-activation, i.e. the ability of Fis to out-compete 
CRP for binding at their overlapping sites (Fis III and CRP I) (Fig. 8). In contrast, 
the contribution of FIS II to inhibition is  unclear. That FIS II contributes to 
inhibition, however, is supported by the observation that its disruption in the WT 
FL promoter construct permits elevated acs transcription that approximately 
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equals that attained by disruption of FIS III (Browning et al 2004). Since FIS II 
does not overlap either CRP I or CRP II, we sought a mechanism distinct from 
the anti-activation mechanism associated with FIS III. To seek its  role, we 
disrupted FIS II in the context of the 1xIHF promoter fragment (1xIHF-F2m; Table 
2).
 The 1xIHF-F2m promoter was compared to 1) its  WT parent 1xIHF, 2) FL, 
and 3) 0xIHF (Fig. 17). As we 
repor ted prev ious ly, 0xIHF 
displayed high promoter activity, 
while 1xIHF exhibited extremely 
low activity (Browning et al., 
2004; Sclavi et al. , 2007). 
S u r p r i s i n g l y , 1 x I H F - F 2 m 
displayed activity similar to that of 
0xIHF or approximately six-fold 
more activity than its WT parent 
(1xIHF). Whereas the activities  of 
the other promoter fragments 
peaked near the transition from 
exponential phase into stationary phase then steadily decreased in stationary 
phase, the 1xIHF-F2m promoter activity remained high despite entry into 
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Figure 18. Both Fis and IHF reorganize RNAP binding 
from P2a to the productive P2U promoter. Potassium 
permanganate footprint analysis was utilized to determine 
the location of open complex formation in the presence of 
constant concentrations of RNAP, CRP, and IHF. 
Increasing concentrations of Fis protein were titrated into 
the mix. P2D, P2 downstream; P2U, P2 upstream.
stationary phase (data not shown). I conclude that FIS II  contributes  to IHF-
mediated inhibition of acs transcription.
 To explore the role of Fis, my collaborator (Dr. Bianca Sclavi) performed a 
potassium permanganate analysis on supercoiled 1xIHF promoter fragment (Fig. 
18). As observed previously (Fig. 13A), modification of the 1xIHF template 
occurred at both P2A and P2 (Fig. 18, lane 1), while the addition of a high 
concentration of CRP (200 nM) decreased modification at P2A, while increasing 
modification at P2UP (indicative of the unproductive transcription complex) and 
P2DOWN (indicative of the productive complex) (Fig. 18, lane 2). Increasing 
concentrations of Fis (up to 60 nM) correlated with increased modification at 
P2UP (Fig. 18, lanes 3-6). The presence of IHF inhibited this effect and further 
reduced the modification at P2A (Fig. 18, lanes 7-10). 
 We conclude that Fis  does not inhibit the binding of RNAP. Furthermore, 
because Fis does  not shift the modification back to P2A, it likely does not inhibit 
the binding of CRP. These results contrast with those obtained in the absence of 
RNAP, a condition under which Fis outcompetes CRP regardless  of the order of 
addition. Yet, in vitro, Fis inhibits CRP-dependent acs transcription (Browning et 
al., 2004). Thus, we propose that Fis-mediated inhibition does not rely 
exclusively on the competition between the overlapping Fis III and CRP I sites 
and raises the possibility that FIS II is indeed involved (Fig. 8). 
 The genetic evidence (Fig. 17) clearly implicates FIS II in IHF-mediated 
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inhibition. However, the potassium permanganate footprint analysis of the 1xIHF 
template does not help to explain how. Intriguingly, the genetic evidence 
conflicts with the previously reported conclusion - formed on the basis of DNase I 
footprint and in vitro transcription analyses - that Fis  and IHF function 
independently to inhibit acs transcription (Browning et al., 2004). Efforts  to 
identify the role of FIS II in IHF-mediated inhibition are clearly warranted.
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CHAPTER FOUR
EVIDENCE THAT IHF III IS A COMPOSITE SITE
Introduction
 In the previous chapter, I presented evidence that IHF-mediated inhibition 
relies upon (1) the ability of IHF to bind IHF III, (2) the occupation of tandem 
CRP sites (CRP I and CRP II) by CRP, and (3) the surface determinant AR2 of 
CRP. On the basis of my genetic evidence and the biochemical evidence of my 
collaborator, I proposed that interactions between these three proteins  and 
RNAP resulted in the formation of a stalled open complex (Fig. 16) (Sclavi et al., 
2007). In brief, our model predicts that IHF-induced DNA bending causes the 
tandem CRP dimers to trap RNAP at the promoter in an unproductive, open 
complex. 
 In this chapter, I will provide evidence that IHF III is actually a complex 
sequence that consists of two overlapping sites for IHF (denoted IHF IIIa and 
IHF IIIb) offset by 2 bp, oriented in opposite directions, and positioned on 
opposing faces of the DNA helix. 
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Shared Protein Binding Sites in the acs-nrf Intergenic Region
 The approximately 300-bp nrf-acs intergenic region includes the 
divergently transcribed nrf and acs promoters (Fig. 6). This region also appears 
to include all of the necessary regulatory elements for both promoters (Wolfe, 
2009). As both promoters share many of these regulatory elements, this presents 
a logistical problem. The solution to this  problem, however, may be simple. By 
evolutionary design or by a fortuitous coincidence, cells  express the acs and nrf 
operons under vastly different, extreme conditions: acs is required for survival 
under carbon starvation (Wolfe, 2009), while nrf is  required under anaerobic-
nitrogen limitation (Browning et al., 2004). Yet, transcription from the acs 
promoter does not seem to influence expression from the nrf promoter and vice 
versa. It is proposed that this lack of competition between promoters in such 
close proximity results from the infrequent firing of both promoters (Browning et 
al. 2002). Thus, it is possible to understand the regulatory control of one 
promoter in relative isolation from the other promoter. However, because many of 
the regulatory elements are the same, lessons learned from the study of one 
promoter can be productively used to understand the other. 
An Argument that IHF III is a Composite Site 
 The central location of the three DNA sites for IHF lends support for the 
hypothesis that they play critical roles  in regulating the transcription from both the 
!""
nrf and acs promoters. This hypothesis  is further supported by the fact that they 
are highly conserved across all sequenced E. coli genomes (Browning et al., 
2006). The experimental data make a compelling case for IHF I: by steric 
hindrance, it represses transcription from both nrf and the minor promoter acsP1 
(Browning et al., 2002; Wolfe, 2009). The experimental data also provide 
evidence that IHF III plays a pivotal role. The binding of IHF to this site helps 
promote transcription from Pnrf by a presently uncharacterized mechanism 
(Browning et al., 2006). Meanwhile, it also mediates the formation of an 
unproductive stalled open complex at the acs promoter through a mechanism 
that also requires tandem CRP dimers and RNAP (Fig. 16) (Sclavi et al., 2007). 
The role of IHF II remains unclear (see Chapter 5).
 Intriguingly, the mutations used to demonstrate the involvement of IHF III 
in the regulation of Pnrf and acsP2 implicate two different DNA sites for IHF 
(Browning et al., 2006; Sclavi et al., 2007). That these two sites might exist came 
from the observation that mutations introduced into the central motif of IHF III did 
not fully relieve IHF-mediated inhibition of acsP2 transcription (Fig. 9) (Sclavi et 
al., 2007). At first, I thought that incomplete relief of inhibition might result from 
incomplete loss of IHF binding. However, this conclusion seemed unlikely, as 
mutations of this kind in the central motif had been shown to cause severe 
defects  in binding (Lee et al., 1991; Hales et al, 1994; Yang and Nash, 1995; and 
Aeling et al, 2006). A clue to this somewhat surprising result came from my 
realization that IHF III might actually be a composite site. The IHF III site reported 
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by our long time collaborators, the Busby lab, activated nrf transcription 
(Browning et al., 2006); however, it was not the same IHF III site that we had 
reported (Sclavi et al., 2007). The two sites overlapped, sat on opposite faces of 
the DNA helix and were offset by 2 bp (Fig. 19). Could both sites exist? 
Preliminary Evidence Supporting the Composite Site Hypothesis    
 To answer this  question, I first tested the alternative hypothesis: that IHF III 
is  a single site consisting of only IHF IIIa. If this  hypothesis is correct, then 
mutations that alter this site should affect 1xIHF promoter activity in a predictable 
fashion. For example, introduction of the double mutation C150G C152G into the 
central motif of the putative IHF IIIa (CCTCAA to CGTGAA) reduces the site’s 
similarity to consensus (WATCAA). As described above, this mutation resulted in 
moderately enhanced transcription from the acsP2 promoter (Sclavi et al., 2007), 
as would be predicted if the binding of IHF to IHF III were an inhibitory event. If 
so, I reasoned that mutations that brought the central motif of IHF III closer to 
consensus would decrease transcription from acsP2. Therefore, I constructed the 
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Figure 19. The putative IHF IIIa and IHF IIIb sites. IHF IIIa is on top reading from left to right with the 
consensus sequence below. IHF IIIb is on the bottom reading from right to left with the consensus 
sequence above. W, A or T; R,  A or G; n, any nucleotide. The 5!-W6, central WATCAA, and 3!-TTR motifs 
are denoted by a light blue, yellow, and green rectangles, respectively.
C152A C153A double mutant, which converts  the native central motif from 
CCTCAA to AATCAA, which is  identical to central motif of the  phage IHF site H’, 
considered by many to be the ideal IHF sequence (Lee et al., 1991).
Both mutations were introduced into the 1xIHF promoter fragment (Table 
3). The mutant promoter fusions were then recombined into a hybrid 
bacteriophage and introduced as a monolysogen into AJW678, a lac strain that is 
WT for both acetate metabolism and crp (Table 1). The resulting monolysogens 
were grown in TB at 37oC, cells  were harvested at approximately one hour 
intervals, and their !-galactosidase activity compared to that of monolysogens 
that carried the parent promoter fragment 1xIHF. As a control, I also tested the 
0xIHF promoter fragment, which does not carry IHF III (Table 3). 
As observed previously (Fig. 9) (Sclavi et al., 2007), the C150G C152G 
mutant (also known as 1xIHF-I3m) yielded activity intermediate to the WT 1xIHF 
and 0xIHF promoter fragments  (Fig. 20). Contrary to our prediction, the C152A 
C153A mutant alleviated inhibition. Thus, I concluded that the alternative 
hypothesis was probably incorrect.
 Coincidentally, the C153A mutation in the IHF IIIa site is predicted to 
strengthen the central motif (from GAACAT to TAACAT) of the putative IHF IIIb 
site reported by Browning et al. (2006). This led us to propose and then test the 
hypothesis  that both sites existed and that they both influence acsP2 
transcription. 
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Systematic Mutation of IHF IIIa and IHF IIIb Sites 
 Since the discovery 
of IHF, extensive work has 
been done to understand 
the mechanism by which it 
recognizes and binds to 
DNA. Like its homologue, 
HU, IHF has the propensity 
t o b i n d t o b e n t D N A 
structures. However, IHF 
does so in a sequence 
specific manner. There are 
two distinct DNA regions in 
an IHF site. The first being the core sequence WATCAA-n4-TTR (W = T or A; R = 
A or G; n = any base). These core bases are sufficient for IHF binding; however, 
binding is further enhanced when a dA-dT rich region is present 5’ to the core 
sequence. Because the bases of the dA-dT rich region vary, it is simply depicted 
as: 5’-W6-n8 (Hales et al, 1996; Goodrich et al, 1990).      
 To identify bases of the core sequence and dA-dT rich region important for 
IHF binding, Lee et al. (1991) generated single base pair mutations in three 
phage IHF sites - H’, H1 and H2 – and tested IHF affinity using a challenge 
phage assay. The resultant mutations were sequenced and categorized as weak, 
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Figure 20. Initial mutagensis of IHF III. !-galactosidase activity 
from promoter fragments 0xIHF, 1xIHF, and the 1xIHF variants 
C152G C150G and C153A C152A fused to lacZYA. The wild type 
strain AJW678 was lysogenized with the hybrid phages. The 
resultant strains were grown in TB, samples harvested at one-
hour intervals, the !-galactosidase activity determined, and the 
peak activity expressed as a percentage of wild-type. Each value 
represents the mean + SEM of at least three independent 
measurements. Promoter activity is relative to that of the 0xIHF 
construct.
moderate, or strong mutants (Fig. 21). Briefly, these studies revealed that single 
base pair mutations in the C of the central WATCAA motif and in the middle T of 
the TTR severely reduced IHF binding. Based on this  study, I introduced a series 
of single base pair replacement mutations into the putative IHF IIIa site or the 
putative IHF IIIb  site or both to favor IHF binding to one site or the other. The goal 
was to: 1) determine if IHF III is a dual overlapping IHF site; 2) assuming that 
both sites do exist, then determine if either or both sites affect acs transcription; 
and 3) finally determine the effect (either positive or negative) on acsP2 
transcription of IHF when bound to either IHF IIIa or IHF IIIb. 
Each mutation was introduced into the 1xIHF promoter fragment. The 
mutant promoter fusions were then recombined into the hybrid  bacteriophage 
and introduced as a monolysogen into AJW678 (Table 1). Each resulting 
monolysogen was aerated in TB at 37oC, cells  were harvested at approximately 
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Figure 21. Mutations reported to cause defects in IHF binding. The 5!-W6, central 
WATCAA, and 3!-TTR motifs of the consensus and H! sites are upper case, bold and blue. The 
non-consensus nucleotides are lower case and black. Substitution mutations reported to cause 
binding defects are shown below. The length of the arrow denotes the strength of the defect. 
(adapted from Lee et al. 1991)
one hour intervals, and their !-galactosidase activity compared to that of 
monolysogens that carried the parent 1xIHF, 0xIHF, and the FL promoter 
fragments (Table 3). Figure 22 summarizes the results of these studies. 
Mutations in the 3’-TTR motifs
A164T T142A. If both sites exist, I predicted that disrupting the second T in each 
TTR, and thus disrupting the ability of IHF to bind both sites, would result in 
behavior that resembles the 0xIHF promoter fragment. Thus, I substituted a T for 
the native A at bp 164 and an A for the native T at bp 142. Each of these 
mutations targets  the middle T of the respective TTR, which is a mutation shown 
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Figure 22. Sytematic mutagenesis of the putative composite IHF III site. The IHF IIIa  and IHF IIIb sites 
and matching consensus are as in Figure 19. The relative promoter activities of the 1xIF and 0xIHF promoter 
fragments are shown above as dashed lines. Nucleotide substitutions are located above the sequences. 
Nomenclature is according to the top strand (IHF IIIa). Blue, red, and purple mutations are predicted to 
disrupt IHF IIIa only, IHF IIIb only, or both IHF IIIa  and IHF IIIb, respectively. The length of the arrow denotes 
the mutant promoter strength relative to that of the 1xIHF and 0xIHF constructs.  
to severely reduce IHF binding to lambda phage H’ (Fig. 21) (Lee et al., 1991). 
Note that the each mutation also alters the opposing site’s dA-dT rich region in a 
manner that severely diminished IHF binding (Lee et al., 1991). Thus, both 
A164T and T142A are predicted to reduce the consensus of both their respective 
3’-TTR motif and the opposing site’s 5’- W6 motif. The result should be a severe 
reduction in the ability of IHF to bind either site. Indeed, the double mutant 
A164T T142A performed well, resulting in activity that sometimes resembled that 
of the 0xIHF promoter fragment (Fig. 22) and sometimes that of the FL promoter 
(data not shown). 
A164T. Since the A164T mutation reduces the consensus of the 3’-TTR motif of 
IHF IIIb and the 5’-W6 motif of IHF IIIa (Fig. 22), I chose to test this single mutant. 
As predicted, this mutation in the context of the 1xIHF promoter fragment 
increased promoter activity to a level that resembled that of the 0XIHF promoter 
fragment.
T142A. In contrast, the T142A mutation reduces the consensus of the 3’-TTR 
motif of IHF IIIa and the 5’-W6 motif of IHF IIIb (Fig. 22) and, as such, is also 
predicted to reduce IHF binding to both IHF III sites. Unlike A164T, the T142A 
mutant promoter fragment exhibited activity intermediate to the 1xIHF and 0xIHF 
promoter fragments. 
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A141T. To be thorough, I also mutated the R of the IHF IIIa TTR motif, 
substituting a T for the native A, reducing consensus and thus likely binding 
affinity. According to Lee (Fig. 21), this  mutation also should slightly increase 
consensus of the IHF IIIb 5’-W6 motif, by substituting the more consensus A for 
the native T on the complementary strand. The result of this mutation was 
promoter activity at or above that observed with the 0xIHF construct (Fig. 22).
 Together, these results confirm the key role that IHF III plays in the inhibition 
of CRP-dependent acsP2 transcription. However, since these mutations  are 
predicted to disrupt binding of IHF to both sites (Lee et al., 1991), I could not 
distinguish the influence of each individual site. To do that, I had to introduce 
mutations predicted to exert a major effect on only one site. For IHF IIIb, I 
introduced G156T, the mutation reported by Browning and co-workers (Browning 
et al., 2006) and T155G; for IHF IIIa, I introduced C150A and A149C.
Mutations that disrupt one site or the other but not both
G156T and T155G. The substitution of either a T for the native G at bp 156 or G 
for the native T at bp 155 reduces the consensus of the central WATCAA motif of 
IHF IIIb  (located on the complementary strand) from GAACAT to GAAAAT or 
GACCAT, respectively. They both are predicted to disrupt binding of IHF to IHF 
IIIb  (Lee et al., 1991). Because they alter the n8 between the 5’-W8 and the 
central motif, however, these substitutions should exert little or no effect upon the 
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binding of IHF to IHF IIIa. The G156T mutation severely diminished Pnrf activity, 
leading to the hypothesis  that IHF III played a role in nrf transcription (Browning 
et al., 2006). Both mutations resulted in acsP2 transcription intermediate to that 
of the 1xIHF and 0xIHF promoter fragments (Fig. 22). On the basis of these 
observations, it appears that IHF IIIb  exists, that it plays a positive role for Pnrf 
activity, and that it plays some inhibitory role at acsP2.
 
C150A and A149C. In contrast, replacement of either an A for the native C at bp 
150 or C for the native A at bp 149 reduces the consensus of the central 
WATCAA motif of IHF IIIa from CCTCAA to CCTAAA and CCTCCA, respectively. 
Both substitutions are predicted to disrupt binding to IHF IIIa (Lee et al., 1991). 
However, both mutations  should be without substantial, if any, affect on the 
binding of IHF to IHF IIIb  because both substitutions alter the n8 located between 
the central and 5’ motifs. Both mutations exerted strong effects on acsP2 
transcription, resulting in activity that matched or exceeded that of 0xIHF (Fig. 
22). On the basis of these results, it appears that IHF IIIa exists and that it plays 
a major inhibitory role at acsP2.
Replacement of IHF IIIa with IHF IIIb and Vice Versa 
 The experiments described above are consistent with the hypothesis that 
IHF III is  a composite site composed of two overlapping sites that are oriented in 
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o p p o s i t e 
directions and that 
sit on opposing 
faces of the DNA. 
M u t a t i o n s 
p r e d i c t e d t o 
severely reduce 
the affinity of both 
IHF IIIa and IHF 
I I Ib  (A164T or 
T142A or both) 
r e s u l t e d i n 
e l e v a t e d 
transcription from 
t h e 1 x I H F 
p r o m o t e r 
f r a g m e n t . 
M u t a t i o n s 
p r e d i c t e d t o 
severely reduce the affinity of either IHF IIIa (C150A or A149C) or IHF IIIb 
(T155G or G156T) provided evidence that both sites exist. However, the data are 
not definitive. To perform a more rigorous test of the composite site hypothesis, I 
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Figure 23. Swapping IHF IIIa and IHF IIIb. (A) The native IHF III sequence with 
the conserved motifs shown in red. (B) The VF sequence, in which IHF IIIb is 
positioned in the native IHF IIIa location and vice versa. (C) !-galactosidase activity 
from promoter fragments FL, 1xIHF, 0xIHF, 1xIHF-VF fused to lacZYA. The wild 
type strain AJW678 was lysogenized with the hybrid phages and the resultant 
strains were grown in TB, samples harvested at one-hour intervals, the !-
galactosidase activity determined, and the peak activity expressed as a percentage 
of wild-type. Each value represents the mean + SEM of at least three independent 
measurements. Promoter activity relative to that of the FL construct.
constructed a promoter fusion (1xIHF-VF; Table 3) in which the IHF IIIa and IHF 
IIIb  sites are swapped. If IHF III is a composite site and if both sites contribute to 
regulation of acsP2 transcription, then I reasoned that the activity of the mutant 
promoter 1xIHF-VF would exhibit behavior that is similar, if not identical, to the 
WT 1xIHF promoter.
 I constructed the 1xIHF-VF promoter (see Figure 23B) using a 45 bp primer 
encoding the 5’ – IHF IIIb – 3’ aligning it on the same DNA strand as  the tandem 
CRP sites (CRP I and CRP II) and the RNAP binding site. Thus, in 1xIHF-VF, 
IHF IIIb  is positioned in the exact original location of IHF IIIa. Simultaneously, 
IHF IIIa is placed onto the opposite DNA strand in the original location of IHF IIIb. 
 I recombined the mutant promoter fusion, 1xIHF-VF into the hybrid 
bacteriophage and introduced it as a monolysogen into AJW678 (Table 1). I grew 
the resulting monolysogen in TB at 37oC, harvested cells at approximately one 
hour intervals, and compared its !-galactosidase activity to that of monolysogens 
that carried the 1xIHF, 0xIHF, or FL promoter constructs (Fig. 23C).
 As shown previously (Fig. 9C), the FL promoter fragment exhibited the most 
activity, while the 0xIHF promoter fragment displayed somewhat less activity. In 
contrast, the 1xIHF promoter fragment exhibited even less. Strikingly, the 1xIHF-
VF promoter fragment displayed activity that most closely resembles the weak 
activity of the 1xIHF promoter. Although this result is consistent with the 
hypothesis that IHF III is a composite site, alternative explanations could be 
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envisioned. It is unlikely, however, that other mechanisms would require all of the 
elements shown to be required for IHF-mediated inhibition of transcription from 
the 1xIHF promoter fragment. I reasoned that the more properties that 1xIHF-VF 
shares with 1xIHF, the more likely that the same mechanism regulates their 
transcription. Thus, I tested whether the poor activity elicited by 1xIHF-VF 
required the same surfaces of CRP that influence the activity exhibited by 1xIHF.
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Figure 24. 1xIHF and 1xIHF-VF activities involve AR2 and AR3 of CRP. !-galactosidase activity from 
promoter fragments 1xIHF and 1xIHF-VF fused to lacZYA. Each lysogen was deleted for crp and 
transformed with plasmids expressing wild-type CRP or mutant variants. Wild-type CRP possesses AR1 
and AR2, but not AR3 and is designated as 1+2+3o. The mutants either lack AR1 (1-) or AR2 (2-) or possess 
the non-native AR3 (3+) or combinations of each. The resultant transformants were grown in TB, samples 
harvested are regular intervals, and the peak !-galactosidase activity determined and expressed relative to 
the mutant that lacks AR2 1+2-3o. Each value represents the mean ± SEM of at least three independent 
measurements.
Activity from the 1xIHF-VF and 1xIHF Promoters Involves the Same 
Activation Regions
 As described previously, CRP possesses three surfaces that interact with 
RNAP: AR1, AR2, and AR3 mediate protein-protein interactions with the -CTD, 
the -NTD, and region 4.2 of the sigma subunit, respectively (Fig. 4). Transcription 
activation from the 1xIHF promoter fragment requires  AR1; without it, activation 
does not take place, regardless of the status of AR2 and AR3. In contrast, AR2 is 
a key component of IHF-mediated inhibition; eliminating AR2 relieves inhibition. 
In the absence of AR2, the presence of AR3 can compensate while the presence 
of both AR2 and AR3 causes an even more severe inhibition of transcription 
(Sclavi et al., 2007).
 Monolysogens of either the parental 1xIHF or the mutant 1xIHF-VF 
promoter fusion, defective for endogenous CRP (crp::kan), were transformed with 
plasmids carrying either WT CRP, the AR2 mutant, the AR2/AR3 mutant, the AR3 
mutant, or the AR1 mutant (Table 1). The resultant transformants were aerated in 
TB at 37oC, the cells were harvested at approximately one hour intervals, and 
their !-galactosidase activity measured. 
 The behavior of the 1xIHF-VF promoter fragment (Fig. 24B) completely 
resembled that of its 1xIHF parent (Fig. 24A). Transformants of either promoter 
fragment that expressed WT CRP (AR1+ AR2+ AR3o) exhibited poor 
transcriptional activity, while those that expressed the AR2 mutant (AR1+ AR2- 
AR3o) displayed substantially more activity and those that expressed the AR2/
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AR3 double mutant (AR1+ AR2- AR3+) exhibited activity similar to that of WT. In 
contrast, transformants of either promoter fragment that expressed the AR3 
mutant (AR1+ AR2+ AR3+) exhibited activity about as low as that displayed by the 
AR1 mutant (AR1- AR2+ AR3o).  Thus, for both promoters, disruption of AR2 
caused relief of inhibition in the context of both promoter fragments, the 
unmasking of AR3 on a CRP protein that retains  AR1 compensated for the 
disruption of AR2, the presence of all three surfaces caused extremely low 
transcription that resembled that of the AR1 mutant.  
 Thus, the requirements  for IHF-mediated inhibition are the same for 1xIHF 
and 1xIHF-VF. The simplest explanation is  that IHF III  is indeed a composite 
binding site consisting of two overlapping IHF sites.
Discussion
IHF III is a composite site
 The data obtained from the systematic mutational analysis is consistent with 
the hypothesis that transcription depends on more than one IHF III site. For 
example, A149C disrupts  the central IHF binding motif of IHF IIIa. This  mutation, 
predicted to reduce or eliminate IHF binding to IHF IIIa, resulted in activity that 
was higher than that of the 0xIHF promoter fragment. This behavior might be 
explained in terms of enhanced binding of IHF to the opposing site IHF IIIb, 
which would function in a positive manner. This scenario is unlikely, however, 
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because disruption of the central motif of IHF IIIb also resulted in enhanced 
promoter activity. Furthermore, these central motif mutations resulted in activity 
similar to that obtained when both sites  were disrupted. I therefore proposed that 
both sites exist and that they both contribute to IHF-mediated inhibition of acs 
transcription. My proposal was validated by the behavior of the 1xIHF-VF 
promoter construct that, in all tested characteristics, mirrored that of the parental 
1xIHF promoter fragment.
 The degree to which each mutation altered inhibition varied from mutation 
to mutation. A simple explanation for the different degrees of promoter activities 
may be attributed to the relative importance of certain bases in protein-DNA 
interactions between IHF and the two IHF III binding sites. Mutations in single 
IHF sites show profound differences  in protein binding and thus activity (Lee et 
al., 1991). This  is not to suggest that this is true for all IHF sites. It is entirely 
possible that mutations  made in overlapping IHF sites may be masked by the 
presence of an additional site. IHF binding to the weakened IHF III sequence 
may be compensated by the second IHF site or by preserving the general DNA 
secondary structure or through sequence recognition. Additionally, the 
requirement for specific bases may vary from binding site to binding site and is 
probably dictated, to some degree, by upstream and downstream sequences as 
well as the proteins present at any given time. Taken together, however, the 
results presented in this chapter support our hypothesis that both IHF IIIa and 
IHF IIIb exist.
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Both IHF IIIa and IHF IIIb Contribute to Inhibition
 On the basis  of these results, I also propose that both sites contribute to 
IHF-mediated inhibition. In support of this  hypothesis, Dr. Cathy Lawson (Rutgers 
University) used in silico molecular modeling to determine the overall structure of 
an IHF/IHF IIIa- or IHF/IHF IIIb-mediated complex in the context of CRP dimers 
bound to the downstream CRP II and CRP I and the -CTD bound to the region 
just adjacent to CRP I (Fig. 25). The modeled output for both complexes shows 
almost identical DNA bends when IHF is placed on either IHF IIIa or IHF IIIb. 
Thus, when the downstream sites are occupied, IHF is predicted to bend the 
DNA in the same manner regardless  of the IHF III  site that it binds. Though the 
modeling program generated structures that are consistent with available 
crystallography data, these predictions were performed out of the context of the 
upstream sites (e.g. IHF II) and some of the downstream sequences (e.g. the -35 
and -10 hexamers). Though IHF interaction with either site may result in similar 
bend angles, it should be noted that the DNA structure in vivo might prove to be 
very different when bound along side the proteins that bind these additional sites.
 It is  curious that both IHF III  sites seem to mediate inhibition. Originally, we 
had predicted that the opposing IHF site, IHF IIIb, would counterbalance the 
negative affects of IHF IIIa in order for transcription to proceed. However, 
according to my data, both sites are required for inhibition – mutating either site 
resulted in promoter activity higher than that of the 1xIHF fragment and often as 
high as that of the 0xIHF construct. Based on these results, I conclude that 
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inhibition is not advanced by the reduction of binding affinity of either site. 
Perhaps IHF oscillates between IHF IIIa and IHF IIIb, interrupting the interaction 
between CRP and RNAP and thereby disrupting transcription. For transcription to 
occur, it is possible that proteins bound to upstream sequences insulate the 
transcription apparatus from the effects of the IHF/IHF III complex (see Chapter 
Five). Further investigation is warranted to identify the exact mechanism of IHF 
III-mediated inhibition by this complex site.
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Figure 25. A folding model for IHF IIIa versus IHF IIIb in the context of 1xIHF. IHF (purple) 
bound to either IHF IIIb or IHF IIIa, CRP (blue) bound to CRP II and CRP I, and one !-CTD 
(green) bound to the region directly adjacent to CRP I. The DNA double helix is in white and 
cream. Note the similarity of the bends caused by the binding of IHF to IHF IIIb and to IHF IIIa 
and the lack of difference of effect on the downstream structure. Also note the lack of space 
between the CRP dimers for the binding of the other !-CTD   (modeling performed by C. 
Lawson, Rutgers University).
CHAPTER FIVE
EVIDENCE THAT THE UPSTREAM SINGLE IHF II SITE 
ANTAGONIZES IHF IIIa/b-MEDIATED INHIBITION
Introduction
 In the previous chapter, I presented evidence that IHF III is  a composite 
site, comprised of inverted dual-overlapping sites (denoted IHF IIIa and IHF IIIb). 
I proposed that when IHF binds to either IHF IIIa or IHF IIIb, it severely inhibits 
CRP-dependent transcription, at least in the context of the 1xIHF promoter 
fragment. This severe inhibition appears  to require both sites  through some 
currently unknown mechanism.
 However, IHF-mediated inhibition is relieved by DNA sequences located 
upstream of IHF III (Browning et al., 2004; Sclavi et al., 2007). Since IHF is 
always present at moderately high levels in the cell (Azam, 2004), the low level of 
transcription exhibited by the 1xIHF promoter fragment is what we would expect 
from the FL promoter in vivo. Instead, the FL promoter exhibits  considerably 
higher activity. 
 To explain this dichotomy, we propose that a cis element and/or a trans-
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factor must antagonize IHF-dependent inhibition - otherwise acs transcription 
might never take place. Interestingly, the region encompassing both IHF III and a 
short sequence immediately upstream includes two sequences that may offer an 
explanation for how IHF-mediated inhibition is counteracted: a perfect palindrome 
and IHF II.
 In this chapter, I will provide evidence that the palindrome does not appear 
to influence acs transcription. I will then present evidence that supports the 
hypothesis that IHF II can antagonize the negative effects of IHF III  on acsP2 
transcription and that occupancy of IHF II could guide IHF binding to IHF IIIb  and, 
as a consequence, activate transcription from acsP2.
The Palindrome does not Modulate IHF-Mediated Inhibition
 Experimental evidence verified the existence of a DNA site for IHF (IHF II) 
located immediately upstream of IHF III  (Browning et al., 2004; Sclavi et al., 
2007). Bioinformatic analysis also revealed the existence of a perfect palindrome 
that overlaps the junction between IHF III and IHF II. 
To determine if either sequence influenced acs transcription, I constructed 
two promoter constructs: 1xIHF+5 and 2xIHF (Fig. 26A; Table 4). The former 
adds 5 bp to the 5’ end of the 1xIHF promoter fragment; thus, reconstituting the 
entire palindrome. The latter adds 25 bp; thus, reconstituting both the palindrome 
and IHF II. 
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Both promoter fragments were recombined into a hybrid bacteriophage 
and introduced as a monolysogen into AJW678 (Table 1). The resulting 
monolysogens were grown in TB at 37oC, cells were harvested at approximately 
one hour intervals, and their !-galactosidase activity compared to that of 
monolysogens that carried the FL, 1xIHF and 0xIHF promoter fragments. 
 As shown previously, the FL promoter exhibited the highest activity, the 
1xIHF construct yielded the least activity, and the 0xIHF construct displayed an 
intermediate activity (Fig. 26B). Interestingly, the 1xIHF+5 promoter exhibited 
somewhat more activity than 1xIHF, while the 2xIHF promoter fragment yielded 
activity that resembled that of 1xIHF. 
 On the basis of these results, I hypothesized that the palindrome was an 
antagonist of IHF III-mediated inhibition. A palindromic sequence can function 
either as a binding site for a homodimeric transcription factor or as  a region of 
DNA that can form a secondary structure, called a cruciform, that could influence 
protein binding or some aspect of DNA metabolism. If the increased transcription 
exhibited by 1xIHF+5 resulted from the presence of the palindrome, then 
disruption of one of its half sites would be predicted to prevent protein binding or 
efficient formation of cruciform DNA. Thus, we expected to observe reduced 
promoter activity to levels  similar to that exhibited by the 1xIHF promoter. 
Because the downstream half-site overlaps IHF IIIa and IHF IIIb, I scrambled the 
5 bps of the upstream half-site. Unexpectedly, this construct (1xIHF+5S; Table 4) 
exhibited activity similar to that of the 1xIHF+5 promoter (data not shown). 
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 Based on this result, I conclude that the palindrome does not affect acs 
transcription, either 
as a binding site for 
a p r o t e i n 
homodimer or as a 
site for hairpin loop 
formation. I do not 
understand why the 
5 bp adjacent to 
I H F I I I  i n t h e 
c o n t e x t o f t h e 
1x IHF p romote r 
fragment enhances 
t r a n s c r i p t i o n ; 
however, the negative result in response to such a massive alteration in 
sequence led me to end this line of investigation and instead focus on IHF II.
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Figure 26. Presence of the complete palindrome sequence increases transcription from 1xIHF+5 
promoter. (A) This schematic shows the acs promoter region from positions -379 to +65 relative to the acsP2 
transcription start site (+1). It shows the locations of each promoter, each CRP and IHF binding site and the 
extent of the promoter fragments. The bent arrows indicate the approximate location of each promoter and its  
direction of transcription. Inverted arrows indicate the locations of CRP I and CRP II, as determined by 
similarity to consensus. Hatched boxes designate the locations of IHF I-III, also determined by similarity to 
consensus The orange rectangle indicated the approximate location of the palindrome. (B) !-galactosidase 
activity from promoter fragments 0xIHF, 1xIHF, 1xIHF+5, 2xIHF, or FL fused to lacZYA. The wild type strain 
AJW678 was lysogenized with the hybrid phages carrying the corresponding acs promoter fragment. The 
resultant strains were grown in TB, samples harvested at one-hour intervals, the !-galactosidase activity 
determined, and the peak activities compared. Each value represents the mean + SEM of at least three 
Evidence that IHF II is a Positive Modulator of IHF III-Mediated Inhibition
The weak promoter activity exhibited by the 2xIHF construct (Fig. 26B) is 
consistent with a model in which IHF bound at IHF II plays a minor role at best. 
Indeed, a mutation in its  central motif, changing the sequence from TTTCAA to 
TTTGAA such that the binding of IHF to IHF II should be substantially diminished 
(Table 4), resulted in activity similar to that of the 1xIHF and 2xIHF promoter 
fragments (data not shown).
 To determine if this weak promoter activity resulted from the same 
mechanism as observed in the context of the 1xIHF promoter construct, I tested 
the involvement of the activation surfaces of CRP. To do so, I used P1 
transduction to introduce crp into the monolysogen that carried the 2xIHF 
promoter fragment. The resultant strain was then transformed with plasmids 
carrying various mutant CRP genes (Table 1). The resultant transformants  were 
grown in TB at 37oC, the cells were harvested at approximately one hour 
intervals, and their !-galactosidase activities were compared. Like the 1xIHF 
promoter fragment, promoter activity from the 2xIHF construct required AR1 and 
was inhibited by AR2 and AR3 (data not shown). On the basis of these results, it 
would seem that IHF II plays no significant role in acs transcription; however, 
subsequent studies revealed that this conclusion was untrue. 
In an effort to thoroughly examine the role of IHF II in the context of IHF III-
mediated inhibition, I disrupted CRP II and IHF IIIa in the context of the 2xIHF 
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construct. The resulting mutant promoter constructs (denoted 2xIHF-IHF3m and 
2xIHF-C2m; Table 4) were recombined into the hybrid  bacteriophage and 
introduced as  monolysogens and compared to that of monolysogens that carried 
the FL, 2xIHF, 1xIHF and 0xIHF promoter constructs. The controls all behaved as 
expected based on the results of previous experiments. The mutant 2xIHF-C2m 
exhibited activity similar to that of 0xIHF (Fig. 27), a result that also suggests that 
the weak promoter activity of 2xIHF results  from a mechanism similar or identical 
to the one that maintains low transcription from 1xIHF. Intriguingly, however, the 
activity from the 2xIHF-I3m promoter fragment was substantially higher than both 
the 0xIHF and full-length promoter constructs. On the basis  of this  result, we 
proposed that IHF II can play a positive role in the regulation of acs transcription 
and that IHF IIIa might antagonize this effect.
Using EMSA and DNase I footprint analyses, Drs. Douglas  Browning and 
Bianca Sclavi obtained evidence that IHF binds  IHF III  with higher affinity than it 
does IHF II (Browning, Sclavi, and Wolfe, unpublished data). Thus, it is  possible 
that occupation of the higher affinity IHF III might interfere with occupation of the 
lower affinity IHF II. Armed with this information, I used genetics to direct IHF/
DNA interaction to either IHF II or IHF III  by simply strengthening or weakening 
IHF II  (i.e. mutating the native sequence to bring it closer to or further from 
consensus). The promoter fragments, 2xIHF-I2wk (IHF II  weakened) and 2xIHF-
I2st (IHF II strengthened), were cloned into pRW50, a low copy plasmid that 
permits more rapid analysis of promoter-lacZ fusions. Similar constructs were 
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built for FL, 1xIHF and 2xIHF (Table 4). The resultant plasmids were introduced 
into AJW678 by transformation, the resultant transformants were grown in TB at 
37oC, cells were harvested at approximately one hour intervals, and their !-
galactosidase activity compared.
 As expected, the FL promoter displayed high promoter activity whereas 
1xIHF was low (Fig. 28C). However, 2xIHF showed an unusually high level of 
transcription unlike that observed when 2xIHF was assayed as a monolysogen 
(Fig. 26). Thus, despite the previously described evidence to the contrary (in the 
phage system), the 1xIHF and 2xIHF promoter constructs  did not behave 
identically (in the plasmid system). The simplest explanation is that the presence 
of IHF II can influence acs transcription, at least when the promoter is  located on 
a plasmid. But why does  the 2xIHF promoter fragment exhibit vastly different 
behaviors when carried by the two different reporter systems? The different 
behavior could be attributed to the difference in copy number. The plasmid 
pRW50 is  present in about ~10 copies  per cell (Lodge et al, 1992), whereas the 
monolysogen is  by definition present in single copy. Another possibility involves 
differences in topology. Topological state can impact local gene expression either 
promoting transcription or inhibiting it. DNA supercoiling tends to promote protein 
binding and the binding of those proteins can influence transcription (Niehaus et 
al, 2008). Plasmids tend to be more supercoiled than the chromosome. Because 
the prophage that carries the acs::lacZ fusion integrated into the chromosome, 
the fusion is  expected to take on the degree of supercoiling characteristic of the 
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loop-domain into which it has inserted.  
 To determine if the plasmid system is a valid tool for assessing the behavior 
of the acs promoter, I disrupted IHF III  in the context of the 1xIHF construct (Fig. 
28B), introducing the C152G C150G and C153A C153A double mutations used 
in Chapter 4 to assess the behavior of the 1xIHF monolysogen (Table 4). For 
both mutations  (here denoted I3wk and I3st), I observed the same behavior, i.e. 
alleviation of inhibition (Fig. 28C). Thus, the plasmid system appears to be valid.
 Next, I introduced two different mutations into the TTR motif of IHF II in the 
2xIHF promoter construct (Fig. 28B). By substituting CC for the native AT, the first 
mutation (I2wk) should reduce affinity. By substituting a T for the native A, the 
second mutation (I2st) should increase affinity. In the context of 2xIHF, 
weakening of IHF II resulted in transcription similar to that obtained with the 
1xIHF promoter fragment, while strengthening of IHF II resulted in a slight 
increase in promoter activity compared to that exhibited by the 2xIHF promoter.
 Taken together, these data are consistent with the hypothesis that IHF II can 
behave as an IHF III  antagonist. Thus, we now possess genetic evidence that 
each site can antagonize the other. 
 Because they are predicted to sit on the same face of the DNA helix, IHF II 
and IHF IIIa are unlikely to be bound by IHF simultaneously. In contrast, since 
IHF II and IHF IIIb are predicted to sit on opposing faces, it is possible for both of 
these sites to be occupied simultaneously (Fig. 29). This led me to re-investigate 
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the influence of IHF IIIa and IHF IIIb on acs transcription.
     
Individual Analysis of IHF IIIa and IHF IIIb
 I chose to perform this re-investigation in the plasmid context because it 
seems to enhance the effect of IHF II. To reduce the complexity of the analysis, I 
deleted the composite IHF III site and instead replaced it with two single IHF sites 
(Fig. 30A): one construct had the DNA site for IHF in the position of IHF IIIa 
(denoted 1xIHF-2R3a; Table 4) and one had the site in the position of IHF IIIb 
(denoted 1xIHF-2R3b). In this manner, I could determine how the individual sites 
might contribute to acs regulation. For the single site, I chose the confirmed 
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Figure 27. Mutating IHF IIIa in the context of 2xIHF alleviates inhibition. !-
galactosidase activity from promoter fragments 0xIHF, 1xIHF, 2xIHF, 2xIHF-C2m, 
or 2xIHF-I3m fused to lacZYA. The wild type strain AJW678 was lysogenized with the 
corresponding hybrid phages. The resultant strains were grown in TB, samples 
harvested at one-hour intervals, the !-galactosidase activity determined, and the peak 
single site IHF II. 
Intriguingly, 1xIHF-2R3a and 1xIHF-2R3b had opposite effects on their 
promoter activities (Fig. 30B). 1xIHF-2R3a resulted in extremely low activity. In 
contrast, 1xIHF-2R3b displayed much higher activity, even more than that 
exhibited by the 0xIHF promoter. Thus, it appears that IHF bound in the IHF IIIa 
position can exert a negative effect on acs transcription and that IHF bound in the 
IHF IIIb position can exert a positive effect. 
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Figure 28. IHF II is a positive modulator of acs transcription. (A) Alignment of the IHF consensus, IHF IIIa,  
IHF IIIb,  and IHF II. The consensus nucleotides are in bold blue. (B) The native arrangement of IHF II and IHF 
IIIa. The consensus nucleotides are in bold blue. Mutations above the sequence improve consensus, while the 
mutations below the sequence diminish consensus. (C) !-galactosidase activity from promoter fragments FL, 
1xIHF, 1xIHFwk, 1xIHFst, 2xIHF, 2xIHFwk, or 2xIHFst fused to lacZYA. The fusions were carried by the low 
copy reporter plasmid pRW50. The resultant constructs were transformed into the wild type strain AJW678 
Notably, when carried by the phage system, the same constructs  both 
displayed higher promoter activity relative to that exhibited by 1xIHF (data not 
shown). Such a result might be due to a less topologically constrained DNA 
template, which could partially negate the effects of IHF IIIa.
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Figure 29. Proposed model of simultaneous occupation of IHF III and IHF II. (A) Diagram of 
2xIHF promoter fragment. Relative positions of IHF, CRP and Fis binding half-site positions are 
indicated above or below their respective sites. IHF III and IHF II are contiguous sites predicted to 
access the minor groove of the top DNA strand. (B) Proposed space-filling model of the DNA bend 
induced by the simultaneous occupation of IHF III and IHFII in the absence of CRP and RNAP. ! 
and " subunits are depicted in teal and purple, respectively. Red and yellow DNA strands represent 
the coding strand for IHF III and IHF II, respectively. (Adapted from D. Browning; personal 
communication)
Discussion
A Proposed Model
 We propose that the occupancy status  of IHF II plays a major role in 
dictating whether IHF binds  to IHF IIIa or to IHF IIIb  and thus whether 
transcription from acsP2 becomes activated or becomes stalled by the 
mechanism described in Chapter 3. 
 This  hypothesis  is supported by the following observations: (1) in the 
context of the phage system, a mutation (C152G C150G, also known as I3m or 
I3wk) that reduces the consensus of IHF IIIa and enhances the consensus of 
IHF IIIb  resulted in activity from the 2xIHF promoter construct greater than that 
exhibited by the 0xIHF or FL constructs  (Fig. 27); (2) also in the context of the 
phage system, the 2xIHF promoter exhibited 1xIHF-like activity (Fig. 26B) that 
was unaltered by a mutation that reduces IHF II consensus (data not shown); (3) 
like the poor activity of 1xIHF, this  poor activity of 2xIHF depends on AR2 (data 
not shown) and CRP II  (Fig. 27); (4) in the context of the plasmid system, 2xIHF 
exhibited high activity, while 1xIHF exhibited weak activity (Fig. 28C); (5) also in 
the plasmid system, the I2wk mutation, which is predicted to decrease the affinity 
of IHF II for IHF, resulted in low levels of transcription resembling that of the 
1xIHF construct (Fig. 28C); (6) also in the plasmid system, the placement of a 
simple site into the IHF IIIa position resulted in poor promoter activity from the 
1xIHF construct, while placement of that same simple site into the IHF IIIb 
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position resulted in strong activity (Fig. 30B); and finally (7) IHF II and IHF IIIa are 
predicted to sit on the same face of the DNA helix, while IHF II and IHF IIIb  are 
predicted to site on opposite faces (Fig. 29). 
IHF III Competes with IHF II
In the context of 2xIHF, the weakening of IHF IIIa coupled with the 
strengthening of IHF IIIb  (C152G C150G) resulted in acs transcription that was 
far greater than that of the 0xIHF construct (Fig. 27). This observation suggests 
that IHF II can play a positive role. It also supports the hypothesis that occupation 
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Figure 30. IHF bound at the IHF IIIa or IHF IIIb positions can be a negative or positive 
effector, respectively. !-galactosidase activity from promoter fragments 0xIHF, 1xIHF, 1xIHF-
A164T/T142A, 2R3a, 2R3a-rev, or 2R3b fused to lacZYA. The fusions were carried by the low 
copy reporter plasmid pRW50. The resultant constructs were transformed into the wild type strain 
AJW678 The resultant strains were grown in TB, samples harvested at one-hour intervals, the !-
galactosidase activity determined, and the peak activities compared. Each value represents the 
mean + SEM of at least three independent measurements. 2R3a, 2R3a-rev, and 2R3b are 
described in the text. 
of IHF IIIa can inhibit the positive function of IHF II, at least when the promoter 
fusion is integrated into the chromosome. 
When both IHF sites are available (as in the 2xIHF construct), perhaps 
IHF prefers to bind to IHF IIIa because of a more favorable consensus  site. This 
preference would have to be due to specific nucleotide composition rather than 
divergence from consensus, because both IHFII and IHF IIIa have the same 
number of differences from consensus. 
Alternatively, the preference for IHF IIIa may rely on the pre-existing DNA 
structure induced by the CRP/RNAP complex (Sclavi et al., 2007). CRP binding 
within a promoter region bends DNA up to 45 angles per homodimer. RNAP also 
induces DNA bending when bound to DNA. Together, the total DNA bend angle 
may exceed 90. Studies on the effects  of DNA curvature (e.g. as AT-rich 
stretches) and DNA binding proteins (specifically the nucleoid protein IHF and its 
paralog HU) show that these proteins  have a greater affinity for curved DNA 
(Bonnefoy and Rouvière-Yaniv, 1991). Therefore, the affinity for IHF IIIa may not 
be as dependent on sequence as it is on the proximity of IHF IIIa in relation to the 
CRP/RNAP complex. 
In either case, the weak activity of the 2xIHF promoter may be the result of 
the inability of IHF to occupy both IHF II and IHF IIIa simultaneously. With a 
preference for IHF IIIa, IHF would mediate inhibition of CRP-dependent 
transcription. And, yet, DNase I analyses show that IHF can occupy both IHF II 
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and IHF III simultaneously (Browning et al., 2004; Sclavi et al., 2007). Because 
IHF should be unable to simultaneously bind IHF II and IHF IIIa, I propose that 
simultaneous binding occurs at IHF II and IHF IIIb. 
Why does the 2xIHF construct behave differently in the plasmid and 
phage systems? 
 In the context of the phage reporter system, the 2xIHF promoter exhibits 
about as much activity as the 1xIHF promoter (Fig. 26B). Thus, when integrated 
into the chromosome, the natural IHF II site cannot overcome the inhibitory 
effects of IHF IIIa. In contrast, in the context of the plasmid system, the 2xIHF 
construct yielded activity that resembled that of the 0xIHF construct. As 
described above, the two obvious reasons for this dichotomy is copy number and 
superhelicity. 
 The copy number difference is about one order of magnitude. If some trans 
factor that helped determine whether occupancy of IHF II was favored was 
limiting, then the increase in copy number could have a significant impact on acs 
transcription. The simplest possibility is  IHF itself. Although IHF is synthesized in 
large amounts, its  DNA sites are numerous. Thus, titration could influence the 
occupancy of the three binding sites in the 2xIHF construct: IHF II, IHF IIIa, and 
IHF IIIb. Titration of IHF would likely favor the higher affinity IHF III site over the 
lower affinity IHF II. Thus, for titration to influence acs transcription, it would have 
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to favor occupancy of IHF IIIb over that of IHF IIIa.
 Alternatively, the key factor might be a difference in the superhelicity of the 
plasmid relative to that of the integrated phage. This  is important because the 
degree of superhelicity affects the binding of proteins and the binding of those 
proteins can influence transcription (Niehaus et al, 2008). 
In either case, the plasmid system allowed me to demonstrate that IHF II 
can antagonize IHF III-mediated inhibition and might explain how (in the FL 
construct) the upstream sequences counteract IHF IIIa-mediated inhibition. In this 
model, the binding of a protein upstream would somehow help IHF to bind to IHF 
II. As a consequence, IHF would bind to IHF IIIb instead of IHF IIIa. 
Does IHF IIIb Function as a Positive Modulator of acs Transcription?
 If this model is correct, then occupancy of IHF IIIb must have a positive 
effect on acs transcription. In the context of the phage system, this is  clearly not 
true: mutations predicted to favor binding to IHF IIIb did not enhance transcription 
from the 1xIHF construct. In contrast, such a mutation (C152G C150G or I3m) in 
the 2xIHF construct resulted in the highest transcription observed (Fig. 27). This 
led me to ask if IHF IIIb  could favor acs transcription. In fact, in the plasmid 
system, it did. Placement of a simple IHF site (IHF II) in the location of IHF IIIb 
resulted in strong promoter activity in the 1xIHF construct (1xIHF-2R3b). In 
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construct, placement of the same site in the position of IHF IIIa resulted in very 
weak activity (1xIHF-2R3a) (Fig. 30).
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CHAPTER SIX 
!DISCUSSION
!Prior Studies
 To survive a variety of environmental conditions, a bacterium must adjust 
swiftly and efficiently to signals it perceives concerning its  milieu (Roszak and 
Colwell, 1987) (Kussell et al., 2005). To adapt to harsh conditions, bacteria up- or 
downregulate genes and/or operons that are necessary for survival. Therefore for 
immediate reaction some transcription factors with global activities responsible 
for coordinating the response preexist in the cytoplasm eliminating some time 
required for transcription factor synthesis  (Zhou et al., 2008) (Kort et al., 2008) 
(Kussell et al., 2005). The expression of proteins, such as acs during carbon 
starvation, that respond to the specific signal/stress are upregulated to help the 
bacterium adapt to the altered milieu. This network of effectors and sensors are 
precisely coordinated to reduce or eliminate any inefficiency (Slauch et al., 1997) 
(Khmel, I. A., 2005). Removal drastically alters  the cells survivability under 
normal conditions and spell disaster in challenging ones. 
Due to the large variety of environmental stresses encountered by a 
bacterium, many genes are needed to survive. However, the volume of the 
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absolutely required. To conserve space, bacterial genes are often organized as 
operons, with many genes or operons overlapping, while others are encoded on 
opposing DNA strands.
Much like this  dense organization of genes on the chromosome, promoter 
elements also maximize the amount of regulatory information for precise gene 
expression. Missteps in transcription can lead to cellular death during times of 
carbon limitation. At the most basic promoter, DNA sequence information directs 
RNAP to bind to the -35 and -10 sequences, hallmarks of any promoter. At these 
“simple” promoters, the stability of RNAP binding does not require a transcription 
factor to stably bind the promoter region. However, not all promoters allow for 
stable RNAP binding. To more stably anchor RNAP to the DNA some promoters 
have an additional cis element located just upstream of the -35 hexamer, called 
an UP element. The UP element is  an A-T rich sequence that is recognized and 
bound by the RNAP !-CTD, thereby providing a more stable RNAP/DNA 
interaction. Not only does  promoter sequence provide a means for RNAP 
recognition for higher affinity binding but also DNA structure. The UP element 
and -10 hexamer (TATAAT) are A-T rich regions that are prone to creating 
intrinsic DNA bends. This sequence-induced DNA secondary structure creates an 
environment that is more conducive for DNA recognition and protein docking to 
the promoter region*. However, the location of an UP element may exist 100 bp 
further upstream than ones found proximal to the -35. To activate and enhance 
transcription at these promoters, a transcription factor solely utilized for DNA 
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remodeling is  required to bring this distant UP element into close proximity to the 
!-CTD. Despite the straightforward regulation of simple promoters, the protein/
DNA dynamics at the majority of bacterial promoters involve more than one 
activator,!more than one inhibitor, and many relevant DNA sequences within the 
same region of DNA. 
The majority of bacterial promoters have many multiple relevant 
sequences where cis and trans factors contribute to regulating transcription. Due 
to the various DNA sequences, and the proteins that bind to them, within 
complex bacterial promoters the dynamics  between transcriptionally relevant 
inputs complicates our understanding of the mechanisms by which transcription 
occurs. This  limits  our ability to utilize this knowledge for applications ranging 
from treating disease to enhancing biotechnology. At a complex promoter, 
multiple transcription factors bind to multiple sites to either activate or inhibit 
transcription. The nucleotide sequence arrangement of transcription factor and 
RNAP binding sites  of complex promoters  have evolved to optimally position 
DNA binding sites to ensure precise regulation of a given gene or operon. 
Deciphering the code of gene regulation is not a straightforward process because 
the positioning of DNA binding sites makes it rather complex to understand the 
precise role of inhibitors, activators, RNAP, and the contribution of promoter 
sequence and structure to regulation. Thus, to deconstruct the operating 
mechanisms of a given promoter region, we must study the individual and group 
contributions of any identified, putatively relevant sequence. My studies revolved 
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around the isolation of individual nucleotide elements and then introducing point 
mutations to each site within the whole to measure the transcriptional output of a 
reporter construct. 
The acs-nrf intergenic region, our model promoter, was an ideal choice to 
study regulation of a complex promoter for many reasons. Among them are: 1) 
the acs operon and its  protein products are not essential under our assay 
conditions and media (37°C with aeration in tryptone broth, or TB); therefore, 
reduced or disabled gene expression does not interfere with promoter analysis; 
2) the complexity of the promoter region is sufficiently crowded – the acs 
promoter contains four RNAP binding sites, Pnrf, acsP1, acsP2A, and acsP2, two 
Fis binding sites, two CRP site, three IHF sites, and a putatative ArcA site whose 
function will not be discussed further. The protein binding sites identified as 
acting upon acs do not include the transcription factors  NarL, FNR, and NarP that 
regulate transcription of the opposing, divergent nrf promoter. Interestingly, a few 
of the protein binding sites shared by both regulatory regions affect transcription 
of each operon, specifically those for the nucleoid protein IHF (Fig. 6) (reviewed 
by Wolfe, 2005; Wolfe, 2009). 
The functions of these promoters and binding sites  were identified through 
the use of nested 5’ truncations with the intent to identify those DNA sequences 
that most affected transcription from the major acs promoter, acsP2. To ensure 
that no relevant sequences were missed, Beatty and Wolfe designed a 444 bp 
‘full-length’ promoter (FL, acs444) that included the entire acs-nrf intergenic 
 138
region and its flanking sequences (from +101 bases downstream of the nrf 
transcription start site (+1) to +76 bases downstream of the acsP2 +1). The merit 
of this  approach became apparent when 3’-truncations (lacking the 76 bases 
downstream of the acsP2 +1) showed noticeably different promoter behaviors 
than their more full-length variants (Thach, Beatty and Wolfe, unpublished data). 
Although this phenomenon supports the hypothesis that the downstream 
sequences contribute to the regulation of acs transcription, the mechanism 
remains unknown and dissection of that mechanism remained outside the scope 
of this dissertation. To evaluate the function(s) of specific promoters and sites, 
these researchers also chose to mutate specific DNA sites rather than deleting 
the gene that encodes the transcription factor or NAP predicted or known to bind 
to that sequence. Beatty and Wolfe reasoned that the complete absence of a 
global regulator might result in formation of a non-native nucleoid and thus 
increase the probability that the resulting data would reflect a non-native 
mechanism. They also reasoned that deletion of a global regulator with multiple 
functions at a given promoter would reflect only one of those functions. The merit 
of this approach was demonstrated by the behavior of a himA mutant, which 
exhibited substantially reduced acs transcription despite the clear indication that 
its gene product, IHF, functions primarily as  an inhibitor (Beatty and Wolfe, 
unpublished data). I chose to follow their lead, working with and constructing 
additional 5’ nested truncations of the FL promoter and introducing specific and, 
wherever possible, well-characterized point mutations into those truncations. 
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 Coupling the point mutation strategy with conventional in vitro transcription 
assays, Wolfe and co-workers demonstrated that acsP2 functioned as the 
primary promoter. They further showed that the ability of acsP2 to transcribe 
depends on the ability of CRP to bind to a high-affinity promoter-proximal site 
(CRP I) from where one of its surfaces (AR1) must make physical contact with a 
surface (determinant 287) of the !-CTD of RNAP (Beatty et al., 2003). Moreover, 
they showed that modulation of this CRP-dependent activation involves the 
binding of multiple proteins (CRP, IHF, and Fis) to multiple binding sites located 
5’ to CRP I. For example, they showed that the binding of CRP to a low-affinity 
promoter-distal site (CRP II) enhanced transcription about two-fold (Beatty et al., 
2003). They also demonstrated that Fis inhibits CRP-dependent transcription in 
part by binding to Fis III, which overlaps CRP I. Thus, the binding of Fis to FIS III 
hinders the required binding of CRP to CRP I. Since Fis interferes with the 
activator CRP and not RNAP itself, the inhibitory process is termed anti-activation 
(Browning et al., 2004). In contrast, the mechanism by which the binding of Fis to 
FIS II remained unclear. 
Wedding the truncation strategy to in vitro transcription assays, Wolfe and 
co-workers further identified a 31-bp sequence located just upstream of CRP II 
that exerted a strong inhibitory effect on the CRP-dependent activation of acs 
transcription. They further showed that sequences located further upstream 
alleviated this inhibition. On the basis of their observation that the 31-bp 
sequence bound IHF, they proposed that the inhibition resulted from the binding 
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of IHF to this  31-bp sequence (Browning et al., 2004). It was the purpose of my 
dissertation to test this hypothesis and to dissect the underlying mechanism.
IHF Mediates Formation of a Stalled Open Complex
First, I verified the genetic observations that led to this hypothesis. As 
reported previously (Browning et al., 2004), the FL construct displayed the 
highest promoter activity and the 0xIHF (acs205) promoter fragment exhibited 
about two-thirds the FL activity. In contrast, the 1xIHF (acs236) promoter 
fragment achieved very low activity, reaching levels less than one-fourth of 0xIHF 
and one-sixth that of FL (Fig. 9C). Thus, my co-authors and I concluded that the 
31-bp sequence (denoted IHF III) exerted a negative influence on acsP2 
transcription.
I extended these observations by introducing individual mutations into the 
CRP I, CRP II, and IHF III sites  of the 1xIHF promoter fragment (Fig. 9). As 
expected, introduction into CRP I of a mutation predicted to severely decrease its 
affinity for CRP essentially eliminated acs transcription. In contrast, introduction 
into CRP II of a similar mutation gave us a most peculiar result. This  promoter, 
denoted 1xIHF-C2m, exhibited promoter activity similar to that of the 0xIHF 
promoter fragment. This  result was  consistent with an inhibitory role for CRP II, a 
conclusion diametrically opposed to that obtained from the introduction of the 
identical mutation into the FL promoter (Beatty et al., 2003). To verify that CRP II 
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could enhance CRP I-dependent transcription, I tested the promoter fragment 
1xCRP (acs155), whose transcription is controlled by the single CRP I site. As 
expected if CRP II  can function as  a positive element, 1xCRP exhibited about 
half the activity of 0xIHF, which carries both CRP sites. We concluded that CRP II 
could function either as a positive or negative element and that the mechanism 
underlying IHF-mediated inhibition depends  on the status  of CRP II (Sclavi et al. 
2007). 
I next tested a mutant 1xIHF promoter fragment (1xIHF-I3m) in which a G 
was substituted for the native conserved C within the central WATCAA motif. This 
mutant fragment exhibited activity intermediate to 1xIHF and 0xIHF, suggesting 
that the 31-bp-dependent inhibition depends  on IHF, as previously proposed (Fig. 
9) (Browning et al., 2004; Sclavi et al., 2007). IHF is a protein demonstrated to 
affect DNA structure by inducing an IHF-DNA bend angle reaching up to 180°. 
Though hard biochemical evidence measuring the bend angle induced by IHF at 
the acs promoter in the presence of RNAP and CRP has not been reported here, 
we do provide genetic evidence to support the requirement of IHF-mediated 
DNA remodeling. This was a surprising result, as disruption of CRP II, in the 
context of 1xIHF, resulted in a transcription profile similar to 0xIHF. This result 
suggested that CRP II was more important for inhibition than IHF III. Yet, as I 
explained above, CRP II functions as a positive effector in the absence of the 31-
bp sequence that includes IHF III. Thus, my co-authors and I concluded that IHF-
mediated inhibition required the combined function of IHF III and CRP II. We 
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proposed that together these two sites  determine whether CRP bound to CRP I 
can activate transcription by RNAP bound at the acsP2 promoter (Sclavi et al., 
2007). 
 To gain insight into the mechanism by which this IHF-CRP tandem inhibits 
transcription, I identified the surfaces of CRP required for or involved in IHF-
mediated inhibition of CRP-dependent acs transcription. By deleting the crp gene 
and complementing with either WT CRP or mutants of the surfaces known to 
interact with RNAP, I learned that IHF-mediated inhibition requires AR2 (Fig. 10). 
Interestingly, the non-native AR3 can compensate in the absence of AR2 (Sclavi 
et al., 2007). Armed with the results of my genetic analyses  and plasmid 
constructs  that I specifically constructed for in vitro analyses, my collaborator (Dr. 
Bianca Sclavi) performed DNase I and potassium permanganate footprint 
analyses. On the basis  of her studies, we concluded that IHF mediates the 
formation of a complex that also includes RNAP and both CRP homodimers. This 
complex, we proposed, entraps RNAP in an unproductive open complex (Fig. 
16). The specific role of AR2 remains unknown. Since this unproductive complex 
includes two CRP homodimers and since each subunit of the CRP dimer 
includes  its own AR2 surface, there exist four distinct AR2 surfaces within the 
stalled complex. To identify the required AR2 surface(s) would require the use of 
oriented heterodimer analysis (Zhou et al, 1993), a genetic ‘trick’ that allows the 
investigator to direct a mutant surface to a specific binding site and to orient that 
surface either upstream or downstream. 
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How does IHF mediate the formation of this stalled complex? I propose 
that this is all made possible by the conformational and torsional strain induced 
on DNA by IHF when bound to IHF III. Upon binding to DNA, IHF inserts proline 
“fingers” into the minor groove of DNA. This  insertion helps induce a bend but 
does not change the superhelicity of the immediate DNA strands of the IHF 
binding site. In contrast, DNA superhelicity is changed upstream (positive) and 
downstream (negative) (Aeling et al, 2006; Swinger and Rice, 2004; Swinger et 
al, 2003). The introduction of negative supercoiling in the region where CRP and 
RNAP bind may cause the CRP dimers to come into close contact with each 
other and RNAP. The additional protein-protein interaction then stabilizes the 
complex, thwarting promoter escape. Our genetic and footprint analyses support 
this  conclusion, but analysis of the actual DNA structure of the inhibition complex 
remained beyond the scope of this thesis.
Countering IHF-Mediated Inhibition
The conclusions drawn from the study described in Chapter 3 (Sclavi et 
al., 2007) are limited to the 236-bp promoter fragment, 1xIHF. Although both 
genetic and biochemical analyses also were performed on the FL promoter, the 
differences in the architecture and behavior are substantial. The FL promoter 
measures 444 base pairs  long and includes many additional protein binding sites 
that are not only relevant to acs regulation but also to the divergent promoter, 
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Pnrf. Furthermore, this construct exhibits six times more promoter activity than 
does 1xIHF (Fig. 9). This behavior is most interesting. Clearly, the upstream 
sequences somehow counterbalance the inhibitory effect caused by the binding 
of IHF to IHF III.
In Chapter 3, I proposed that the countering mechanism might revolve 
around the occupancy of CRP II (Fig. 16). If IHF III remains occupied during 
exponential growth, then the occupancy of CRP II becomes the critical factor. 
During mid-exponential growth, when cAMP begins to accumulate, the higher 
affinity CRP I  can become occupied, but the lower affinity CRP II remains 
unoccupied, the CRP dimer bound at CRP I would be free to activate acs 
transcription by a typical Class I, AR1-dependent mechanism. As the 
concentration of cAMP increases, however, CRP II can become occupied and 
RNAP becomes stalled in an AR2-dependent mechanism. 
Another intriguing possibility that is not mutually exclusive with the 
mechanism proposed in the previous  paragraph is titration. IHF is a global 
regulator of many DNA-related events  of which transcription is only one. Although 
IHF is made in moderately large amounts  during exponential growth, the pool is 
limited. The chromosome possesses a large number of DNA sites for IHF. 
Perhaps the combination of limited IHF molecules and excess DNA sites titrates 
IHF away from IHF III, permitting some acs transcription even when both CRP 
sites are filled. 
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Together, these and other mechanisms could explain the expression 
profile of acs. Under the conditions tested (37°C in tryptone broth with aeration), 
acs transcription remains low during early exponential growth, gradually 
increases during mid-exponential growth, peaks  upon the transition into 
stationary phase, and drops markedly as the culture progresses further into 
stationary phase (Kumari et al, 2000). 
Inhibition during early exponential growth. During early exponential 
growth, acs transcription remains low most likely through a lack of CRP-
dependent activation and Fis-dependent anti-activation. As described at the end 
of Chapter 3, if IHF were also bound to IHF III, the Fis-dependent anti-activation 
would be even stronger. 
Activation during mid-exponential growth. As the favored carbon sources 
become depleted, cAMP becomes more prevalent and Fis becomes less so, 
shifting the balance of acs-bound proteins from Fis to CRP. Even if IHF is  bound 
at IHF III, there should only be enough CRP to bind the higher affinity CRP I site 
and thus transcription would ensue. 
Inhibition following entry into stationary phase. As the culture enters into 
stationary phase, the concentration of cAMP continues to increase and the 
concentration of IHF approaches its maximum, while Fis becomes undetectable. 
Under these conditions, the lower affinity CRP II  site could become occupied 
simultaneously with IHF III. The binding of both RNAP and CRP should induce a 
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DNA bend. Since IHF targets bent DNA the secondary structure induced by the 
binding of both RNAP and CRP should facilitate the binding of IHF (Swinger and 
Rice, 2007; Teter et al, 2000). 
If this were indeed the mechanism that underlies  IHF-mediated inhibition 
of CRP-dependent acs transcription, then the 1xIHF promoter would follow a 
similar pattern of gene expression, albeit at a lower level due to the absence of 
upstream sequences required for the maximal transcription as seen with the full-
length (FL) promoter. Because expression levels from 1xIHF reaches only 
13-15% of FL during the course of an 8-10 hr experiment, we conclude that IHF-
mediated regulation is not solely dependent upon the number of IHF molecules 
available for binding. If IHF-mediated inhibition of the 1xIHF promoter depended 
on only the number of IHF molecules present, then we should observe 
transcription to be higher that the reported level (13-15% of FL) when IHF levels 
are relatively low during log phase. A precipitous drop in transcription should 
occur when the cellular concentration of IHF reaches its  peak. This  led us to 
ponder how the inhibitory effect of IHF at acs is regulated. 
IHF III is a composite site
Mutational analysis of the 31-bp sequence that includes IHF III  restored 
1xIHF promoter activity to approximately 50% of that exhibited by the 0xIHF 
promoter fragment. If the binding of IHF to IHF III  was the underlying reason for 
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the 31-bp-dependent inhibition, we expected this mutation to restore transcription 
to a level similar, if not identical, to that of the 0xIHF promoter fragment (Beatty et 
al, 2004). The puzzling results provided me with a new focus: if the 31-bp 
sequence includes a single 27-bp IHF III site, then why does a replacement 
mutation predicted to severely decrease IHF binding fail to completely restore 
transcription to the level exhibited by the 0xIHF promoter fragment?
As mentioned earlier, the intergenic region between the acs and nrf 
operons share protein binding sites that regulate their expression, albeit under 
different physiological conditions. acs transcription occurs under aerobic 
conditions as preferred carbon sources diminish. In contrast, nrf expression is 
activated under anaerobic, nitrogen limiting conditions (Wolfe, 2005). However, a 
key factor in transcription at both promoters is  IHF III – activating transcription at 
nrf and inhibiting acs expression (Browning et al, 2004; Browning et al., 2006). 
Initially, it was unclear how a single IHF III  site could have contradictory functions 
at divergent promoters. We imagined that the function of IHF at both promoters 
was dependent upon the specific conditions under which transcription takes 
place from both promoters, i.e. anaerobic in the presence of RNAP and FNR at 
Pnrf and aerobic in the presence of CRP with RNAP at Pacs. But how does an 
IHF binding site 127 base pairs upstream of the nrf +1 activate transcription from 
one strand of DNA, while functioning as an inhibitor of acs expression on the 
other DNA strand?
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Theoretically, IHF III could exist as  a single site and function as both an 
activator of transcription and inhibitor because of its ability to cause topological 
changes. IHF binding not only causes DNA bending and folding, but it also can 
cause changes in DNA supercoiling both upstream and downstream of its binding 
site and, as a consequence, affect gene expression at either long or short 
distances from that site. For example, at the !54 Pu promoter of Pseudomonas 
putida, IHF binding to an upstream region spanning -56 to -86 is crucial for 
activating transcription. The folding of DNA brings an enhancer region 
(surrounding position -104) into contact with the "-CTD of RNAP (Macchi et al 
2003). Not surprisingly, the direction of DNA bending is crucial to activation as 
insertion of an additional five bp, which places the IHF binding site on the 
opposite face of the DNA helix, causes a loss of transcription. 
Our collaborators at the University of Birmingham (UK) have 
demonstrated that their predicted IHF III  (denoted as IHF IIIb) sequence is 
physiologically relevant to nrf regulation (Browning et al., 2006), while we have 
published reports  on the negative affects of our predicted IHF III sequence 
(referred to as IHF IIIa) on acs transcription (Browning et al., 2004; Sclavi et al., 
2007). When we analyzed the sequence of both predicted sites, we concluded 
that they both could be real, as they each possess strong similarities to the IHF 
consensus site (WATCAANNNNTTR) with the same number of bases diverging 
from consensus. Furthermore, they overlap and are offset by two bases. 
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van Rijn and co-workers first reported the presence of two transcriptionally 
relevant, overlapping and inverted IHF sites (1991). The early promoter (Pe) and 
the repressor promoter (Pc) of bacteriophage Mu share the same intergenic 
region. These convergent promoters are both activated by IHF. These dual 
inverted overlapping IHF binding sites (designated ihfa and ihfb) are offset by 
three bases and are the only reported activators of transcription in this intergenic 
region. Thus, the mechanism of transcriptional activation appears  to be solely 
dependent on the conformation of DNA induced by IHF. 
Like van Rijn et al., we tested the hypothesis that IHF III is a composite 
site containing an IHF IIIa site relevant to acs transcription and an IHF IIIb  site 
that controls nrf transcription. To determine whether two overlapping IHF binding 
sites existed and whether either or both sites were relevant to acs promoter 
regulation, I introduced single base pair mutations  into the conserved motifs  in 
accordance to results reported by Lee et al, (1991) and Hales et al (1994). 
Coincidentally, IHF IIIa and IHF IIIb  sequences are offset by two base pairs. Each 
of their 3’ TTR motifs  sits  opposite the opposing dA-dT region. Whereas 
mutations in the dA-dT have been reported to cause weak to moderate defects in 
IHF binding (Lee et al, 1994; Hales et al, 1996; Fyfe and Davies, 1998), 
mutations in the TTR have been shown to cause severe defects in IHF binding, 
For example, the substitution of the second T with an A disrupts  required 
hydrogen bonding between E44, R42, and R46 of the ! subunit of IHF, resulting 
in a severe decrease of IHF/DNA interaction (Granston and Nash, 1993; 
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Mengeritsky et al, 1993). Using this information as  my guide, I inserted mutations 
into the TTR and coincidentally into the opposing dA-dT region. Because of the 
overlap, these substitutions were predicted to reduce IHF binding to both sites 
and, as expected, they caused moderate to severe loss of IHF-mediated 
inhibition. I next inserted mutations into the central WATCAA motifs  of either site. 
Since these mutations were predicted to disrupt binding to one site at a time, I 
used them to determine whether either or both sites existed. On this basis, I 
concluded that both sites likely existed and that they both exerted an inhibitory 
effect upon acs transcription.
To test this hypothesis, I swapped the two IHF III sites. I reasoned that if 
two IHF III sites existed, then re-positioning IHF IIIa to the native location of IHF 
IIIb  on the opposite DNA strand, and vice versa, would result in promoter activity 
from this mutant construct (denoted 1xIHF-VF) that was similar, if not identical, to 
the wild-type 1xIHF promoter. Indeed, I observed virtually identical levels of 
promoter activity from both 1xIHF and 1xIHF-VF. Their near identical promoter 
activities led us to test whether the low transcription activity exhibited by 1xIHF-
VF required the same distinguishing features for low transcription activity as 
displayed by 1xIHF. These include IHF, RNAP, both CRP dimers, and at least one 
of the four AR2 surfaces (Sclavi et al., 2007). Thus, the effects  of IHF-mediated 
inhibition can be bypassed if: a) CRP cannot bind CRP II and/or b) the AR2 
surface has been eliminated. I chose to test the involvement of the CRP 
surfaces, as they provide more information than simply disrupting CRP II. 
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In the context of the 1xIHF promoter fragment (Chapter 3), IHF-mediated 
inhibition requires a functional AR2 surface. In its absence, the non-native AR3 
surface can compensate and the presence of both AR2 and AR3 results in 
extreme inhibition. Remember that all three activation surfaces (AR1, AR2, and 
the mutant AR3) mediate protein-protein interaction. Importantly, they are 
independent of the surface responsible for binding DNA. At Class III promoters of 
the Class  I-Class I kind (e.g. acsP2), it is  proposed that the !-CTD, linked to the 
body of RNAP by a flexible tether, contacts  AR1 of both CRP dimers to activate 
transcription (Busby and Ebright, 1999). In contrast, AR2 and AR3 are reported to 
directly contact the body of RNAP. AR2 is reported to interact with the !-NTD 
(Busby and Ebright, 1999) and AR3 is reported to make contact with Region 4 of 
"70 (Rhodius et al; 2000). For AR2 or AR3 to bind to the body of RNAP, a CRP 
site must be located near the RNAP binding site and yet the proximal site is 
located at a distance from the promoter, centered at -69.5. Given that promoter 
constructs  that do not exhibit IHF-mediated inhibition (e.g. 1xIHF-C2m) are 
unaffected by AR2 or AR3, we surmise that IHF alters the local DNA topology 
enough to permit intimate contact between the CRP dimer bound at CRP I and 
either the !-NTD (mediated by AR2) or Region 4 of "70 RNAP (mediated by 
AR3). Application of a similar analysis to 1xIHF-VF yielded results  that were 
virtually identical to those obtained with the parental 1xIHF. Therefore, I conclude 
that IHF III is a composite site and that IHF IIIa and IHF IIIb  both contribute to 
inhibition, at least in the 1xIHF context. 
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IHF III-mediated inhibition of CRP-dependent transcription involves dual 
overlapping IHF III binding sites 
 Previous work on acs regulation and the divergent nrf operon yielded 
contradictory information concerning the function and location of the IHF III site. 
According to data obtained through our studies, IHF bound to IHF III induces  an 
inhibition loop if tandem CRP dimers bind to CRP I and CRP II and RNAP binds 
the promoter. A point mutation introduced into CRP II or the AR2 surface of CRP 
relieves IHF-dependent inhibition. Conversely, Browning et al. demonstrated that 
IHF occupation of IHF III  helps promote transcription of the divergent promoter, 
nrf. Here, IHF assists activation in the absence of inhibitors  (Browning et al., 
2006). The IHF binding site relevant to acs (designated IHF IIIa) is offset by two 
base pairs compared to the IHF site identified as important for nrf activation 
(designated IHF IIIb). Point mutations  in both predicted IHF binding sites do not 
completely abolish IHF binding (Sclavi et al., 2008; Browning et al., 2006), 
though this was not an unreasonable result given the IHF degenerate consensus 
sequence. Mutations in IHF III, within the confines of the 1xIHF promoter, 
decreased transcription as measured by expression of the reporter gene, lacZ. 
Total abolition of lacZ expression, or restoration of transcription to levels  at or 
near that exhibited by the 0xIHF promoter, was never observed. 
 Further, my effort to generate proper mutations that would localize IHF 
heterodimers to either IHF IIIa or IHF IIIb, or to eliminate IHF binding altogether 
was met with less than definitive results. Using published work by Lee et al., I 
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designed a library of 1xIHF promoters that had mutations directed to either the A-
T rich sequence, the central WATCAA motif, or the TTR motif. These mutations 
were constructed in the effort to definitively conclude whether IHF IIIa, IHF IIIb, or 
both sites exist. However, this systematic mutational analysis did not allow us to 
make strong conclusions as  to whether two overlapping IHF sites that are offset 
by two base pairs, oriented in opposite directions, and positioned on opposing 
faces are a reality and have biological significance to acs regulation. Though we 
could not clearly assign function or relevance to either IHF IIIa or IHF IIIb  using 
mutational analysis  by base pair replacement, the varied results did suggest that 
IHF III was  not your typical IHF binding site. Mutations in the single IHF near- 
consensus sequence, H’ of ! phage, reveals specific nucleotide replacement at 
important binding motifs had measurable affects on IHF binding. They observed 
that specific bases strongly inhibited IHF binding, while some base pair 
replacements only mildly or moderately did so. In our study of IHF III, the same 
base pair replacement mutations  that targeted either IHF IIIa or IHF IIIb  only had 
weak to moderate effects. Furthermore, double nucleotide replacement meant to 
severely limit IHF binding to both predicted sites (A164T T142A; both 
replacements were done in the TTR motif) ! restored promoter activity to levels 
matching 0xIHF. The single mutations in the TTR of either site, specifically 
T142A and A141T, displayed only an intermediate effect on promoter activity and 
thus IHF binding. 
 However, replacing IHF IIIa with IHF IIIb, and, consequently, IHF IIIb  with 
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IHF IIIa, produces a promoter (designated 1xIHF-VF) whose activity strongly 
resembles the 0xIHF promoter. Furthermore, the requirements for inhibition are 
the same as the wild-type 1xIHF promoter, namely, AR2 of CRP and CRP bound 
to CRP II. Swapping single IHF sites from one DNA strand to the complementary 
strand would alter the effects of IHF binding on the downstream promoter. For 
example, if IHF IIIa were the only site pertinent to both acs and nrf transcription, 
then repositioning it to other DNA strand, while preserving the directionality of 
binding, IHF would not cause inhibition of acs. In fact, our promoters 1xIHF-2R3a 
and 1xIHF-2R3b confirm this prediction. Placement of the single IHF binding site, 
IHF II, in the position of IHF IIIa inhibited acs transcription. In contrast, 
replacement of IHF III with the single IHF II site did not cause inhibition. 
 Interestingly, the activities of these 1xIHF promoter variants behaved rather 
differently when they were assayed from the low-copy plasmid pRW50 relative to 
the single copy promoter fusions inserted into the chromosome using !phage. As 
single fusions, 1xIHF-2R3a increased transcription beyond the activity of the 
0xIHF promoter, whereas 1xIHF-2R3b displayed activity similar to that of 0xIHF. 
We postulate that the difference in promoter activity from the plasmid versus the 
single-copy fusion depends on the surrounding DNA and its protein-associated 
contents. pRW50 is not a typical plasmid as it is  larger (~17 kb) than the 
everyday cloning plasmid (~3 kb) and, like all plasmid DNA, undergoes 
compaction and supercoiling much like genomic DNA. However, the number of 
genes on pRW50 (~6; Lodge et al., 1992) pales in comparison to the E. coli 
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genome, which contains over 4300 genes, thus providing more promoter DNA for 
transcription factors and RNAP to bind. Therefore, I suspect that the difference in 
reporter gene expression from the pRW50 plasmid and the integrated single-
copy of the same promoter construct on the genome is due to a titration effect of 
available transcription factors and RNAP. To wit, not only do proteins specific for 
transcription affect gene expression but also local DNA structure, surrounding 
protein content, and relative transcription activity within the surrounding region 
influence transcription (Speck et al., 1999; Su’etsugu et al., 2001; Han et al., 
2009). Thus, the depth of DNA decoration on the genome may cause the single 
2R3a IHF site to behave as  a co-activator of transcription rather than an inhibitor. 
On the other hand, repositioning a single IHF site to yield 2R3b might allow IHF 
to bind with minimal consequence to acs transcription due to the direction of the 
DNA bend. However, when both sites are layered, as they are within the natural 
promoter, IHF may dynamically change binding positions from IHF IIIa to IHF IIIb. 
Finally, the consequence of IHF binding to either site is brought forth by the 
proteins that are bound downstream, and perhaps, upstream of IHF IIIa/b. It is 
well documented that proteins affect DNA structure upon binding and the 
aftereffect of such interactions provides the groundwork for further protein 
binding (Han et al., 2009). 
 In future studies, we would need to address  whether the dual-overlapping 
IHF sites could function at other promoters similar to the acs architecture (i.e. 
tandem activator sites)? How would IHF IIIa/b  affect a Class II promoter or a 
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complex Class II promoter? Can we find promoters in other organisms that have 
opposing dual-overlapping binding sites for the same transcription factor? Are 
there nucleotides outside of the consensus  motifs  that are critical to IHF binding 
that might be mutated to more completely reduce binding to either or both sites? 
This  particular experiment would be useful to discern the effects of IHF choosing 
to bind to either IHF IIIa or IHF IIIb  through the use of oriented heterodimer 
analysis. This type of analysis would provide us more control over the location of 
IHF binding and better understand IHF IIIa and IHF IIIb  by dictating when 
occupation takes place.  If we were able to isolate distinct mutations that affected 
only IHF IIIa or IHF IIIb then we could use the resultant promoters to generate 
IHF mutants that recognize the distinct mutants as was done by Busby and 
Ebright for CRP (1994). This would allow us to introduce mutant IHF 
heterodimers into single-copy phage lysogens without eliminating the native IHF 
gene. We would bypass the metabolic problems seen in cells lacking this global 
regulator and avoid competition for binding by the natural IHF heterodimer. Such 
a study would permit us to analyze the activity of the 1xIHF promoter in a more 
natural state while determining the functional properties of the individual IHF IIIa 
and IHF IIIb  sites. Additionally, we would like to ask: does the current location of 
IHF IIIa/b  in relation to the tandem CRP sites and RNAP allow it to function 
optimally? Or would shifting it up- or downstream change how IHF IIIa and IHF 
IIIb  effect transcription? And finally, how does the swapping of IHF IIIa with IHF 
IIIb  affect the opposing divergent promoter, nrf? Thorough investigation of IHF 
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IIIa/b is  needed to understand how this unique transcription factor binding site 
influences transcription and the surrounding protein binding sites at divergent 
promoters, acs and nrf, under different metabolic conditions. Designing  finely 
tuned future synthetic promoters may benefit from utilizing such as site for 
manipulation in drug production, metabolic enhancements, etc.  
Tipping the Scales of acs Promoter Regulation by IHF IIIa/b
 In this thesis, I provided evidence that the upstream, contiguous IHF binding 
site, IHF II, may help determine the location of IHF binding to IHF IIIa/b  at a given 
time. Whereas we had seen severe IHF-mediated inhibition in the context of the 
1xIHF promoter, the additional presence of IHF II  (in the promoter fragment 
denoted 2xIHF) modestly relieved inhibition and produced gene expression 
levels  similar to the 1xIHF mutant constructed by Dr. Beatty (Sclavi et al., 2008). 
When I extended Dr. Beatty’s mutant by adding IHF II expression levels  of the 
reporter gene (lacZ) soared past her mutant 1xIHF fragment and even the full-
length promoter, a construct with the highest possible expression tested to date. 
We reason that the 1xIHF mutant weakens IHF binding to both IHF IIIa/b  but 
does not eliminate binding altogether; thus, it results in intermediate level of gene 
expression. The addition of IHF II appears to have positioned an IHF heterodimer 
at either IHF IIIa or IHF IIIb. Based on their locations  relative to IHF II, we believe 
that two IHF heterodimers  would be sterically hindered at IHF II-IHF IIIa 
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positions. However, it would be more feasible for two IHF proteins to bind at an 
IHF II-IHF IIIb  conformation. The latter scenario would not form an inhibition loop 
and may position all proteins in an optimal or a better than optimal position for 
transcription. Alternatively, IHF may bind to only IHF II as it would be a higher 
affinity site than the mutant composite IHF III site. This scenario may actually be 
more ideal because there would be one less DNA bending protein. A less 
crowded acs promoter would permit CRP dimers to fully wrap promoter DNA and 
extend the bend angle they impose positioning both DNA and CRP proteins in a 
more optimal location relative to RNAP. 
 To discern between the two different scenarios, promoter fragments with 
single IHF IIIa and IHF IIIb  binding sites, in the context of the 2xIHF promoter, 
would be tested. The single IHF site, IHF II, would be used construct the 
promoters 2xIHF-2R3a and 2xIHF-2R3b to answer the questions: does IHF to 
IHF II and IHF IIIa or b  simultaneously? If so, what are the affects on 
transcription? The proposed promoters would help determine the optimal 
orientation of IHF binding to two scenarios where dual IHF sites allows two 
heterodimers to bind either on the same DNA face or on opposing strands. 
Additionally, the same promoter fragments could be used to determine whether 
either 2xIHF-2R3a and 2xIHF-2R3b fragments have different IHF binding 
affinities. 
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IHF II is a Positive Modulator of IHF-Mediated Inhibition
I next reconsidered the mechanism underlying the vast difference in the 
weak activity exhibited by the 1xIHF promoter construct and that of the FL 
construct. Two sequences upstream of the composite IHF IIIa/b  caught my 
interest: a perfect palindrome and IHF II. A construct that included the palindrome 
but not IHF II (1xIHF+5) reproducibly displayed more activity than 1xIHF (Fig. 
26). Since perfect palindromes are exceedingly rare, I invested a lot of effort 
trying to understand this  behavior. In the end, however, I had to conclude that the 
palindrome did impact acs transcription – at least not under the conditions that I 
tested. I therefore turned my attention to IHF II.  
IHF II is contiguous with IHF III and is  predicted to site on the same face of 
the DNA helix as IHF IIIa. Because of their proximity, we propose that the binding 
of IHF to IHF IIIa would sterically hinder the binding of IHF to IHF II and vice 
versa. Under some conditions, the stronger affinity IHF IIIa would become filled at 
the expense of the lower affinity IHF II. This  would lead to IHF-mediated 
inhibition. Under other conditions, IHF II would be occupied at the expense of 
IHF IIIa. Since IHF IIIb  is  predicted to sit on the opposite face of the helix from 
IHF II, occupancy of IHF II  would permit the simultaneous occupancy of IHF IIIb. 
This  complex would mediate CRP-dependent activation of acs transcription. The 
following observations support these proposals. (1) Using the crystallographic 
data for IHF bound to H’, a model was constructed for the simultaneous binding 
of two IHF heterodimers to IHF II and IHF IIIb  (Fig. 29).  A similar model for 
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simultaneous binding to IHF II  and IHF IIIa was unsuccessful (Doug Browning, 
personal communication). (2) In the phage system, the 2xIHF construct behaved 
like the 1xIHF construct (Figs. 26-28). It exhibited low activity that depended on 
both CRP II and AR2. In contrast, weakening IHF IIIa and strengthening IHF IIIb 
relative to consensus (the I3m or C152G C150G mutation) caused a much more 
dramatic increase in transcription in the context of 2xIHF than in the context of 
1xIHF (Fig. 27). Thus, the balance between IHF IIIa and IHF IIIb  appears  to be 
the fulcrum controlling transcription from the 2xIHF construct. (3) In the plasmid 
system, the weakening of IHF II in the 2xIHF construct resulted in low activity 
similar to that of the 1xIHF construct. In contrast, strengthening IHF II  caused a 
small increase in activity. (4) Also in the plasmid system, the placement of a 
simple site (IHF II) into the native location of IHF IIIa resulted in poor transcription 
from the 1xIHF construct, while the placement of that same simple site into the 
native location of IHF IIIb  resulted in strong transcription. On the basis  of these 
observations, we hypothesize that binding of IHF to IHF II induces the switch 
from IHF IIIa to IHF IIIb and thus the transition from the stalled unproductive 
complex to a transcriptionally active complex. We further propose that, at the 
native acs promoter, some upstream cis element and/or trans factor helps IHF II 
to dictate whether IHF will bind to IHF IIIa or IHF IIIb  and thus whether acs 
transcription will be inhibited or activated.
The underlying cause(s) of the difference in 2xIHF behavior when assayed 
in the phage and plasmid systems remain(s) unknown. The simplest explanation 
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is  that the different behaviors result from some basic property of plasmids relative 
to a prophage integrated into the chromosome. The two most obvious differences 
are copy number and superhelicity. In the plasmid system, the copy number is 
about one order of magnitude greater than in the phage system. This could result 
in a titration effect that would alter the balance between the trans factors  that 
control acs transcription. Similarly, the superhelicity of a plasmid is  likely different 
than that of a phage genome that has integrated itself into the chromosome. 
Such a difference in superhelicity could have definite consequences on 
transcription because superhelicity influences the binding of transcription factors, 
NAPs, and RNAP. By controlling copy number, one could test its role. There are 
numerous ways to do this, but one of them is a temperature-sensitive expression 
plasmid that permits control of its  average copy number (Lin et al, 1994; 
Hashimoto and Sekiguchi, 1976; Sheridan et al, 1999). We could test the role of 
superhelicity in vivo by using combinations of gyrase and topoisomerase mutants 
and in vitro using templates that possess different states of supercoiling. It should 
be noted that the manipulation of topoismerase and gyrase activity would affect 
the overall health of the cell thus making interpretation difficult.
We are left questioning whether a competition takes place between IHF 
IIIa and IHF IIIb  for IHF binding. Does IIIa help promote transcription whereas IIIb 
exists  to regulate IHF binding to IIIa? If IIIa does indeed enhance transcription, 
then does this mean transcription may be unregulated in the absence of IIIb? 
Does the dynamic nature of IHF III, due to the dual-overlapping sites, help 
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determine when inhibition takes place in conjunction with the available 
components: CRP, protein contacts via AR2, DNA bending by IHF leading the 
“trapping” of RNAP at acsP2? Finally, are there fundamental differences in IHF 
binding affinities between IHF II and IHF IIIa/b? Though intriguing, the answers to 
these questions are beyond the scope of this dissertation.
The Dynamics of Fis- and IHF-dependent Inhibition on CRP-dependent 
Activation 
Previous studies have determined that the binding of CRP to CRP I and 
CRP II  activates transcription (REF). In contrast, two FIS binding sites, one (Fis 
II) that overlaps CRP I  and one (Fis III) situated between both CRP sites, inhibit 
transcription by competing with the binding of the activator CRP (REF). 
Interestingly, a point mutation introduced into CRP I completely disables 
transcription, despite the presence of an intact CRP II. It is clear that acs 
transcription depends upon CRP I and the interaction between RNAP and CRP. 
Any point of regulation would begin with modulating CRP binding to CRP I, in this 
case by Fis occupation of the overlapping Fis II  site. Therefore, inhibition of CRP-
dependent activation takes place through competition when Fis occupies Fis II. In 
contrast, the contribution of Fis III is  currently unknown; but, based on the 
influence of Fis on DNA topology (bend angles from 50 to 90°), the occupation of 
both Fis I and Fis II may incur a change in promoter structure not conducive to 
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CRP binding. As Fis and CRP compete for binding at their overlapping sites, the 
second Fis dimer could tip the balance in favor of inhibition when active CRP 
concentrations are low. This raises the question: if Fis is an effective inhibitor of 
CRP-dependent transcription, why would acs regulation need IHF?
I speculate that fluctuations of intracellular concentrations of Fis and CRP, 
during the course of growth and glucose depletion, will reach a point where there 
are equimolar concentrations  of both proteins and will result in an event where 
neither protein can influence promoter activity. This would lead to RNAP binding 
inducing only basal transcription. Possibly, to overcome this  stalemate the 
presence of IHF, specifically, when bound to IHF III, may be the key to deciding 
the fate of transcription. IHF, whose concentrations are never depleted from the 
cell, but increase during stationary phase, may be the protein that occupies the 
acs promoter region at IHF III more often than CRP, Fis, or RNAP. When Fis 
molecules outnumber active CRP dimers, IHF may remodel the promoter into a 
conformation that promotes Fis-mediated inhibition - possibly when bound to IHF 
IIIa - thus preventing any competition from CRP. The presence of Fis  may allow 
IHF to bind more stably to IHF IIIa based on the downstream distance of both Fis 
sites. However, with IHF still bound, Fis molecules decrease as active CRP 
dimers increase, and with the constant presence IHF, a more active competition 
between Fis  and CRP takes place at the overlapping Fis II/CRP I sites, perhaps 
destabilizing IHF at IHF IIIa. As IHF moves back and forth from IHF IIIa and IHF 
IIIb  it now disfavors Fis and decreases  the effect of Fis I. As the rising 
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concentration of CRP outcompetes Fis, maximal transcription takes place, 
perhaps with IHF now bound to IHF IIIb. However, transcription then comes to a 
halt when active CRP becomes unavailable and IHF concentrations increase 
thereby forming an inhibition loop preventing additional CRP dimer access and 
RNAP promoter escape.
Relevance and Contribution to the Field
 The morphological line that distinguishes eukaryotes from bacteria is 
beginning to blur. The cellular organelles characteristic of eukaryotes might be 
absent in bacteria, but much of their basic organizations are similar. For example, 
it is well established that the cellular processes of eukaryotes  tend to be 
compartmentalized and that specialized cytoskeletal proteins  provide the 
scaffolds that allow these processes to take place without the cell collapsing. In 
the past, compartmentalization and cytoskeletal proteins were thought to be 
absent in bacteria. With the advancement of biological technology, however, the 
gap between the ‘sophistication’ of eukaryotes and the ‘primitiveness’ of bacteria 
has been closing rapidly. For example, early data mining of bacterial genomes 
revealed no obvious homologues  of eukaryotic cytoskeletal proteins. Through the 
use of high resolution imaging methods and fluorescence technology, however, it 
was discovered that bacteria actually do possess cytoskeletal proteins, many of 
which turn out to be distantly related to eukaryotic cytoskeletal proteins. 
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Furthermore, these techniques have been able to resolve subcellular structures.
Likewise, the once defining characteristics of the eukaryotic chromosome 
(i.e. chromosomal multiplicity, ploidy, linearity, transcriptional silencing, 
partitioning, and packaging) also have now been described for bacteria (Bendich 
and Drlica, 2001). For example, it is now clear that the E. coli chromosome is a 
highly compact and organized structure. Despite being compact, it is  very 
dynamic, undergoing massive reorganization to adjust to the environmental 
conditions. Both bacterial and eukaryotic chromosomes are bound by proteins 
that package these enormous structures into the relatively small confines  of the 
cell. However, unlike the eukaryotic chromosome, which has stationary histone 
proteins to wrap and package DNA into the membrane-bound nucleus, the NAPs 
associated with the bacterial chromosome do not remain stationary. Furthermore, 
they perform functions above and beyond packaging. Many of these functions 
are critical for survival.
Interestingly, some NAPs share sequence and/or functional homology with 
eukaryotic histones. For example, HU shares amino acid homology, while H-NS 
shares functional activity with histone H2B. By regulating promoter access and 
DNA topology, histones and NAPs can regulate transcription (Higgins  et al, 2005; 
Rouviere-Yaniv et al, 1979). For example, both histones and NAPs (together with 
topoisomerases) induce DNA looping. This important topological change in DNA 
has consequences for genomic compaction and thus transcription regulation. In 
transcription, these domains act as a barrier, confining gene expression to a 
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particular gene, operon, or region. They also provide a structure more conducive 
to transcription. In bacteria, these loop-domains also protect the integrity of a 
functional chromosomal structure. If a nick in the DNA double strand occurs 
within a negatively supercoiled loop, the rest of the chromosome is insulated 
from this potentially detrimental event. In contrast, a nick in plasmid DNA relaxes 
its structure, rendering it transcriptionally inactive (Postow et al, 2006). 
Eukaryotic and bacterial promoters also share structural similarities, e.g. 
low stability, higher curvature, and bendability (Kanhere and Bansal, 2005). The 
transcriptional machinery, the RNAP holoenzyme, first must gain access to the 
promoter and then bind to the appropriate sequences. Promoter activity is 
dependent on cis and trans factors. The sequences of the -35 and -10 hexamers 
in bacteria and the TATA and CAAT boxes  in eukaryotes are identified consensus 
sites for RNAP binding. The relative promoter strength correlates  with the 
similarity of a given promoter sequence to the consensus sequence of these 
hexamers and boxes. For example, a weak promoter generally possesses poor 
resemblance to consensus. At such promoters, an activator is  generally needed 
to stabilize the interaction of the RNAP with the promoter. In contrast, a strong 
promoter generally shares much similarity with consensus. Such promoters are 
often repressed by the binding of a transcription factor to a DNA site adjacent to 
or overlapping the transcription initiation site (+1), the -10 hexamer or the -35 
hexamer.  
In addition to the basic principles  of promoter recognition and binding of 
 167
the RNAP holoenzyme, the next set of steps that lead to transcription are similar 
in all organisms. For example, in all organisms, the binding of RNAP results in 
closed complex formation followed by formation of an open complex around the 
-10 hexamer (the TATA box in eukaryotes). The low stability of the AT-rich 
sequence allows for the strand separation of the DNA duplex characteristic of 
open complex formation, which permits RNAP to begin ribonucleotide 
polymerization. An assessment of the region upstream of the transcription start 
site reveals a propensity for DNA curvature. This curvature promotes RNAP and 
transcription factor binding and thus transcription. Upon binding, RNAP, as  well 
as  some transcription factors, wraps the DNA around itself, perhaps for a more 
stable interaction. The bendability of the DNA strand also brings  distant upstream 
enhancer sequences with their associated proteins into close proximity to the 
RNAP. 
It is generally accepted that eukaryotic promoters are very complex, often 
encoding many sites for the binding of a multitude of transcription and accessory 
factors. In contrast, the early (and too often prevailing) view of bacterial 
promoters suggested a simple mechanism of activation, where one transcription 
factor (activator or inhibitor) influences RNAP function (see above). Yet, a survey 
of bacterial promoters demonstrates the existence of both simple and complex 
promoters. Within a complex bacterial promoter there can be many binding sites 
for a variety of DNA binding proteins, as  well as multiple start sites, enhancer 
sequences, and regions of DNA recombination. The location of these features 
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within a promoter provides the platform that determines the mechanism of 
regulation.
The information gathered from the studies described in this dissertation 
expands our knowledge of the complex acs promoter and bacterial gene 
regulation, in general. My dissection of the complex nrf-acs intergenic region 
allows us  to build on the general knowledge of bacterial transcription and 
contribute insight into the rules  of promoter design that Nature has  encoded into 
DNA regulatory regions. 
Not surprisingly, the multifaceted nature of NAPs is location-dependent 
and is influenced by proteins bound upstream and downstream of the promoter. 
For example, IHF bound to a single site located midway between an enhancer 
activation sequence (UAS) 100 bp upstream and the downstream RNAP site in 
the Pu promoter behaves as an activator of transcription. It does so by folding the 
DNA, thereby bringing the UAS into close proximity to RNAP. Eliminating IHF 
binding to this site shuts off transcription. However, replacing this IHF site with a 
DNA sequence with an intrinsic bend compensates  for the loss of IHF. Similarly, 
IHF activates transcription at the ilv promoter, also by bending the DNA and 
repositioning a UAS (Sheridan et al, 1999). Indeed, DNA remodeling by IHF is  so 
profound that it has the capability of inducing V(D)J recombination in !RAG B-
cells.
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In contrast, IHF can also behave as an inhibitor. For example, at the ilvPG1 
promoter, the IHF binding site at this promoter overlaps that of RNAP, these sites 
are not located on the same face of the DNA helix. Thus, although IHF occludes 
RNAP binding, it does not do so through physical occlusion. Instead, it remodels 
the DNA structure, preventing RNAP from gaining access to the promoter. 
In this  dissertation, I provided evidence that supports the existing notion 
that the location of an IHF protein binding is just as important as the affinity of 
that site for IHF. What is  novel is  the discovery of a composite IHF site (IHF III) 
comprised of two inverted and overlapping sites. This  dissertation also reports 
the ability of an upstream, contiguous site (IHF II) that can counteract the 
inhibitory effect of IHF III, presumably by guiding IHF to bind to IHF IIIb, which 
appears to function as a positive effector of acs transcription, instead of IHF IIIa, 
which appears to be a negative effector.  The most pressing issue is  how IHF II 
becomes occupied. In the context of the 2xIHF promoter construct, activation 
required expression from a highly supercoiled multicopy plasmid or disruption of 
IHF IIIa. The mechanism by which IHF II becomes occupied in the native acs 
context requires further exploration.
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